CHURCH & DWIGHT CO INC /DE/, 10-K filed on 2/12/2026
Annual Report
v3.25.4
Document and Entity Information - USD ($)
$ in Billions
 12 Months Ended
Dec. 31, 2025
Feb. 09, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2025    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Trading Symbol CHD    
Entity Registrant Name CHURCH & DWIGHT CO., INC.    
Entity Central Index Key 0000313927    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   236,694,241  
Entity Public Float     $ 22.9
Title of 12(b) Security Common Stock, $1 par value    
Security Exchange Name NYSE    
Entity File Number 1-10585    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 13-4996950    
Entity Address, Address Line One 500 Charles Ewing Boulevard    
Entity Address, City or Town Ewing    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 08628    
City Area Code 609    
Local Phone Number 806-1200    
Document Annual Report true    
Document Transition Report false    
Auditor Name DELOITTE & TOUCHE LLP    
Auditor Location Morristown, NJ    
Auditor Firm ID 34    
Documents Incorporated by Reference

Documents Incorporated by Reference

Certain provisions of the registrant’s definitive proxy statement to be filed not later than April 30, 2026 are incorporated by reference in Items 10 through 14 of Part III of this Annual Report on Form 10‑K (this “Annual Report”). 		   
Auditor Opinion [Text Block]

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Church & Dwight Co., Inc. and subsidiaries (the "Company") as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2025, of the Company and our report dated February 12, 2026, expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

   
v3.25.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net Sales $ 6,203.2 $ 6,107.1 $ 5,867.9
Cost of sales 3,428.4 3,317.0 3,279.4
Gross Profit 2,774.8 2,790.1 2,588.5
Marketing expenses 708.9 698.1 641.3
Selling, general and administrative expenses 988.3 927.8 889.8
VMS Trade name and other asset impairments   357.1  
Income from Operations 1,077.6 807.1 1,057.4
Equity in earnings of affiliates 7.9 9.1 8.7
Interest income 23.5 26.3 13.0
Interest expense (95.2) (95.0) (110.9)
Other income (expense), net (56.9) 8.8 (0.8)
Income before Income Taxes 956.9 756.3 967.4
Income taxes 220.1 171.0 211.8
Net Income $ 736.8 $ 585.3 $ 755.6
Weighted average shares outstanding - Basic 242,700,000 244,400,000 244,900,000
Weighted average shares outstanding - Diluted 244,300,000 246,900,000 247,600,000
Net income per share - Basic $ 3.04 $ 2.39 $ 3.09
Net income per share - Diluted 3.02 2.37 3.05
Cash dividends per share $ 1.18 $ 1.13 $ 1.09
VMS Trade Name [Member]      
VMS Trade name and other asset impairments $ 0.0 $ 357.1 $ 0.0
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net Income (Loss) $ 736.8 $ 585.3 $ 755.6
Other comprehensive income, net of tax:      
Foreign exchange translation adjustments 21.9 (15.4) 8.6
Defined benefit plan gain (loss) 0.4 (0.2) 2.9
Income (loss) from derivative agreements (11.3) 11.9 (9.4)
Other comprehensive income (loss) 11.0 (3.7) 2.1
Comprehensive income $ 747.8 $ 581.6 $ 757.7
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 409.0 $ 964.1
Accounts receivable, less allowances of $3.7 and $5.1 593.4 600.8
Inventories 534.8 613.3
Other current assets 59.8 62.4
Total Current Assets 1,597.0 2,240.6
Property, Plant and Equipment, Net 822.8 [1] 931.7
Equity Investment in Affiliates 10.3 11.1
Trade Names and Other Intangibles, Net 3,511.5 2,888.5
Goodwill 2,627.5 2,433.2
Other Assets 343.3 378.0
Total Assets 8,912.4 8,883.1
Current Liabilities    
Accounts payable 732.4 705.1
Accrued expenses and other liabilities 583.0 605.5
Business acquisition liabilities 178.9 0.0
Income taxes payable 3.4 5.3
Total Current Liabilities 1,497.7 1,315.9
Long-term Debt 2,205.1 2,204.6
Deferred Income Taxes 886.9 669.2
Deferred and Other Long-term Liabilities 320.5 332.6
Total Liabilities 4,910.2 4,522.3
Commitments and Contingencies
Stockholders' Equity    
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued 0.0 0.0
Common Stock, $1.00 par value, Authorized 600,000,000 shares; 293,709,982 shares issued as of December 31, 2025 and 2024 293.7 293.7
Additional paid-in capital 625.1 563.1
Retained earnings 6,768.2 6,319.7
Accumulated other comprehensive loss (19.9) (30.9)
Common stock in treasury, at cost: 57,156,105 shares as of December 31, 2025 and 47,830,141 shares as of December 31, 2024 (3,664.9) (2,784.8)
Total Stockholders' Equity 4,002.2 4,360.8
Total Liabilities and Stockholders’ Equity $ 8,912.4 $ 8,883.1
[1] In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 3.7 $ 5.1
Preferred Stock, par value $ 1 $ 1
Preferred Stock, Authorized 2,500,000 2,500,000
Preferred Stock, issued 0 0
Common Stock, par value $ 1 $ 1
Common Stock, Authorized 600,000,000 600,000,000
Common stock restricted shares 293,709,982 293,709,982
Common Stock in Treasury 57,156,105 47,830,141
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flow From Operating Activities      
Net Income (Loss) $ 736.8 $ 585.3 $ 755.6
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation expense 89.7 83.2 72.8
Amortization expense 157.7 155.9 152.4
Change in fair value of business acquisition liabilities 19.0 0.0 0.0
Deferred income taxes 36.0 (82.0) (13.8)
Business exit related impairments 45.6 0.0 0.0
VMS Trade name and other asset impairments   357.1  
Loss on sale of vitamin business 58.5 0.0 0.0
Equity in net earnings of affiliates (7.9) (9.1) (8.7)
Distributions from unconsolidated affiliates 8.8 8.9 9.5
Non-cash compensation expense 58.0 59.2 63.6
Asset impairment charge and other asset write-offs 10.1 12.1 8.9
Other (6.7) (6.2) (0.4)
Subtotal 1,205.6 1,164.4 1,039.9
Change in assets and liabilities:      
Accounts receivable 39.4 (81.5) (97.4)
Inventories 56.1 2.0 38.5
Other current assets 1.2 (0.5) 10.4
Accounts payable 2.4 98.6 (58.1)
Accrued expenses (60.9) (1.1) 113.3
Income taxes payable (5.1) (7.1) (1.8)
Other operating assets and liabilities, net (23.3) (18.6) (14.2)
Change in Working Capital 9.8 (8.2) (9.3)
Net Cash Provided By Operating Activities 1,215.4 1,156.2 1,030.6
Cash Flow From Investing Activities      
Additions to property, plant and equipment (122.4) (179.8) (223.5)
Acquisitions (656.0) (19.9) 0.0
Proceeds from Sale of Passport 0.0 6.6 0.0
Proceeds from Sale of Vitamin Business 160.3 0.0 0.0
Other 1.2 9.8 (10.8)
Net Cash Used In Investing Activities (616.9) (183.3) (234.3)
Cash Flow From Financing Activities      
Repayments of long-term debt 0.0 (204.6) (200.0)
Short-term debt (repayments), net of borrowings 0.0 (3.6) (70.6)
Proceeds from stock options exercised 35.6 142.9 111.7
Payment of cash dividends (287.2) (277.0) (266.5)
Purchase of treasury stock (900.0) 0.0 (300.1)
Payment of business acquisition liability (5.9) 0.0 0.0
Other (4.9) (1.1) (0.1)
Net Cash Used In Financing Activities (1,162.4) (343.4) (725.6)
Effect of exchange rate changes on cash and cash equivalents 8.8 (9.9) 3.5
Net Change In Cash and Cash Equivalents (555.1) 619.6 74.2
Cash and Cash Equivalents at Beginning of Period 964.1 344.5 270.3
Cash and Cash Equivalents at End of Period 409.0 964.1 344.5
Cash paid during the year for:      
Interest (net of amounts capitalized) 94.6 94.4 111.9
Income taxes 188.1 259.6 228.2
Supplemental disclosure of non-cash investing activities:      
Property, plant and equipment expenditures included in Accounts Payable 16.9 10.6 30.7
VMS Trade Name [Member]      
Adjustments to reconcile net income to net cash provided by operating activities:      
VMS Trade name and other asset impairments $ 0.0 $ 357.1 $ 0.0
v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock, Common [Member]
Beginning Balance at Dec. 31, 2022 $ 3,489.9 $ 293.7 $ 366.2 $ 5,524.6 $ (29.3) $ (2,665.3)
Beginning Balance (in shares) at Dec. 31, 2022   293,700,000        
Beginning Balance (in shares) at Dec. 31, 2022           (49,800,000)
Net Income (Loss) 755.6     755.6    
Other comprehensive income (loss) 2.1       2.1  
Cash dividends (266.5)     (266.5)    
Stock purchases (300.1)         $ (300.1)
Stock purchases (in shares)           (3,300,000)
Stock based compensation expense and stock option plan transactions 174.4   88.6 (1.4)   $ 87.2
Stock based compensation expense and stock option plan transactions (in shares)           2,500,000
Ending Balance at Dec. 31, 2023 3,855.4 $ 293.7 454.8 6,012.3 (27.2) $ (2,878.2)
Ending Balance (in shares) at Dec. 31, 2023   293,700,000        
Ending Balance (in shares) at Dec. 31, 2023           50,600,000
Net Income (Loss) 585.3     585.3    
Other comprehensive income (loss) (3.7)       (3.7)  
Cash dividends (277.0)     (277.0)    
Stock based compensation expense and stock option plan transactions 200.8 $ 0.0 108.3 (0.9) 0.0 $ 93.4
Stock based compensation expense and stock option plan transactions (in shares)   0       2,800,000
Ending Balance at Dec. 31, 2024 $ 4,360.8 $ 293.7 563.1 6,319.7 (30.9) $ (2,784.8)
Ending Balance (in shares) at Dec. 31, 2024   293,700,000        
Ending Balance (in shares) at Dec. 31, 2024 47,830,141         (47,800,000)
Net Income (Loss) $ 736.8     736.8    
Other comprehensive income (loss) 11.0       11.0  
Cash dividends (287.2)     (287.2)    
Stock purchases (909.1)   (9.1)     $ (900.0)
Stock based compensation expense and stock option plan transactions 89.9   71.1 (1.1)   $ 19.9
Stock based compensation expense and stock option plan transactions (in shares)           (9,400,000)
Ending Balance at Dec. 31, 2025 $ 4,002.2 $ 293.7 $ 625.1 $ 6,768.2 $ (19.9) $ (3,664.9)
Ending Balance (in shares) at Dec. 31, 2025   293,700,000        
Ending Balance (in shares) at Dec. 31, 2025 57,156,105         (57,200,000)
v3.25.4
Pay vs Performance Disclosure - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure      
Net Income (Loss) $ 736.8 $ 585.3 $ 755.6
v3.25.4
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.4
Cybersecurity Risk Management, Strategy, and Governance
 12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]

ITEM 1C. CYBERSECURITY

 

Cybersecurity Risk Management and Strategy

We collect, use and store personal information of our employees, consumers and other third parties in the ordinary course of business. In addition, we sell certain products directly to consumers online and through websites, mobile apps and connected devices, and we offer promotions, rebates, loyalty and other programs through which our data systems may receive personal information. We recognize the importance of data privacy and security and are committed to safeguarding and protecting our information and any other information entrusted to us. We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information which is integrated with our overall risk management program. Our cybersecurity risk management program includes a cybersecurity incident response plan to respond to security breaches and cyberattacks. Our cybersecurity incident response plan is part of our overall Information Security Program, which is led by the Company’s Vice President, Global Chief Information Security Officer (“CISO”) and overseen by the Company’s Executive Vice President, Chief Technology & Analytics Officer, and is designed to protect and preserve the confidentiality, integrity and continued availability of all information owned by, or in the care of, the Company, and the Company’s ability to operate. Our cybersecurity incident response plan includes controls and procedures for timely and accurate reporting of any material cybersecurity incident. We design and assess our program based on the National Institute of Standards and Technology (NIST) Cybersecurity Framework (CSF).

Our cybersecurity risk management program includes:

•
risk assessments designed to help identify material cybersecurity risks to our critical systems, information, products, services, and our global enterprise IT environment;
•
a security team responsible for managing our (1) cybersecurity risk assessment processes, (2) security controls, and (3) response to security breaches and cyberattacks;
•
the use of external service providers, where appropriate, to assess, perform tabletop exercises or otherwise assist with aspects of our security controls and designed to anticipate cyberattacks and respond to breaches, including a biennial maturity assessment of our program by an external third-party;
•
cybersecurity information security awareness training that all employees, including the Executive Leadership Team and independent contractors who have a Church & Dwight email address participate in annually, to help them better understand the issues and risks relative to cybersecurity, as well as data privacy (for our employees). We have also conducted training programs for our Board of Directors to enhance Directors’ literacy on information security issues;
•
periodically throughout the year, our IT department performs phishing and other exercises to both test our systems and reinforce training of our personnel;
•
a cybersecurity incident response plan managed by our CISO that includes procedures for responding to cybersecurity incidents and is designed to protect and preserve the confidentiality, integrity and continued availability of all information possessed by the Company;
•
policies to establish requirements for protecting information assets and defining acceptable behaviors to ensure compliance, mitigate risks, prevent unauthorized access, and foster a culture of security awareness and accountability, thereby enhancing the organization's overall security posture; and
•
a third-party risk management process for service providers, suppliers, and vendors.

We have not experienced any material cybersecurity events or incidents. Although third party service providers that we engage have encountered cybersecurity events or incidents during the year ended December 31, 2025, our investigation of each event or incident concluded that these occurrences have not resulted in a material impact on our systems, computing environments, customers, or data. We follow our cybersecurity incident response plan, to monitor for threats when a third-party we use experience a cyberattack. We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected or are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or cash flows.

 

Cybersecurity Governance

Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to the Audit Committee oversight of cybersecurity and other information technology risks. The Audit Committee oversees management’s implementation of our cybersecurity risk management program, including reviewing risk assessments from management with respect to our information technology systems and procedures, and overseeing our cybersecurity risk management processes.

The Audit Committee, which is tasked with oversight of certain risk issues, including cybersecurity, receives reports from the Executive Vice President, Chief Technology & Analytics Officer and the Vice President, Chief Information Security Officer each quarter. At least annually, the Board of Directors and the Audit Committee also receive updates about the results of exercises and response readiness assessments led by outside advisors who provide a third-party independent assessment of our technical program and our internal response preparedness. The Audit Committee regularly briefs the full Board of Directors on these matters, and the full Board also receives periodic briefings regarding our Information Security Program and cyber threats, including threats faced by our peers, in order to enhance our directors’ literacy on cyber issues. In addition, management will update the Audit Committee, as necessary, regarding cybersecurity incidents that we may experience.

Our management team, including our Executive Vice President, Chief Technology & Analytics Officer, is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and oversees both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our management team’s cybersecurity risk management is led by our CISO, who has significant experience across digital innovation and technology-enabled growth, information security, infrastructure, operations and compliance.

Our management team supervises efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which include briefings from internal security personnel; threat intelligence and other information obtained from governmental, law enforcement, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in the IT environment.

Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] We collect, use and store personal information of our employees, consumers and other third parties in the ordinary course of business. In addition, we sell certain products directly to consumers online and through websites, mobile apps and connected devices, and we offer promotions, rebates, loyalty and other programs through which our data systems may receive personal information. We recognize the importance of data privacy and security and are committed to safeguarding and protecting our information and any other information entrusted to us. We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information which is integrated with our overall risk management program.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]

Cybersecurity Governance

Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to the Audit Committee oversight of cybersecurity and other information technology risks. The Audit Committee oversees management’s implementation of our cybersecurity risk management program, including reviewing risk assessments from management with respect to our information technology systems and procedures, and overseeing our cybersecurity risk management processes.

The Audit Committee, which is tasked with oversight of certain risk issues, including cybersecurity, receives reports from the Executive Vice President, Chief Technology & Analytics Officer and the Vice President, Chief Information Security Officer each quarter. At least annually, the Board of Directors and the Audit Committee also receive updates about the results of exercises and response readiness assessments led by outside advisors who provide a third-party independent assessment of our technical program and our internal response preparedness. The Audit Committee regularly briefs the full Board of Directors on these matters, and the full Board also receives periodic briefings regarding our Information Security Program and cyber threats, including threats faced by our peers, in order to enhance our directors’ literacy on cyber issues. In addition, management will update the Audit Committee, as necessary, regarding cybersecurity incidents that we may experience.

Our management team, including our Executive Vice President, Chief Technology & Analytics Officer, is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and oversees both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our management team’s cybersecurity risk management is led by our CISO, who has significant experience across digital innovation and technology-enabled growth, information security, infrastructure, operations and compliance.

Our management team supervises efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which include briefings from internal security personnel; threat intelligence and other information obtained from governmental, law enforcement, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in the IT environment.

Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] The Audit Committee oversees management’s implementation of our cybersecurity risk management program, including reviewing risk assessments from management with respect to our information technology systems and procedures, and overseeing our cybersecurity risk management processes.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The Audit Committee, which is tasked with oversight of certain risk issues, including cybersecurity, receives reports from the Executive Vice President, Chief Technology & Analytics Officer and the Vice President, Chief Information Security Officer each quarter
Cybersecurity Risk Role of Management [Text Block]

The Audit Committee, which is tasked with oversight of certain risk issues, including cybersecurity, receives reports from the Executive Vice President, Chief Technology & Analytics Officer and the Vice President, Chief Information Security Officer each quarter. At least annually, the Board of Directors and the Audit Committee also receive updates about the results of exercises and response readiness assessments led by outside advisors who provide a third-party independent assessment of our technical program and our internal response preparedness. The Audit Committee regularly briefs the full Board of Directors on these matters, and the full Board also receives periodic briefings regarding our Information Security Program and cyber threats, including threats faced by our peers, in order to enhance our directors’ literacy on cyber issues. In addition, management will update the Audit Committee, as necessary, regarding cybersecurity incidents that we may experience.

Our management team, including our Executive Vice President, Chief Technology & Analytics Officer, is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and oversees both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our management team’s cybersecurity risk management is led by our CISO, who has significant experience across digital innovation and technology-enabled growth, information security, infrastructure, operations and compliance.

Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our management team, including our Executive Vice President, Chief Technology & Analytics Officer, is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and oversees both our internal cybersecurity personnel and our retained external cybersecurity consultants.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our management team’s cybersecurity risk management is led by our CISO, who has significant experience across digital innovation and technology-enabled growth, information security, infrastructure, operations and compliance.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]

Our management team supervises efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which include briefings from internal security personnel; threat intelligence and other information obtained from governmental, law enforcement, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in the IT environment.

v3.25.4
Significant Accounting Policies
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Significant Accounting Policies
1.
Significant Accounting Policies

Business

The Company, founded in 1846, develops, manufactures and markets a broad range of household, personal care and specialty products focused on animal productivity, chemicals and cleaners. The Company sells its consumer products under a variety of brands through a broad distribution platform that includes supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar, pet and other specialty stores and websites and other e-commerce channels, all of which sell the products to consumers. The Company also sells specialty products to industrial customers, livestock producers and through distributors.

Basis of Presentation

 

The accompanying Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the U.S. (“US GAAP”) and include the accounts of the Company and its majority‑owned subsidiaries. Material subsequent events are evaluated and disclosed through the report issuance date. For equity investments in which the Company does not control or have the ability to exert significant influence over the investee, which generally is when the Company has less than a 20% ownership interest, the investments are accounted for under the cost method. In circumstances where the Company has greater than a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee, the investment is accounted for under the equity method. As a result, the Company accounts for its 50% interest in its Armand Products Company (“Armand”) joint venture and its 50% interest in The ArmaKleen Company (“ArmaKleen”) joint venture under the equity method. The Company's 50% interest in ArmaKleen was sold to our joint venture partner in October of 2024. Armand and ArmaKleen are specialty chemical businesses. The Company’s equity in earnings of Armand and ArmaKleen are not reflected in a reportable segment.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Management makes estimates regarding inventory valuation, promotional and sales returns reserves, the carrying amount of goodwill and other intangible assets, the realization of deferred tax assets, tax reserves, business acquisition liabilities, liabilities related to other postretirement benefit obligations and other matters that affect the reported amounts and other disclosures in the financial statements. These estimates are based on judgment and available information. Actual results could differ materially from those estimates, and it is possible that changes in such estimates could occur in the near term.

Revenue Recognition

Revenue is recognized when control of a promised good is transferred to a customer in an amount that reflects the consideration that the Company expects to be entitled to in exchange for that good. This usually occurs when finished goods are delivered to the Company’s customers or when finished goods are picked up by a customer or a customer’s carrier.

a.
Nature of Goods and Services

The Company primarily ships finished goods to its customers and operates in three segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”). The segments are based on differences in the nature of products and management organizational structures. The Consumer Domestic and Consumer International segments market a variety of personal care, household and over-the-counter products, including but not limited to baking soda, cat litter, laundry detergent, condoms, stain removers, hair removal, gummy dietary supplements, dry shampoo, oral care, cold remedy, acne treatment, and water flossers. The SPD segment focuses on sales to businesses and participates in three product areas: Animal Nutrition, Specialty Chemicals and Commercial & Professional. The Company’s products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation.

The Company sells consumer products under a variety of brands through a broad distribution platform that includes supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar, pet and other specialty stores and websites and other e-commerce channels, all of which sell its products to consumers. The Company sells its specialty products to industrial customers, livestock producers and through distributors.

Refer to Note 18 for disaggregated revenue information with respect to each of the Company’s segments.

 

 

b.
When Performance Obligations are Satisfied

For performance obligations related to the shipping and invoicing of products, control transfers at the point in time upon which finished goods are delivered to the Company’s customers or when finished goods are picked up by a customer or a customer’s carrier. Once a product has been delivered or picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to have transferred upon delivery or customer receipt because the Company has an enforceable right to payment at that time, the customer has legal title to the asset, the Company has transferred physical possession of the asset, and the customer has significant risk and rewards of ownership of the asset.

c.
Variable Consideration

The Company conducts extensive promotional activities, primarily through the use of off-list discounts, slotting, coupons, cooperative advertising, periodic price reduction arrangements, and end-aisle and other in-store displays. The costs of such activities are netted against sales and are recorded when the related sale takes place. The reserves for sales returns and consumer and trade promotion liabilities are established based on the Company’s best estimate of the amounts necessary to settle future and existing obligations for products sold as of the balance sheet date. The Company uses historical trend experience and coupon redemption inputs in arriving at coupon reserve requirements, and uses forecasted appropriations, customer and sales organization inputs, and historical trend analysis in determining the reserves for other promotional activities and sales returns.

d.
Practical Expedients

The Company expenses incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. These costs are recorded in SG&A expenses in the accompanying consolidated statements of income.

The Company accounts for shipping and handling costs as fulfillment activities which are therefore recognized upon shipment of the goods.

The Company has applied the portfolio approach to all open contracts as they have similar characteristics and can reasonably expect that the effects on the financial statements of applying this guidance to the portfolio of contracts would not differ materially from applying this guidance to the individual contracts within the portfolio.

The Company excludes from its revenue any amounts collected from customers for sales (and similar) taxes.

Sales of Accounts Receivable

The Company entered into a factoring agreement with a financial institution to sell certain customer receivables at discounted rates in 2015. Transactions under this agreement are accounted for as sales of accounts receivable and are removed from the Consolidated Balance Sheet at the time of the sales transaction. The level of customers associated with the Company’s factoring program and the sales performance by those customers has driven the amount factored each year. The total amount factored in each year was $100.5, $105.9, and $144.2 during the years ended December 31, 2025, 2024 and 2023, respectively.

Cost of Sales, Marketing and Selling, General and Administrative Expenses

Cost of sales include costs related to the manufacture and distribution of the Company’s products, including raw material, inbound freight, import duties and tariffs, direct labor (including employee compensation benefits) and indirect plant costs such as plant supervision, receiving, inspection, maintenance labor and materials, depreciation, taxes and insurance, purchasing, production planning, operations management, logistics, freight to customers, warehousing costs, internal transfer freight costs and plant impairment charges.

Marketing expenses include costs for advertising (excluding the costs of cooperative advertising programs, which are reflected in net sales), costs for coupon insertion (mainly the cost of printing and distribution), consumer promotion costs (such as on-shelf advertisements and floor ads), public relations, package design expense and market research costs.

Selling, general and administrative (“SG&A”) expenses include, among others, costs related to functions such as sales, corporate management, research and development, marketing administration, information technology, finance and legal. Such costs include salary compensation related costs (such as benefits, incentive compensation and profit sharing), stock-based award costs, depreciation, travel and entertainment related expenses, professional and other consulting fees and amortization of intangible assets.

 

Foreign Currency Translation

Unrealized gains and losses related to currency translation are recorded in Accumulated Other Comprehensive Income (Loss). Gains and losses on foreign currency transactions are recorded in the Consolidated Statements of Income.

Cash Equivalents

Cash equivalents consist of highly liquid short-term investments and term bank deposits, which mature within three months of their original maturity date.

Inventories

Inventories are valued at the lower of cost or market (net realizable value, which reflects any costs to sell or dispose). The Company identifies any slow moving, obsolete or excess inventory to determine whether an adjustment is required to establish a new carrying value. The determination of whether inventory items are slow moving, obsolete or in excess of needs requires estimates and assumptions about the future demand for the Company’s products, technological changes, and new product introductions. Estimates as to the future demand used in the valuation of inventory involve judgments regarding the ongoing success of the Company’s products. The Company evaluates its inventory levels and expected usage on a periodic basis and records adjustments as required. Adjustments to reflect inventory at net realizable value were $33.5 at December 31, 2025, and $45.2 at December 31, 2024.

Property, Plant and Equipment

Property, Plant and Equipment (“PP&E”) are stated at cost. Depreciation is recorded using the straight-line method over the estimated useful lives of the respective assets. Estimated useful lives for building and improvements, machinery and equipment, and office equipment range from 9-40, 3-20 and 3-10 years, respectively. Routine repairs and maintenance are expensed when incurred. Leasehold improvements are depreciated over a period no longer than the respective lease term, except where a lease renewal has been determined to be reasonably assured and failure to renew the lease results in a significant penalty to the Company.

PP&E is reviewed annually and whenever events or changes in circumstances indicate that possible impairment exists. The Company’s impairment review is based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of Company assets and liabilities. The analysis requires management judgment with respect to changes in technology, the continued success of product lines, and future volume, revenue and expense growth rates. The Company conducts annual reviews to identify idle and underutilized equipment, and reviews business plans for possible impairment. An indication of impairment occurs when the carrying value of the asset exceeds the future undiscounted cash flows. When an impairment is indicated, the estimated future cash flows are then discounted to determine the estimated fair value of the asset and an impairment charge is recorded for the difference between the carrying value and the net present value of estimated future cash flows.

Software

The Company capitalizes certain costs of developing computer software. Amortization is recorded using the straight‑line method over the estimated useful life of the software, which is estimated to be no longer than 10 years.

Fair Value of Financial Instruments

Certain financial instruments are required to be recorded at fair value. The estimated fair values of such financial instruments (including investment securities and other derivatives) have been determined using market information and generally accepted valuation methodologies. Changes in assumptions or estimation methods could affect the fair value estimates. Other financial instruments, including cash equivalents and short-term debt, are recorded at cost, which approximates fair value. Additional information regarding the Company’s risk management activities, including derivative instruments and hedging activities, is separately disclosed. See Notes 2 and 3.

Goodwill and Other Intangible Assets

The Company has intangible assets of substantial value on its consolidated balance sheet. Intangible assets are generally related to intangible assets with a useful life, indefinite-lived trade names and goodwill. The Company determines whether an intangible asset (other than goodwill) has a useful life based on multiple factors, including how long the Company intends to generate cash flows from the asset.

Carrying values of goodwill and indefinite-lived trade names are reviewed periodically for possible impairment. The Company’s impairment analysis is based on a discounted cash flow approach that requires significant judgment with respect to unit volume, revenue and expense growth rates, and the selection of an appropriate discount rate and royalty rate. Management uses estimates based on expected trends in making these assumptions. With respect to goodwill, impairment occurs when the carrying value of the reporting unit exceeds the discounted present value of cash flows for that reporting unit. For trade names and other intangible assets, an impairment charge is recorded

for the difference between the carrying value and the net present value of estimated future cash flows, which represents the estimated fair value of the asset. Judgment is required in assessing whether assets may have become impaired between annual valuations. Indicators such as unexpected adverse economic factors, unanticipated technological change, distribution losses, or competitive activities and acts by governments and courts may indicate that an asset has become impaired. Intangible assets with finite lives are amortized over their estimated useful lives, which range from 3-20 years, using the straight-line method, and reviewed for impairment when changes in market circumstances occur.

Research and Development

The Company incurred research and development expenses in the amount of $145.6, $139.7 and $122.4 in 2025, 2024 and 2023, respectively. These expenses are included in SG&A expenses and are expensed as incurred.

Earnings Per Share (“EPS”)

Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted-average number of shares outstanding during the reported period. Diluted EPS includes dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options. The following table sets forth a reconciliation of the weighted-average number of shares of Common Stock outstanding to the weighted-average number of shares outstanding on a diluted basis:

 

2025

 

 

2024

 

 

2023

 

Weighted average common shares outstanding - basic

 

242.7

 

 

 

244.4

 

 

 

244.9

 

Dilutive effect of stock options

 

1.6

 

 

 

2.5

 

 

 

2.7

 

Weighted average common shares outstanding - diluted

 

244.3

 

 

 

246.9

 

 

 

247.6

 

Antidilutive stock options outstanding

 

2.1

 

 

 

1.1

 

 

 

2.6

 

Employee and Director Stock Based Compensation

The fair value of stock-based compensation is determined at the grant date and the related expense is generally recognized over the required employee service period in which the share-based compensation vests. For employees and Directors that meet retirement eligibility requirements, the expense related to stock-based compensation is recognized on the date of grant as there is no service period required to vest in the awards. The following table presents the pre-tax expense associated with the fair value of stock awards included in SG&A expenses and in cost of sales:

 

 

For the Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Cost of sales

$

2.8

 

 

$

3.9

 

 

$

3.4

 

Selling, general and administrative expenses

 

54.2

 

 

 

56.2

 

 

 

61.5

 

Total

$

57.0

 

 

$

60.1

 

 

$

64.9

 

 

Income and Other Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized to reflect the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the differences are expected to be recovered or settled. Management provides a valuation allowance against deferred tax assets for amounts which are not considered “more likely than not” to be realized. The Company records liabilities for potential assessments in various tax jurisdictions in accordance with GAAP. The liabilities relate to tax return positions that, although supportable by the Company, may be challenged by the tax authorities and do not meet the minimum recognition threshold required under applicable accounting guidance for the related tax benefit to be recognized in the income statement. The Company adjusts this liability as a result of changes in tax legislation, interpretations of laws by courts, rulings by tax authorities, changes in estimates and the expiration of the statute of limitations. Many of the judgments involved in adjusting the liability involve assumptions and estimates that are highly uncertain and subject to change. In this regard, settlement of any issue with, or an adverse determination in litigation against, a taxing authority could require the use of cash and result in an increase in the Company’s annual effective tax rate. Conversely, favorable resolution of an issue with a taxing authority would be recognized as a reduction to the Company’s annual effective tax rate.

The Company elected to record the payment of excise tax associated with Treasury Stock purchases in the financing section of the cash flow in accordance with ASC 230.

Recently Adopted Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The standard was effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company has adopted the standard retrospectively to all prior periods in the financial statements, which resulted in additional disclosures. Refer to Note 18 for additional information.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosure which includes amendments that further expand income tax disclosures, by requiring the disaggregation of information in the rate reconciliation table, and income taxes paid by jurisdiction. The amendments are effective for fiscal years beginning after December 15, 2024. The Company has elected to adopt ASU 2023-09 prospectively beginning in fiscal year 2025. As a result, the rate reconciliation disclosure for fiscal years 2023 and 2024 will remain unchanged, and the expanded disaggregation requirements are reflected in these financial statements. Refer to footnote 12.

Recent Accounting Pronouncements Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). The ASU requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including purchases of inventory, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. ASU 2024-03, as clarified by ASU 2025-01 is effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with prospective or retrospective application permitted. The Company is currently evaluating the impact of adoption on the Company’s related disclosures.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
v3.25.4
Fair Value Measurements
 12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements
2.
Fair Value Measurements

Fair Value Hierarchy

Accounting guidance on fair value measurements and disclosures establishes a hierarchy that prioritizes the inputs used to measure fair value (generally, assumptions that market participants would use in pricing an asset or liability) based on the quality and reliability of the information provided by the inputs, as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

Fair Values of Other Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at December 31, 2025 and 2024:

 

 

 

December 31, 2025

 

 

December 31, 2024

 

 

Input

 

Carrying

 

 

Fair

 

 

Carrying

 

 

Fair

 

 

Level

 

Amount

 

 

Value

 

 

Amount

 

 

Value

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

Level 1

 

$

217.5

 

 

$

217.5

 

 

$

793.3

 

 

$

793.3

 

Financial Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

3.15% Senior notes due August 1, 2027

Level 2

 

 

424.9

 

 

 

420.1

 

 

 

424.9

 

 

 

411.1

 

2.3% Senior notes due December 15, 2031

Level 2

 

 

399.5

 

 

 

355.4

 

 

 

399.4

 

 

 

338.9

 

5.6% Senior notes due November 15, 2032

Level 2

 

 

499.3

 

 

 

532.3

 

 

 

499.2

 

 

 

515.3

 

3.95% Senior notes due August 1, 2047

Level 2

 

 

397.9

 

 

 

318.4

 

 

 

397.8

 

 

 

307.7

 

5.0% Senior notes due June 15, 2052

Level 2

 

 

499.9

 

 

 

457.3

 

 

 

499.9

 

 

 

451.9

 

The Company recognizes transfers between input levels as of the actual date of the event. There were no transfers between input levels during the twelve months ended December 31, 2025.

 

The following methods and assumptions were used to estimate the fair value of each class of financial instruments reflected in the Consolidated Balance Sheets:

Cash Equivalents: Cash equivalents consist of highly liquid short-term investments and term bank deposits, which mature within three months. The estimated fair value of the Company’s cash equivalents approximates their carrying value.

Short-Term Borrowings: The carrying amounts of the Company’s unsecured lines of credit and commercial paper issuances approximates fair value because of their short maturities and variable interest rates.

Senior Notes: The Company determines the fair value of its senior notes based on their quoted market value or broker quotes, when possible. In the absence of observable market quotes, the notes are valued using non-binding market consensus prices that the Company seeks to corroborate with observable market data.

Other: The carrying amounts of Accounts Receivable, Accounts Payable, and Accrued Expenses and Other Liabilities approximated estimated fair values as of December 31, 2025 and 2024.
v3.25.4
Derivative Instruments and Risk Management
 12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Risk Management
3.
Derivative Instruments and Risk Management

Changes in interest rates, foreign exchange rates, the price of the Company's Common Stock and commodity prices expose the Company to market risk. The Company manages these risks by the use of derivative instruments, such as cash flow and fair value hedges, diesel and commodity hedge contracts, equity derivatives and foreign exchange forward contracts. The Company does not use derivatives for trading or speculative purposes.

The Company formally designates and documents qualifying instruments as hedges of underlying exposures when it enters into derivative arrangements. Changes in the fair value of derivatives designated as hedges and qualifying for hedge accounting are recorded in other comprehensive income and reclassified into earnings during the period in which the hedged exposure affects earnings. The Company reviews the effectiveness of its hedging instruments on a quarterly basis. If the Company determines that a derivative instrument is no longer effective in offsetting changes in fair values or cash flows, it recognizes the hedge ineffectiveness in current period earnings and discontinues hedge accounting with respect to the derivative instrument. Changes in the fair value of derivatives not designated as hedges or those not qualifying for hedge accounting are recognized in current period earnings. Upon termination of cash flow hedges, the Company reclassifies gains and losses from accumulated other comprehensive income based on the timing of the underlying cash flows, unless the termination results from the failure of the intended transaction to occur in the expected timeframe. Such untimely transactions require immediate recognition in earnings of gains and losses previously recorded in other comprehensive income.

During 2025 and 2024, the Company used derivative instruments to mitigate risk, some of which were designated as hedging instruments. The tables following the discussion of the derivative instruments below summarize the fair value of the Company’s derivative instruments and the effect of derivative instruments on the Company’s consolidated Statements of Income and on other comprehensive income.

Derivatives Designated as Hedging Instruments

Diesel Fuel Hedges

The Company uses independent freight carriers to deliver its products. The carriers charge the Company a basic rate per mile for diesel fuel. The Company has entered into hedge agreements with counterparties to mitigate the volatility of diesel fuel prices, and not to speculate in the future price of diesel fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined at the time the agreements were executed and to receive a floating rate payment that is determined on a monthly basis based on the average price of the Department of Energy’s Diesel Fuel Index during the applicable month and is designed to offset any increase or decrease in fuel costs that the Company pays to it common carriers. The agreements covered approximately 83% of the Company’s 2025 diesel fuel requirements. These diesel fuel hedge agreements qualified for hedge accounting. Therefore, changes in the fair value of such agreements are recorded under Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet.

Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/ Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S Dollar/Chinese Yuan, U.S. Dollar/Australian Dollar and U.S. Dollar/Japanese Yen.

The Company enters into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed sales or purchases denominated in U.S. Dollar, Canadian Dollar, Pound, Euro, Mexican Peso, Chinese Yuan, Japanese Yen, and Australian Dollar. The Company entered into forward exchange contracts to hedge itself from the risk that, due to fluctuations in currency exchange rates, it would be adversely affected by net cash outflows. The face value of the unexpired contracts as of December 31, 2025 totaled $440.6 in U.S. Dollars, of which $438.2 qualifies as foreign currency cash flow hedges and, therefore, changes in the fair value of the contracts are recorded in Accumulated Other Comprehensive Income (Loss) and reclassified to earnings when the hedged transaction affected earnings.

Net Investment Hedge

In 2025, the Company entered into a cross-currency swap contract to hedge a portion of the Company's net investment in its Japanese Yen-denominated foreign operations to reduce foreign currency risk associated with the investment in these operations. The hedge matures in April 2026 and the total notional amount of the net investment hedge was $25.0 as of December 31, 2025. Changes in the fair value of the contract are recorded in Accumulated Other Comprehensive Income (Loss). The interest component is classified within interest income on the consolidated Statements of Income and included in operating activities within the Company's Consolidated Statements of Cash Flows.

Commodity Hedges

The Company is subject to exposure due to changes in prices of commodities used in production. To limit the effects of fluctuations in the future market price paid and related volatility in cash flows, the Company enters into commodity forward swap contracts. These hedges are designated as cash flow hedges for accounting purposes and, therefore, changes in the fair value of the contracts are recorded in AOCI and reclassified to earnings when the hedged transaction affected earnings. The fair value of these commodity hedge agreements is reflected in the Consolidated Balance Sheet within Other Current Assets, Accounts Payable, and Accrued Expenses and Other Liabilities.

Derivatives not Designated as Hedging Instruments

Equity Derivatives

The Company has entered into equity derivative contracts covering its Common Stock in order to minimize its liability under its Executive Deferred Compensation Plan resulting from changes in the quoted fair values of its Common Stock to participants who have investments under the Plan in a notional Common Stock fund. The contracts are settled in cash. Since the equity derivatives contracts do not qualify for hedge accounting, the Company is required to mark such contracts to market throughout the contract term and record changes in fair value in the consolidated Statements of Income.

The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table:

 

 

 

Notional

 

Notional

 

 

 

Amount

 

Amount

 

 

 

December 31, 2025

 

December 31, 2024

 

Derivatives designated as hedging instruments

 

 

 

 

 

Foreign exchange contracts

 

$

438.2

 

$

317.0

 

Diesel fuel contracts

 

4.5 gallons

 

0.8 gallons

 

Commodities contracts

 

43.6 pounds

 

0.0 pounds

 

Net Investment Hedge

 

$

25.0

 

$

0.0

 

Derivatives not designated as hedging instruments

 

 

 

 

 

Foreign exchange contracts

 

$

2.4

 

$

0.0

 

Equity derivatives

 

$

12.0

 

$

24.6

 
The fair values and amount of gain (loss) recognized in income and Other Comprehensive Income (“OCI”) associated with the derivative instruments disclosed above did not have a material impact on the Company’s consolidated financial statements for the periods ended December 31, 2025, 2024, and 2023.
v3.25.4
Inventories
 12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
Inventories
4.
Inventories

Inventories consist of the following:

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Raw materials and supplies

$

143.7

 

 

$

140.4

 

Work in process

 

35.0

 

 

 

45.4

 

Finished goods

 

356.1

 

 

 

427.5

 

Total

$

534.8

 

 

$

613.3

 
v3.25.4
Property, Plant and Equipment, Net ("PP&E")
 12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment, Net ("PP&E")
5.
Property, Plant and Equipment, Net (“PP&E”)

PP&E consists of the following:

 

December 31,

 

 

December 31,

 

 

2025(1)

 

 

2024

 

Land

$

16.0

 

 

$

29.2

 

Buildings and improvements

 

367.5

 

 

 

348.2

 

Machinery and equipment

 

911.1

 

 

 

1,000.4

 

Software

 

138.9

 

 

 

129.6

 

Office equipment and other assets

 

131.6

 

 

 

129.3

 

Construction in progress

 

131.9

 

 

 

215.1

 

Gross PP&E

 

1,697.0

 

 

 

1,851.8

 

Less accumulated depreciation

 

874.2

 

 

 

920.1

 

Net PP&E

$

822.8

 

 

$

931.7

 

 

(1)In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.

 

For the Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Depreciation expense on PP&E

$

89.7

 

 

$

83.2

 

 

$

72.8

 
v3.25.4
Acquisitions
 12 Months Ended
Dec. 31, 2025
Business Combination [Abstract]  
Acquisitions
6.
Acquisitions

 

Touchland Acquisition

On July 16, 2025, the Company completed the acquisition of Touchland Holding Corp ("Touchland"), the developer of TOUCHLAND® hand sanitizer products (the "Touchland Acquisition"). The Company paid $656.0, net of cash acquired, at closing and entered an agreement to pay an additional amount based on 2025 net sales thresholds which will result in a cash payment of $159.0 to be paid in the first half of 2026. In addition, the Company granted rights to Touchland’s founder to receive shares of our Common Stock valued at $50.0, with 50% of such shares vesting at each of the first-and-second-year anniversaries of the closing. The value of Common Stock received by Touchland's founder will be recognized as compensation expense ratably over the two-year vesting period if the individual continues to be employed by the Company. Payment of a $5.0 portion of the purchase price was deferred related to certain indemnification obligations provided by Touchland’s equity holders, which amount, to the extent not used in satisfaction of such indemnity obligations, is payable three years from the closing. The Touchland Acquisition was financed with cash on hand and is managed in the Consumer Domestic and Consumer International segments. Touchland’s annual net sales for the year ended December 31, 2024 were approximately $115.0 million.

The preliminary fair values of the net assets at acquisition are set forth as follows:

 

Accounts receivable

$

9.3

 

Inventory

 

25.8

 

Other current assets

 

1.3

 

Property, plant and equipment

 

5.5

 

Other long-term assets

 

2.1

 

Trade name

 

730.0

 

Customer relationship intangible asset

 

32.8

 

Goodwill

 

206.5

 

Accounts payable, accrued expenses and other liabilities

 

(23.3

)

Business acquisition liabilities - short-term

 

(140.0

)

Deferred income taxes

 

(183.8

)

Deferred and other long-term liabilities

 

(10.2

)

Cash purchase price (net of cash acquired)

$

656.0

 

The trade name and customer relationship intangible assets were valued using a discounted cash flow model and have a useful life of 20 years. The goodwill is a result of expected synergies from combined operations of the acquired business and the Company. Business acquisition liabilities were valued using a Monte Carlo simulation model. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and other intangible assets associated with the Touchland Acquisition are not deductible for U.S. tax purposes.

Graphico Acquisition

On June 3, 2024, the Company acquired substantially all of the issued and outstanding shares of capital stock of Graphico, Inc. ("Graphico"), a Japan-based distributor focused on consumer goods primarily in the Japanese market (the “Graphico Acquisition”). The Company paid $19.9, net of cash acquired, at closing. The Company acquired the remaining minority shares for approximately $2.0 in July 2024. Graphico’s annual net sales for the year ended December 31, 2023 were approximately $38.0. The Graphico Acquisition was financed with cash on hand, is expected to contribute to greater expansion of our business in the Asia-Pacific (APAC) region, and is managed in the Consumer International segment.

The fair values of the net assets at acquisition are set forth as follows:

 

Accounts receivable

$

3.5

 

Inventory

 

11.3

 

Other current assets

 

1.5

 

Other long-term assets

 

5.8

 

Customer relationship intangible asset

 

8.4

 

Goodwill

 

2.8

 

Accounts payable, accrued expenses and other liabilities

 

(6.9

)

Long-term debt

 

(4.4

)

Deferred income taxes

 

(2.1

)

Cash purchase price (net of cash acquired)

$

19.9

 

The customer relationship intangible asset was valued using a discounted cash flow model and has a useful life of 15 years. The goodwill is a result of expected synergies from combined operations of the acquired business and the Company. Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and other intangible assets associated with the Graphico Acquisition are not deductible for U.S. tax purposes.
v3.25.4
Divestitures and Business Exits
 12 Months Ended
Dec. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Divestitures and Business Exits
7.
Divestitures and Business Exits

 

Spinbrush Divestiture

On May 1, 2025, the Company announced that it would exit the Spinbrush business. In connection with the exit the Company recorded a pre-tax loss of $21.2 of which $12.6 was recorded in Cost of Sales and $8.6 was recorded in SG&A expenses. In December 2025, the Company entered into an agreement to transfer all Spinbrush intellectual property to a third party for nominal consideration. Net sales of the Spinbrush business were $53.6 in the year ended December 31, 2025.

Flawless Business Exit

On May 1, 2025, the Company announced that it would exit the Flawless business. We exited this business by the end of 2025, resulting in a pre-tax loss of $17.6, of which $6.0 was recorded in Cost of Sales and $11.6 was recorded in SG&A expenses. Net sales of the Flawless business were $29.3 in the year ended December 31, 2025.

Waterpik Showerheads Business Exit

On May 1, 2025, the Company announced that it would exit the Waterpik showerheads business. We exited this business by the end of 2025, resulting in a pre-tax loss of $6.5 recorded in Cost of Sales. Net sales of the Waterpik showerheads business were $35.5 in the year ended December 31, 2025.

VMS Divestiture

On December 9, 2025, the Company announced a definitive agreement to sell the VitaFusion and L’il Critters brands to Piping Rock Health Products, Inc. This agreement includes the VitaFusion and L’il Critters brands, relevant trademarks and licenses, and the Company's former manufacturing and distribution facilities in Vancouver and Ridgefield, Washington. The transaction closed on December 31, 2025 and includes a short-duration transition services agreement.

In connection with the agreement, the Company divested PP&E of $142.9, inventory of $54.0, goodwill of $12.6 and other net assets including leases of $9.3 for net cash proceeds of $160.3. The VMS brands represented less than 5% of Church & Dwight’s 2025 net sales. As a result of this transaction, Church & Dwight incurred a one-time, pre-tax charge of $58.5 (post-tax of $45.6) in the fourth quarter of 2025 which is included in Other income (expense), net in the Consolidated Statements of Income.

The divestiture of the Company's VMS business does not meet the criteria to be reported as discontinued operations in the consolidated financial statements as the Company's decision to divest this business does not represent a strategic shift that will have a significant impact on the Company's operations and financial results.
v3.25.4
Goodwill and Other Intangibles, Net
 12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangibles, Net
8.
Goodwill and Other Intangibles, Net

 

The Company has intangible assets of substantial value on its consolidated balance sheet. These intangible assets are generally related to intangible assets with a useful life, indefinite-lived trade names and goodwill. The Company determines whether an intangible asset (other than goodwill) has a useful life based on multiple factors, including how long the Company intends to generate cash flows from the asset. These intangible assets are more fully explained in the following sections.

 

Indefinite-Lived Intangible Assets

The following table presents the carrying value of indefinite-lived intangible assets:

 

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Gross Carrying Value Trade Names

$

1,680.7

 

 

$

1,960.7

 

VMS impairment

0.0

 

 

$

(281.3

)

Spinbrush impairment

 

(7.9

)

 

 

0.0

 

Net Carrying Value Trade Names

$

1,672.8

 

 

$

1,679.4

 

The Company’s indefinite-lived intangible impairment review is completed in the fourth quarter of each year.

Fair value of indefinite-lived trade names was estimated based on a “relief from royalty” or “excess earnings” discounted cash flow method, which contains numerous variables that are subject to change as business conditions change, and therefore could impact fair values in the future. The key assumptions used in determining fair value are sales growth, profitability margins, tax rates, discount rates and royalty rates. The Company determined that the fair value of all indefinite-lived trade names for each of the years in the three-year period ended December 31, 2025 exceeded their respective carrying values based upon the forecasted cash flows and profitability, with the exception of the Vitamins, Minerals and Supplements ("VMS") business and the Spinbrush business described below.

On May 1, 2025, the Company announced that it would exit the Spinbrush business. In December 2025, the Company entered into an agreement to transfer all Spinbrush intellectual property to a third party for nominal consideration. Net sales of the Spinbrush business were $53.6 in the year ended December 31, 2025. The Company recorded $12.6 in Cost of Sales for inventory and fixed asset impairments and $8.6 in SG&A, of which $7.9 was related to the indefinite lived Trade name.

During the third quarter of 2024, the Company continued to experience a decline in market share and a deterioration in the financial performance of its VMS business, which includes the VITAFUSION and L'IL CRITTERS trade names, primarily due to significant product competition coming from new category entrants, including private label. The continued decline in profitability caused management to reassess its long-term strategy and financial outlook of the business. The revised financial outlook reflected lower estimates of future sales growth and cash flows which resulted in a triggering event in the third quarter. The triggering event required the Company to review the carrying value of assets supporting the business. The assets supporting the VMS business included the VITAFUSION and L'IL CRITTERS indefinite-lived trade name, a definite-lived customer relationship intangible asset and PP&E specific to the VMS business.

The Company used an excess earnings discounted cash flow model to determine the fair value of the trade name. The assumptions used in the model required significant judgement in determining the expected future cash flows. The key assumptions utilized in the Company's impairment analysis included, but were not limited, net sales growth rates between -15.2% and 2.1%, EBITA margins in the low single digits, and a discount rate of 8.25%. Estimates were based on market conditions and management’s current expectation of the success of growth and profitability initiatives. The valuation resulted in a full impairment of the $281.3 trade name. The remaining carry value of the trade name at December 31, 2024 is $0.0.

On December 9, 2025, the Company announced a definitive agreement to sell the VitaFusion and L’il Critters brands to Piping Rock Health Products, Inc. The transaction closed on December 31, 2025. See Note 7 for further details.

 

 

 

 

A summary of the VMS intangible and fixed asset impairment charges are as follows:

 

December 31,

 

 

2024

 

Trade Name

$

281.3

 

Customer Relationship Intangible Asset

 

15.8

 

PP&E

 

60.0

 

Total VMS impairment charges

$

357.1

 

 

The Company’s global WATERPIK business is experiencing customer distribution losses and a decline in consumer demand, mainly due to lower consumer spending and more customers choosing value brands amid inflation. This has reduced sales, profits, and expected cash flows, eroding much of the excess fair value over carrying value for the WATERPIK trade name. As of October 1, 2025, the trade name’s carrying value was $644.7, with fair value at 117% of carrying value, down from 135% in 2024, reflecting falling sales, rising competition, business exits, and margin pressure from higher costs and tariffs. The Company's impairment analysis used an 8.0% discount rate, projected mid-single- to low double-digit revenue growth, and EBITA margins around 25%, based on current market trends and cost-lowering initiatives. Further declines in performance or adverse changes could trigger an impairment charge for the WATERPIK trade name.

Intangible Assets With a Useful Life

The following table provides information related to the carrying value of amortizable intangible assets:

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

Impairment

 

 

 

 

 

Period

 

Carrying

 

 

Accumulated

 

 

Impairment

 

 

 

 

 

Amount

 

 

Amortization

 

 

Charges(2)

 

 

Net

 

 

(Years)

 

Amount

 

 

Amortization

 

 

Charges(1)

 

 

Net

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade names

$

2,113.4

 

 

$

(562.1

)

 

$

(11.6

)

 

$

1,539.7

 

 

3-20

 

$

1,383.4

 

 

$

(479.6

)

 

$

0.0

 

 

$

903.8

 

Customer Relationships

 

598.5

 

 

 

(365.2

)

 

 

(0.7

)

 

 

232.6

 

 

15-20

 

 

644.9

 

 

 

(402.1

)

 

 

(15.8

)

 

 

227.0

 

Patents/Formulas

 

205.6

 

 

 

(139.2

)

 

 

0.0

 

 

 

66.4

 

 

4-20

 

 

205.5

 

 

 

(127.2

)

 

0.0

 

 

 

78.3

 

Total

$

2,917.5

 

 

$

(1,066.5

)

 

$

(12.3

)

 

$

1,838.7

 

 

 

 

$

2,233.8

 

 

$

(1,008.9

)

 

$

(15.8

)

 

$

1,209.1

 

 

(1) The $15.8 impairment charge relates to the VMS customer relationship intangible asset, which had a gross value of $79.2 and accumulated amortization of $63.4 prior to full impairment (as discussed above).

(2) The $12.3 impairment charge relates to the Flawless trade name and Spinbrush customer relationship intangible asset, which had a gross value of $76.2 and accumulated amortization of $63.9 prior to full impairment. The impairments were a result of the Company's decision to exit these businesses (as discussed above).

Intangible amortization expense amounted to $121.1 for 2025, $121.5 for 2024 and $124.3 for 2023, respectively. The Company estimates that intangible amortization expense will be approximately $135.0 in 2026 and approximately $134.0 declining to $120.0 annually over the next five years.

 

Goodwill

The changes in the carrying amount of goodwill for the years ended December 31, 2025 and 2024 are as follows:

 

Consumer

 

 

Consumer

 

 

Specialty

 

 

 

 

 

Domestic

 

 

International

 

 

Products

 

 

Total

 

Balance at December 31, 2023

$

2,061.1

 

 

$

234.4

 

 

$

136.0

 

 

$

2,431.5

 

Graphico acquired goodwill

 

0.0

 

 

 

2.8

 

 

 

0.0

 

 

 

2.8

 

Passport divestiture

 

0.0

 

 

 

0.0

 

 

 

(1.1

)

 

 

(1.1

)

Balance at December 31, 2024

$

2,061.1

 

 

$

237.2

 

 

$

134.9

 

 

$

2,433.2

 

Touchland acquired goodwill

 

206.5

 

 

 

0.0

 

 

 

0.0

 

 

 

206.5

 

VMS divestiture (as discussed above)

 

(12.6

)

 

 

0.0

 

 

 

0.0

 

 

 

(12.6

)

Other

 

0.4

 

 

 

0.0

 

 

 

0.0

 

 

 

0.4

 

Balance at December 31, 2025

$

2,255.4

 

 

$

237.2

 

 

$

134.9

 

 

$

2,627.5

 

 

The Company tests goodwill for each reporting unit which are also the Company's reportable segments. The result of the Company’s annual goodwill impairment test, performed in the beginning of the second quarter of 2025, determined that the estimated fair value substantially exceeded the carrying values of all reporting units. The determination of fair value contains numerous variables that are subject to change as business conditions change and therefore could impact fair value in the future.

v3.25.4
Leases
 12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases
9.
Leases

 

The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment. Leases with an initial term of twelve months or less are not recorded on the consolidated balance sheet. All recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term. For leases beginning in 2019, lease components (base rental costs) are accounted for separately from the nonlease components (e.g., common-area maintenance costs). For leases that do not provide an implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

 

 

A summary of the Company’s lease information is as follows:

 

 

December 31,

 

 

December 31,

 

 

Classification

2025

 

 

2024

 

Assets

 

 

 

 

 

 

Right of use assets

Other Assets

$

166.0

 

 

$

182.3

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Current lease liabilities

Accrued Expenses and Other Liabilities

$

23.9

 

 

$

32.4

 

Long-term lease liabilities

Deferred and Other Long-term Liabilities

 

153.0

 

 

 

168.5

 

Total lease liabilities

 

$

176.9

 

 

$

200.9

 

 

 

 

 

 

 

 

Other information

 

 

 

 

 

 

Weighted-average remaining lease term (years)

 

 

7.4

 

 

 

7.4

 

Weighted-average discount rate

 

 

5.2

%

 

 

4.6

%

 

 

 

Twelve Months

 

 

 

Twelve Months

 

 

Twelve Months

 

 

 

 

Ended

 

 

 

Ended

 

 

Ended

 

 

 

 

December 31, 2025

 

 

 

December 31, 2024

 

 

December 31, 2023

 

 

Statement of Income

 

 

 

 

 

 

 

 

 

 

 

Lease cost(1)

 

$

42.2

 

 

 

$

40.2

 

 

$

31.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve Months

 

 

 

Twelve Months

 

 

 

 

 

 

 

Ended

 

 

 

Ended

 

 

 

 

 

 

 

December 31, 2025

 

 

 

December 31, 2024

 

 

 

 

 

Other information

 

 

 

 

 

 

 

 

 

 

 

Leased assets obtained in exchange for new lease liabilities(2)

 

$

15.4

 

 

 

$

28.0

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

$

42.5

 

 

 

$

35.3

 

 

 

 

 
(1)
Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The noncash component of lease expense for the twelve months ended December 31, 2025, 2024 and 2023 was $32.7, $30.9 and $24.3, respectively, is included in the amortization caption in the consolidated statement of cash flows.
(2)
Leased assets obtained in exchange for new lease liabilities in 2025 consisted of $48.6 of real estate lease additions and $3.7 of equipment lease additions, net of modifications, offset by $36.9 in lease terminations resulting from the sale of the VMS business. The additions include an increase to the Company's right of use asset and corresponding lease liabilities of $31.7 for an agreement between the Company and a third-party warehouse provider for new warehouse space in December 2025. In April 2025, the Company extended the lease term at one of its leased warehouse facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $11.0 recorded in the second quarter of 2025. Leased assets obtained in exchange for new lease liabilities in 2024 consisted of $16.8 of real estate lease additions and $11.2 of equipment lease additions, net of modifications. These additions included expanded space at one of the Company's leased manufacturing
facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $15.4 recorded in the first quarter of 2024.

The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows:

 

 

 

Operating

 

 

 

Leases

 

2026

 

$

32.4

 

2027

 

 

30.7

 

2028

 

 

26.6

 

2029

 

 

26.0

 

2030

 

 

25.9

 

2031 and thereafter

 

 

73.6

 

Total future minimum lease commitments

 

 

215.2

 

Less: Imputed interest

 

 

(38.3

)

Present value of lease liabilities

 

$

176.9

 
v3.25.4
Accounts Payable, Accrued and Other Liabilities
 12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Accounts Payable, Accrued Expenses and Other Liabilities
10.
Accounts Payable, Accrued Expenses and Other Liabilities

Accounts payable, accrued expenses and other liabilities consist of the following:

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Accounts payable

$

732.4

 

 

$

705.1

 

Accrued marketing and promotion costs

 

221.4

 

 

 

259.6

 

Accrued wages and related benefit costs

 

145.7

 

 

 

151.4

 

Other accrued current liabilities

 

394.8

 

 

 

194.5

 

Total

$

1,494.3

 

 

$

1,310.6

 

 

In 2015, the Company initiated a Supply Chain Finance program (“SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company for early payment. Participating suppliers negotiate their receivables sales arrangements directly with a third party. The Company is not party to those agreements and does not have an economic interest in the suppliers' decisions to sell their receivables and has not been required to pledge any assets as security nor to provide any guarantee to third-party finance providers or intermediaries. The SCF Program may allow suppliers to obtain more favorable terms than they could secure on their own. The terms of the Company's payment obligations are not impacted by a supplier’s participation in the SCF Program. The Company's payment terms with suppliers are consistent between suppliers that elect to participate in the SCF Program and those that do not participate. As a result, the program does not have an impact to the Company's average days outstanding.

The obligations outstanding related to the SCF program amount to $84.7 and $98.5 as of December 31, 2025 and 2024, respectively, and were recorded within Accounts Payable in the consolidated balance sheets. Payments included in operating activities within the Company's Consolidated Statements of Cash Flows amounted to $409.3, $388.7 and $387.1 in the years ended December 31, 2025, 2024 and 2023, respectively.

v3.25.4
Long-Term Debt
 12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Long-Term Debt
11.
Long-Term Debt

Long-term debt consists of the following:

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Long-term debt

 

 

 

 

 

3.15% Senior notes due August 1, 2027

$

425.0

 

 

$

425.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

2.3% Senior notes due December 15, 2031

 

400.0

 

 

 

400.0

 

Less: Discount

 

(0.5

)

 

 

(0.6

)

5.6% Senior notes due November 15, 2032

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.7

)

 

 

(0.8

)

3.95% Senior notes due August 1, 2047

 

400.0

 

 

 

400.0

 

Less: Discount

 

(2.1

)

 

 

(2.2

)

5.0% Senior notes due June 15, 2052

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

Debt issuance costs, net

 

(16.4

)

 

 

(16.6

)

Total long-term debt

$

2,205.1

 

 

$

2,204.6

 

 

Commercial Paper

Under the Company’s commercial paper program, the Company may issue commercial paper notes up to an aggregate principal amount outstanding at any given time of $2,000.0. The maturities of the notes will vary but may not exceed 397 days. The interest rates on the notes will vary based on market conditions and the ratings assigned to the notes by the rating agencies designated in the agreement at the time of issuance. Subject to market conditions, the Company intends to utilize the commercial paper program as its primary short-term borrowing facility. If, for any reason, the Company is unable to access the commercial paper market, the Company's Revolving Credit Facility would be utilized to meet the Company’s short-term liquidity needs. The Company did not have any commercial paper outstanding as of December 31, 2025 or 2024. As of December 31, 2025, the Company had approximately $1,993.0 available through the Revolving Credit Facility and commercial paper program.

3.15% Senior Notes due August 1, 2027

On July 25, 2017, the Company issued $425.0 aggregate principal amount of 3.15% Senior Notes due 2027 (the “2027 Notes”). The 2027 Notes bear interest at 3.15%. Interest on the 2027 Notes is payable semi-annually, on each February 1 and August 1. The 2027 Notes will mature on August 1, 2027 unless earlier retired or redeemed.

2.3% Senior Notes due December 15, 2031

On December 10, 2021, the Company issued $400.0 aggregate principal amount 2.3% Senior Notes due 2031 (the “2031 Notes”). The 2031 Notes bear interest at 2.30%. Interest on the 2031 Notes is payable semi-annually, on each June 15 and December 15. The 2031 Notes will mature on December 15, 2031, unless earlier retired or redeemed. The Company used a portion of the proceeds to finance the TheraBreath Acquisition.

5.6% Senior Notes due November 15, 2032

On October 31, 2022, the Company issued $500.0 aggregate principal amount of 5.60% Senior Notes due 2032 (the “2032 Notes”). The proceeds from the sale of the 2032 Notes were used to repay commercial paper borrowings incurred to finance the Company’s acquisition of Hero Cosmetics, Inc. The 2032 Notes will mature on November 15, 2032, unless earlier retired or redeemed.

3.95% Senior Notes due August 1, 2047

On July 25, 2017, the Company issued $400.0 aggregate principal amount of 3.95% Senior Notes due August 1, 2047 (the “2047 Notes”) to partially finance the Waterpik Acquisition and repay a portion of the Company’s outstanding commercial paper borrowings. The 2047 Notes bear interest at 3.95%. Interest on the 2047 Notes is payable semi-annually, on each February 1 and August 1. The 2047 Notes will mature on August 1, 2047, unless earlier retired or redeemed.

 

5.0% Senior Notes due June 15, 2052

On June 2, 2022, the Company issued $500.0 aggregate principal amount of 5.00% Senior Notes due 2052 (the “2052 Notes”). In July 2022 a portion of the proceeds from the sale of the Notes were used to repay all of the Company's outstanding $300.0 2.45% Senior Notes due August 1, 2022. The remaining proceeds were used to pay a portion of the Company's $400.0 outstanding 2.875% Senior Notes due October 1, 2022. The 2052 Notes will mature on June 15, 2052, unless earlier retired.

 

Revolving Credit Facility

On July 17, 2025, the Company entered into a new unsecured revolving Credit Agreement (the “Credit Agreement”). The Credit Agreement replaced the Company’s prior $1,500.0 unsecured revolving credit facility that was entered into on June 16, 2022. The aggregate commitments of the lenders under the Credit Agreement, as of the effective date, are $2,000.0, with an option to increase such commitments to $2,750.0 pursuant to the terms therein. The revolving credit facility matures on July 17, 2030, unless extended. Borrowings under the Credit Agreement are available for general corporate purposes and are used to support our $2,000.0 commercial paper program.

The Revolving Credit Facility also contains customary events of default, including failure to make certain payments under the Term Loan Facility when due beyond the grace period, event of default on other material indebtedness, breach of covenants, materially incorrect representations and warranties, events of bankruptcy, material adverse judgments, certain events relating to pension plans, the failure of any of the loan documents to remain in full force and effect and the occurrence of any change in control with respect to the Company.
v3.25.4
Income Taxes
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
12.
Income Taxes

The components of income before taxes are as follows:

 

 

2025

 

 

2024

 

 

2023

 

Domestic

 

$

876.6

 

 

$

666.5

 

 

$

872.4

 

Foreign

 

 

80.3

 

 

 

89.8

 

 

 

95.0

 

Total

 

$

956.9

 

 

$

756.3

 

 

$

967.4

 

 

The following table summarizes the provision for U.S. federal, state and foreign income taxes:

 

 

2025

 

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

 

 

 

U.S. federal

 

$

129.5

 

 

$

180.9

 

 

$

159.1

 

State

 

 

31.7

 

 

 

45.2

 

 

 

40.9

 

Foreign

 

 

22.9

 

 

 

26.9

 

 

 

25.6

 

 

 

 

184.1

 

 

 

253.0

 

 

 

225.6

 

Deferred:

 

 

 

 

 

 

 

 

 

U.S. federal

 

 

44.3

 

 

 

(64.5

)

 

 

(11.3

)

State

 

 

(9.7

)

 

 

(15.7

)

 

 

(2.8

)

Foreign

 

 

1.4

 

 

 

(1.8

)

 

 

0.3

 

 

 

 

36.0

 

 

 

(82.0

)

 

 

(13.8

)

Total provision

 

$

220.1

 

 

$

171.0

 

 

$

211.8

 

 

 

Deferred tax assets (liabilities) consist of the following at December 31, 2025 and 2024:

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Accounts receivable

 

$

7.2

 

 

$

7.4

 

Deferred compensation

 

 

55.8

 

 

 

51.7

 

Pension, postretirement, and postemployment benefits

 

 

4.8

 

 

 

2.9

 

Inventory reserve

 

 

7.7

 

 

 

8.6

 

Sec 174 R&D capitalization

 

 

13.4

 

 

 

59.4

 

ASC 842 lease liabilities

 

 

32.9

 

 

0.0

 

Tax credit carryforwards/other tax attributes

 

 

9.1

 

 

 

5.1

 

International operating loss carryforwards

 

 

8.9

 

 

 

8.4

 

Other

 

 

18.1

 

 

 

8.8

 

Total gross deferred tax assets

 

 

157.9

 

 

 

152.3

 

Valuation allowances

 

 

(17.1

)

 

 

(14.3

)

Total deferred tax assets

 

 

140.8

 

 

 

138.0

 

Deferred tax liabilities:

 

 

 

 

 

 

Goodwill

 

 

(311.0

)

 

 

(298.7

)

Trade names and other intangibles

 

 

(579.2

)

 

 

(415.0

)

Property, plant, and equipment

 

 

(96.2

)

 

 

(85.2

)

ASC 842 Right of Use assets

 

 

(30.4

)

 

0.0

 

Interest rate swaps

 

 

(3.2

)

 

 

(3.7

)

Total deferred tax liabilities

 

 

(1,020.0

)

 

 

(802.6

)

Net deferred tax liability

 

$

(879.2

)

 

$

(664.6

)

Long term net deferred tax asset

 

 

7.7

 

 

 

4.6

 

Long term net deferred tax liability

 

 

(886.9

)

 

 

(669.2

)

Net deferred tax liability

 

$

(879.2

)

 

$

(664.6

)

The difference between tax expense and the tax that would result from the application of the federal statutory rate is as follows:

 

 

2025

 

 

Amount

 

Percent

 

Federal

$

119.0

 

 

63.2

%

State

 

40.6

 

 

21.6

%

Foreign

 

28.5

 

 

15.2

%

Total Income Tax Paid

$

188.1

 

 

100.0

%

 

 

2025

 

 

Amount

 

Percent

 

U.S. Federal Statutory Tax Rate

$

200.9

 

 

21.0

%

State and Local Income Taxes, Net of Federal Income Tax Effect (a)

 

17.4

 

 

1.8

 

Foreign Tax Effects

 

8.2

 

 

0.9

 

Effect of Cross-Border Tax Laws

 

(3.1

)

 

-0.3

 

Tax Credits

 

(6.2

)

 

-0.6

 

Changes in Valuation Allowances

 

3.2

 

 

0.3

 

Nontaxable or Nondeductible Items

 

5.2

 

 

0.5

 

Changes in Unrecognized Tax Benefits

 

1.0

 

 

0.1

 

Other Adjustments

 

(6.5

)

 

-0.7

 

     ASC 842 Right of Use Assets

 

26.5

 

 

2.8

 

     ASC 842 Lease Liabilities

 

(28.6

)

 

-3.0

 

     Other

 

(4.4

)

 

-0.5

 

Effective Tax Rate

$

220.1

 

 

23.0

%

 

(a) State taxes in Florida, Illinois, New Jersey, New York, and Texas made up of the majority (greater than 50%) of the tax effect in this category.

 

 

 

 

2024

 

 

2023

 

Statutory rate

 

 

 

21

%

 

 

21

%

Tax that would result from use of the federal statutory rate

 

 

$

158.8

 

 

$

203.1

 

State and local income tax, net of federal effect

 

 

 

23.3

 

 

 

30.1

 

Varying tax rates of foreign affiliates

 

 

 

6.9

 

 

 

6.8

 

Valuation Allowances

 

 

 

2.1

 

 

0.0

 

Stock Options Exercised

 

 

 

(23.0

)

 

 

(21.8

)

Reserve for Uncertain Tax Position

 

 

 

0.3

 

 

 

(0.3

)

Other

 

 

 

2.6

 

 

 

(6.1

)

Recorded tax expense

 

 

$

171.0

 

 

$

211.8

 

Effective tax rate

 

 

 

22.6

%

 

 

21.9

%

At December 31, 2025 and 2024, respectively, certain foreign subsidiaries of the Company had net operating loss carryforwards of approximately $8.1 and $8.3, which are not subject to expiration. The Company believes that it is more likely than not that the benefit from these net operating loss carryforwards will not be realized. In recognition of this risk, the Company has provided a valuation allowance of $8.1 and $8.3 at December 31, 2025 and 2024, respectively, on the deferred tax asset relating to these net operating loss carryforwards.

The Company also believes that it is more likely than not that the benefit from certain additional deferred tax assets of a foreign subsidiary will not be realized. In recognition of this risk, the Company maintains a valuation allowance of $0.6 and $0.7 at December 31, 2025 and 2024, respectively, on these deferred tax assets.

The Company has foreign tax credit carryforwards of approximately $9.3 and $5.2 as of December 31, 2025 and 2024, respectively. The Company believes that it is more likely than not that the benefit from a majority of the foreign tax credit carryforwards as of December 31, 2025 will not be realized. In recognition of this risk, the Company has provided a valuation allowance of $8.4 and $5.2 at December 31, 2025 and 2024, respectively, on the deferred tax asset relating to these foreign tax credit carryforwards. The Company does not have any undistributed earnings of foreign subsidiaries that are considered to be indefinitely reinvested outside of the U.S.

The Company has recorded liabilities in connection with uncertain tax positions, which, although supportable by the Company, may be challenged by tax authorities.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

2025

 

 

2024

 

 

2023

 

Unrecognized tax benefits at January 1

 

$

5.4

 

 

$

5.1

 

 

$

5.8

 

Gross increases - tax positions in current period

 

 

6.1

 

 

 

0.9

 

 

0.0

 

Lapse of statute of limitations

 

 

(0.7

)

 

 

(0.6

)

 

 

(0.7

)

Unrecognized tax benefits at December 31

 

$

10.8

 

 

$

5.4

 

 

$

5.1

 

Included in the balance of unrecognized tax benefits at December 31, 2025, 2024 and 2023 are $9.1, $4.5 and $4.2, respectively, of tax benefits that, if recognized, would affect the effective tax rate. Also included in the balance of unrecognized tax benefits at December 31, 2025, 2024 and 2023 are $1.7, $0.9 and $0.9, respectively, of tax benefits that, if recognized, would result in adjustments to deferred taxes.

The Company is subject to U.S. federal income tax as well as income tax in multiple state and international jurisdictions. The Company’s U.S. federal income tax returns are closed for tax years through 2021. The Company is currently under audit by several state taxing authorities for the years 2017 through 2023. It is reasonably possible that a decrease of approximately $0.5 in the unrecognized tax benefits may occur within the next twelve months related to the settlement of these audits or the lapse of applicable statutes of limitations.

The Company’s policy for recording interest associated with income tax examinations is to record interest as a component of Income before Income Taxes. During the twelve months ended December 31, 2025, 2024, and 2023, the Company recognized interest expense associated with uncertain tax positions of approximately $0.5, $0.4 and $0.3, respectively. As of December 31, 2025, 2024, and 2023, the Company had accrued interest expense related to unrecognized tax benefits of $2.0, $1.3 and $0.9, respectively.

On August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (the “Act”), which contains provisions effective January 1, 2023, including a 15% corporate minimum tax and a 1% excise tax on stock buybacks. The law did not have any material impacts on the Company's consolidated financial position, results of operations or cash flows during the year ended December 31, 2025.

On July 4,2025, President Trump signed into law the legislation formally titled "An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14" and commonly referred to as the One Big Beautiful Bill Act ("OBBBA"). The legislation includes several provisions that may impact the timing and magnitude of certain tax deductions. Key provisions include the permanent extension of several key elements of the 2017 Tax Cuts and Jobs Act, including 100% bonus depreciation and an immediate tax deduction for domestic research costs. The tax provisions in OBBBA did not have a material impact on our financial position and results of operations, and had approximately a minimal benefit to operating cash flows.
v3.25.4
Stock Based Compensation Plans and Other Benefit Plans
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock Based Compensation Plans and Other Benefit Plans
13.
Stock Based Compensation Plans and Other Benefit Plans

The Company's Long-Term Incentive Program (“LTIP”) provides employees with an award of stock options and grants of restricted stock units (“RSUs”), and grants of performance share units (“PSUs”) to members of the Company's Executive Leadership Team (“ELT”). Awards are granted in the first quarter of each year. The Company recognizes the grant-date fair value for each of these awards, less estimated forfeitures, as compensation expense ratably over the vesting period. For employees and directors that meet retirement eligibility requirements, the expense related to share-based compensation is recognized on the date of grant as there is no future service period required for the awards to vest.

Stock Options

The Company has non-qualified options outstanding under the LTIP. Stock options outstanding are issued at market value on the date of grant, vest on the third anniversary of the date of grant and must be exercised within 10 years of the date of grant.

However, upon a participant’s termination of employment (other than termination for cause, death, disability or retirement), a participant will generally have 30 days (90 days for grants made after May 13, 2022) to exercise any vested stock options, subject to specified conditions. If, upon termination of a participant’s employment (other than a termination for cause), a participant is at least 55 years old, has at least five years of service, and the sum of the participant’s age and years of service is at least 65, the participant may exercise any vested stock options granted between 2007 through 2017 within a period of three years from the date of termination or, if earlier, the date such stock options otherwise would have expired, subject to specified conditions. Starting with stock options granted in 2018, a terminated employee who meets the above conditions may exercise any stock options until the date such stock options otherwise would have expired, subject to specified conditions. Issuances of Common Stock to satisfy employee stock option exercises currently are made from treasury stock.

Stock option transactions for the year ended December 31, 2025 were as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

Options

 

 

Price

 

 

Term

 

 

Value

 

Outstanding as of December 31, 2024

 

8.4

 

 

$

77.10

 

 

 

 

 

 

 

Granted

 

1.1

 

 

 

110.19

 

 

 

 

 

 

 

Exercised

 

(0.5

)

 

 

58.25

 

 

 

 

 

 

 

Cancelled

 

(0.2

)

 

 

91.53

 

 

 

 

 

 

 

Outstanding as of December 31, 2025

 

8.8

 

 

$

81.83

 

 

 

5.6

 

 

$

63.9

 

Exercisable as of December 31, 2025

 

5.9

 

 

$

73.65

 

 

 

4.4

 

 

$

63.2

 

The following table summarizes information relating to options outstanding and exercisable as of December 31, 2025:

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

Outstanding

 

 

Average

 

 

Average

 

 

Exercisable

 

 

Average

 

Range of

 

as of

 

 

Remaining

 

 

Exercise

 

 

as of

 

 

Exercise

 

Exercise Prices

 

12/31/2025

 

 

Contractual Life

 

 

Price

 

 

12/31/2025

 

 

Price

 

$40.01 - $50.00

 

 

0.2

 

 

 

0.7

 

 

$

48.94

 

 

 

0.2

 

 

$

48.94

 

$50.01 - $60.00

 

 

1.1

 

 

 

2.2

 

 

$

51.25

 

 

 

1.1

 

 

$

51.25

 

$60.01 - $70.00

 

 

0.0

 

 

 

0.0

 

 

$

0.0

 

 

 

0.0

 

 

$

0.0

 

$70.01 - $80.00

 

 

2.1

 

 

 

4.0

 

 

$

75.34

 

 

 

2.1

 

 

$

75.34

 

$80.01 - $90.00

 

 

3.3

 

 

 

6.3

 

 

$

84.30

 

 

 

2.4

 

 

$

84.73

 

$90.01 - $100.00

 

 

0.2

 

 

 

8.1

 

 

$

94.11

 

 

 

0.1

 

 

$

92.53

 

$100.01 - $110.00

 

 

1.0

 

 

 

8.2

 

 

$

100.76

 

 

 

0.0

 

 

$

0.0

 

$110.01 - $120.00

 

 

0.9

 

 

 

9.2

 

 

$

112.06

 

 

 

0.0

 

 

$

0.0

 

 

 

 

8.8

 

 

 

5.6

 

 

$

81.83

 

 

 

5.9

 

 

$

73.65

 

The table above represents the Company’s estimate of stock options fully vested and expected to vest. Expected forfeitures are not material and, therefore, are not reflected in the table above.

The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards:

 

2025

 

 

2024

 

 

2023

 

Intrinsic Value of Stock Options Exercised

$

23.0

 

 

$

134.0

 

 

$

125.5

 

Stock Compensation Expense Related to Stock Option Awards

$

26.9

 

 

$

28.7

 

 

$

26.3

 

Issued Stock Options

 

1.1

 

 

 

1.1

 

 

 

1.0

 

Weighted Average Fair Value of Stock Options issued (per share)

$

32.86

 

 

$

29.90

 

 

$

24.06

 

Fair Value of Stock Options Issued

$

34.9

 

 

$

31.5

 

 

$

24.9

 

The following table provides a summary of the assumptions used in the valuation of issued stock options:

 

2025

 

 

2024

 

 

2023

 

Risk-free interest rate

 

4.2

%

 

 

4.2

%

 

 

4.0

%

Expected life in years

 

7.0

 

 

 

7.2

 

 

 

7.3

 

Expected volatility

 

22.6

%

 

 

22.3

%

 

 

22.4

%

Dividend yield

 

1.1

%

 

 

1.1

%

 

 

1.3

%

The fair value of stock options is based upon the Black Scholes option pricing model. The Company determined the stock options’ lives based on historical exercise behavior and their expected volatility and dividend yield based on the historical changes in stock price and dividend payments. The risk-free interest rate is based on the yield of an applicable term Treasury instrument.

As of December 31, 2025, there was a fair value of $22.6 related to unamortized stock option compensation expense, which is expected to be recognized over the next three years. The Company’s Consolidated Statements of Cash Flow reflect an add back related to stock option awards of $26.9, $28.7 and $26.3 in 2025, 2024 and 2023, respectively, for non-cash compensation expense.

 

Restricted Stock Units

The Company granted employees 145,550 RSUs with a total fair value of $15.2 at a weighted average grant date fair value of $104.72 per RSU during the year ended December 31, 2025. The Company granted employees 121,050 RSUs with a total fair value of $12.4 at a weighted average grant date fair value of $102.40 per RSU during the year ended December 31, 2024. The annual RSU grants vest in one-third increments on each of the first, second and third anniversaries of the grant date, subject to the recipient’s continued employment with the Company from the grant date through the applicable vesting date, and are settled with shares of the Company’s Common Stock within 60 days following the applicable vesting date.

 

In connection with the Hero Acquisition, 854,882 shares of restricted stock were issued to certain individuals in October 2022 with a total fair value of $61.5. This restricted stock is recognized as compensation expense ratably over the vesting period if those individuals continue to be employed by the Company. The vesting requirements are satisfied at various dates over a three-year period from the date of the acquisition. 854,882 shares have vested as of December 31, 2025. The restricted stock expense associated with the Hero Acquisition for the twelve months ended December 31, 2025, 2024 and 2023 was $5.8, $20.3 and $29.2, respectively, and is included in the Non-cash compensation expense caption in the consolidated statement of cash flows.

In connection with the Touchland Acquisition, Touchland’s founder was granted rights to receive shares of our common stock valued at $50.0, with 50% of such shares vesting at each of the first and second year anniversaries of the closing. The value of common stock received by Touchland's founder will be recognized as a compensation expense ratably over the two-year vesting period if the individual continues to be employed by the Company. The restricted stock expense associated with the Touchland Acquisition for the twelve months ended December 31, 2025 was $11.5, and is included in the non-cash compensation expense caption in the consolidated statement of cash flows. Refer to Note 6 for additional details.

In January 2021, the Company issued cash-settled stock units under the Omnibus Equity Plan to all employees at the level of vice president and below. These restricted stock units have vested and were settled on the fifth anniversary of the date of grant. As a result of the issued cash-settled stock units, the Company recorded stock compensation expense of $0.9 and $1.3 in 2024 and 2023, respectively. The liability was approximately $3.4 and $4.4 as of December 31, 2025 and 2024, respectively.

 

Performance Stock Units

 

In the first quarter each of 2025, 2024, and 2023, respectively, the Company granted PSUs to members of the ELT, including the CEO, with an aggregate award of 18,140, 19,960, and 19,650 PSUs, respectively. The PSUs were valued at a weighted average grant date fair value equal to $136.76 in 2025, $122.24 in 2024 and $110.95 in 2023 per PSU using a Monte Carlo model. The performance target is based on the Company's total shareholder return ("TSR") relative to a Company selected peer group. The PSUs vest on the later of (i) the third anniversary of the grant date, and (ii) the date that the Board's Compensation & Human Capital Committee certifies the achievement of the applicable performance goals, in each case, subject to the recipient’s continued employment with the Company from the grant date through the vesting date. The number of shares that may be issued ranges from 0% to 200% based on relative TSR during the three-year performance period.

 

Employee Stock Purchase Plan

The Company’s Employee Stock Purchase Plan (“ESPP”) was adopted in February 2023 by the Company’s Board of Directors and became effective in April 2023 upon approval by the Company’s stockholders. There are 750,000 shares of Common Stock reserved for issuance under the ESPP. The ESPP, which is intended to be an “employee stock purchase plan” under Section 423 of the Internal Revenue Code, permits eligible employees to purchase Common Stock through after-tax payroll deductions. Currently, the purchase price under the ESPP is 85% of the fair market value of our Common Stock on the last trading day of the applicable quarterly purchase period. The maximum value of Common Stock that an eligible employee may purchase each calendar year is the lesser of 10% of an eligible employee’s annual pay and $25,000. There are four purchase periods in each calendar year under the ESPP, which begin on the first business day of each calendar quarter and end on the last business day of each calendar quarter. The first purchase period commenced in January 2025. There are 660,582 Common Shares remaining as of December 31, 2025 that are reserved for issuance under the ESPP.

Deferred Compensation Plans

The Company maintains a non-qualified deferred compensation plan under which certain members of management are eligible to defer a maximum of 85% of their regular compensation (i.e., salary) and, in general, up to 85% of their incentive bonus. As of January 1, 2024, the

limit was decreased from 85% to a maximum of 70% for both regular compensation and incentive bonus. The amounts deferred under this plan are credited with earnings or losses based upon changes in values of notional investments selected by the plan participant. The investment options available include notional investments in various stock, bond and money market funds as well as the Company’s Common Stock. Each plan participant is fully vested in the amounts the participant defers. The plan permits the Company to make profit sharing contributions that cannot otherwise be contributed to the qualified savings and profit-sharing plan due to limitations established by the Internal Revenue Service. These contributions vest under the same vesting schedule applicable to the qualified plan.

The liability to plan participants for contributions designated for notional investment in Common Stock is based on the quoted fair value of the Common Stock plus any dividends credited. The Company uses cash-settled hedging instruments to minimize the cost related to the volatility of Common Stock. At December 31, 2025 and 2024, the amount of the Company’s liability under the deferred compensation plan is included in Current and Deferred and Other Long-term Liabilities and was $134.9 and $135.8 respectively and the funded balances recorded in Other Assets amounted to $120.9 and $127.2, respectively. The amounts charged to earnings, including the effect of the hedges, totaled expense of $2.8, $2.0 and $3.7 in 2025, 2024 and 2023, respectively.

Non-employee members of the Company’s Board are eligible to defer up to 100% of their directors’ compensation into a similar plan; however, the only option for investment is Common Stock. Members of the Board are fully vested in their account balance. As of December 31, 2025, there were approximately 92,000 shares of Common Stock from shares held as Treasury Stock in a rabbi trust to protect the interest of the directors’ deferred compensation plan participants in the event of a change of control.
v3.25.4
Share Repurchases
 12 Months Ended
Dec. 31, 2025
Payments for Repurchase of Equity [Abstract]  
Share Repurchases
14.
Share Repurchases

On October 28, 2021, the Board authorized a new share repurchase program, under which the Company may repurchase up to $1,000.0 in shares of Common Stock (the “2021 Share Repurchase Program”). The 2021 Share Repurchase Program does not have an expiration and replaced the 2017 Share Repurchase Program.

As of December 31, 2025, there remains $228.9 of share repurchase availability under the 2021 Share Repurchase Program.

In May 2025, the Company entered into an accelerated share repurchase ("ASR") contract with a commercial bank to purchase Common Stock. The Company paid $300.0 to the bank, inclusive of fees, and received 2.8 million shares in May 2025 and 0.3 million shares in August 2025 at an average total share price of $95.71. The Company purchased all 3.1 million shares under the evergreen share repurchase program and used cash on hand to fund the purchase price.

In August and September 2025, the Company executed open market purchases of 3.2 million shares for $300.0, inclusive of fees, of which $170.0 was purchased under the evergreen share repurchase program and $130.0 was purchased under the 2021 Share Repurchase Program. The shares were purchased at an average share price of $92.81 and the Company used cash on hand to fund the open market purchases.

In November and December 2025, the Company executed open market purchases of 3.6 million shares for $300.0, inclusive of fees, of which all 3.6 million shares were purchased under the 2021 Share Repurchase Program. The shares were purchased at an average share price of $83.59 and the Company used cash on hand to fund the open market purchases.
v3.25.4
Accumulated Other Comprehensive Income (Loss)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
15.
Accumulated Other Comprehensive Income (Loss)

Comprehensive income is defined as net income and other changes in stockholders’ equity from transactions and other events from sources other than stockholders.

The components of changes in accumulated other comprehensive income (“AOCI”) are as follows:

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

Foreign

 

 

Defined

 

 

 

 

 

Other

 

 

Currency

 

 

Benefit

 

 

Derivative

 

 

Comprehensive

 

 

Adjustments

 

 

Plans

 

 

Agreements

 

 

Income (Loss)

 

Balance December 31, 2022

$

(46.4

)

 

$

1.7

 

 

$

15.4

 

 

$

(29.3

)

Other comprehensive income (loss) before reclassifications

 

8.6

 

 

 

3.9

 

 

 

(4.9

)

 

 

7.6

 

Amounts reclassified to consolidated statement of
   income(a)

 

0.0

 

 

 

0.0

 

 

 

(7.3

)

 

 

(7.3

)

Tax benefit (expense)

 

0.0

 

 

 

(1.0

)

 

 

2.8

 

 

 

1.8

 

Other comprehensive income (loss)

 

8.6

 

 

 

2.9

 

 

 

(9.4

)

 

 

2.1

 

Balance December 31, 2023

$

(37.8

)

 

$

4.6

 

 

$

6.0

 

 

$

(27.2

)

Other comprehensive income (loss) before reclassifications

 

(15.4

)

 

 

(0.2

)

 

 

20.8

 

 

 

5.2

 

Amounts reclassified to consolidated statement of
   income(a)

 

0.0

 

 

 

0.0

 

 

 

(4.0

)

 

 

(4.0

)

Tax benefit (expense)

 

0.0

 

 

 

0.0

 

 

 

(4.9

)

 

 

(4.9

)

Other comprehensive income (loss)

 

(15.4

)

 

 

(0.2

)

 

 

11.9

 

 

 

(3.7

)

Balance December 31, 2024

$

(53.2

)

 

$

4.4

 

 

$

17.9

 

 

$

(30.9

)

Other comprehensive income (loss) before reclassifications

 

21.9

 

 

 

0.6

 

 

 

(10.1

)

 

 

12.4

 

Amounts reclassified to consolidated statement of
   income(a)

 

0.0

 

 

 

0.0

 

 

 

(5.1

)

 

 

(5.1

)

Tax benefit (expense)

 

0.0

 

 

 

(0.2

)

 

 

3.9

 

 

 

3.7

 

Other comprehensive income (loss)

 

21.9

 

 

 

0.4

 

 

 

(11.3

)

 

 

11.0

 

Balance December 31, 2025

$

(31.3

)

 

$

4.8

 

 

$

6.6

 

 

$

(19.9

)
Amounts reclassified to cost of sales, selling, general and administrative expenses, or interest expense.
v3.25.4
Commitments, Contingencies and Guarantees
 12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments, Contingencies and Guarantees
16.
Commitments, Contingencies and Guarantees

Commitments

a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. The Company is not engaged in any other material transactions with the partnership or the partner supplier.

b. As of December 31, 2025, the Company had commitments of approximately $361.4. These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements.

c. As of December 31, 2025, the Company had various guarantees and letters of credit totaling $9.1.

d. In connection with the December 1, 2020 acquisition of the ZICAM® brand (the "Zicam Acquisition"), the Company deferred an additional cash payment of $20.0 related to certain indemnifications provided by the seller. The Company has withheld payment as of December 31, 2025 for any future indemnity obligations.

In connection with the December 24, 2021 acquisition of the THERABREATH® brand (the "TheraBreath Acquisition"), the Company deferred payment of a $14.0 portion of the purchase price related to certain indemnity obligations provided by the seller. The deferred amount is payable in installments between two and four years from the closing, with the first installment payment of $2.0 paid in January 2024, an additional $5.9 paid in the first quarter of 2025. The Company paid a final amount of $5.0 in January 2026.

In connection with the October 13, 2022 Hero Acquisition, the Company deferred an additional cash payment of $8.0 to satisfy certain indemnification obligations. The additional amount, to the extent not used in satisfaction of such indemnity obligations, is payable five years from the closing.

In connection with the July 16, 2025 Touchland Acquisition, the business acquisition liability was contingent upon the achievement of certain 2025 net sales thresholds, and will require a cash payment of $159.0 in the first half of 2026. The initial fair value of this business acquisition liability was $140.0, which was established in the purchase price allocation. During 2025, the Company increased the fair value of the business acquisition liability to $159.0 based on updated 2025 net sales. The changes in fair value were recorded within the Consumer Domestic segment. The Company deferred an additional cash payment of $5.0 to satisfy certain indemnification obligations. The additional amount, to the extent not used in satisfaction of such indemnity obligations, is payable three years from the closing.

e. In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition, results of operations and cash flows.

Legal proceedings

f. In addition to the matters described above, from time to time in the ordinary course of its business the Company is the subject of, or party to, various pending or threatened legal, regulatory or governmental actions or other proceedings, including, without limitation, those relating to, intellectual property, commercial transactions, product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety and other compliance related matters. Such proceedings are generally subject to considerable uncertainty and their outcomes, and any related damages, may not be reasonably predictable or estimable. Any such proceedings could result in a material adverse outcome negatively impacting the Company’s business, financial condition, results of operations or cash flows.
v3.25.4
Related Party Transactions
 12 Months Ended
Dec. 31, 2025
Related Party Transactions [Abstract]  
Related Party Transactions
17.
Related Party Transactions

The following summarizes the balances and transactions between the Company and each of Armand and ArmaKleen, in which the Company held a 50% ownership interest.

 

Armand

 

 

ArmaKleen(2)

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

 

2025

 

 

2024

 

 

2023

 

Purchases by Company

$

13.0

 

 

$

13.7

 

 

$

14.9

 

 

$

0.0

 

 

$

0.0

 

 

$

0.0

 

Sales by Company

$

0.0

 

 

$

0.0

 

 

$

0.0

 

 

$

0.0

 

 

$

0.9

 

 

$

1.4

 

Outstanding Accounts Receivable

$

1.1

 

 

$

0.9

 

 

$

1.6

 

 

$

0.0

 

 

$

0.0

 

 

$

1.4

 

Outstanding Accounts Payable

$

1.2

 

 

$

1.0

 

 

$

0.8

 

 

$

0.0

 

 

$

0.0

 

 

$

0.0

 

Administration & Management Oversight Services(1)

$

2.6

 

 

$

2.3

 

 

$

2.3

 

 

$

0.0

 

 

$

1.6

 

 

$

2.1

 
(1)
Billed by Company and recorded as a reduction of SG&A expenses.
(2)
In October 2024, the Company sold its 50% interest in ArmaKleen to our joint venture partner.
v3.25.4
Segments
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segments
18.
Segments

Segment Information

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division. These segments are determined based on differences in the nature of products and organizational and ownership structures.

Segment revenues are derived from the sale of the following products:

Segment

 

 

Products / Other

 

Consumer Domestic

 

Household and personal care products

Consumer International

 

Primarily personal care products

SPD

 

Specialty Products

As of December 31, 2025, the Company holds a 50% ownership interest in Armand. The Company's 50% interest in ArmaKleen was sold to our joint venture partner in October of 2024. The transaction is not material to the Company’s results of operations or cash flows. The Company’s equity in earnings of Armand and ArmaKleen, totaling $7.9, $9.1, and $8.7 for the three years ending December 31, 2025, 2024 and 2023, respectively, are not included in a reportable segment.

Our reportable segments comprise the structure used by our Chief Executive Officer, who has been determined to be the Chief Operating Decision Maker ("CODM") to make key operating decisions and assess performance. The CODM considers Income from Operations for evaluating performance of each segment and making decisions about allocating capital and other resources to each segment. Asset information and capital expenditures are not regularly provided to the CODM.

The following tables present financial information relating to the Company’s segments for each of the three years in the period ended December 31, 2025:

 

 

Year Ended December 31, 2025

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

4,774.8

 

 

$

1,129.4

 

 

$

299.0

 

 

 

-

 

 

$

6,203.2

 

Cost of sales

 

 

2,544.0

 

 

 

625.5

 

 

 

190.4

 

 

 

68.5

 

 

 

3,428.4

 

Gross Profit

 

 

2,230.8

 

 

 

503.9

 

 

 

108.6

 

 

 

(68.5

)

 

 

2,774.8

 

Marketing expenses

 

 

532.7

 

 

 

172.7

 

 

 

3.5

 

 

 

-

 

 

 

708.9

 

Research and Development(2)

 

 

129.1

 

 

 

13.5

 

 

 

3.0

 

 

 

-

 

 

 

145.6

 

Selling, general and administrative expenses

 

 

648.2

 

 

 

201.5

 

 

 

61.5

 

 

 

(68.5

)

 

 

842.7

 

Income from Operations

 

 

920.8

 

 

 

116.2

 

 

 

40.6

 

 

 

-

 

 

 

1,077.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2024

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

4,732.3

 

 

$

1,071.5

 

 

$

303.3

 

 

$

-

 

 

$

6,107.1

 

Cost of sales

 

 

2,450.1

 

 

 

605.5

 

 

 

193.5

 

 

 

67.9

 

 

 

3,317.0

 

Gross Profit

 

 

2,282.2

 

 

 

466.0

 

 

 

109.8

 

 

 

(67.9

)

 

 

2,790.1

 

Marketing expenses

 

 

538.5

 

 

 

156.9

 

 

 

2.7

 

 

 

-

 

 

 

698.1

 

Research and Development(2)

 

 

123.7

 

 

 

12.7

 

 

 

3.3

 

 

 

-

 

 

 

139.7

 

Selling, general and administrative expenses

 

 

607.7

 

 

 

183.6

 

 

 

64.7

 

 

 

(67.9

)

 

 

788.1

 

VMS Trade name and other asset impairments

 

 

327.4

 

 

 

29.7

 

 

 

-

 

 

 

-

 

 

 

357.1

 

Income from Operations

 

 

684.9

 

 

 

83.1

 

 

 

39.1

 

 

 

-

 

 

 

807.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2023

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

4,571.2

 

 

$

975.7

 

 

$

321.0

 

 

 

-

 

 

$

5,867.9

 

Cost of sales

 

 

2,434.0

 

 

 

568.7

 

 

 

216.3

 

 

 

60.4

 

 

 

3,279.4

 

Gross Profit

 

 

2,137.2

 

 

 

407.0

 

 

 

104.7

 

 

 

(60.4

)

 

 

2,588.5

 

Marketing expenses

 

 

509.5

 

 

 

127.7

 

 

 

4.1

 

 

 

-

 

 

 

641.3

 

Research and Development(2)

 

 

107.1

 

 

 

11.1

 

 

 

4.2

 

 

 

-

 

 

 

122.4

 

Selling, general and administrative expenses

 

 

590.9

 

 

 

164.0

 

 

 

72.9

 

 

 

(60.4

)

 

 

767.4

 

Income from Operations

 

 

929.7

 

 

 

104.2

 

 

 

23.5

 

 

 

-

 

 

 

1,057.4

 

 

 

(1)
Reflects the administrative costs of the production planning and logistics functions which are elements of Cost of Sales in the Company’s Consolidated Statements of Income but are allocated to the operating segments in Selling, General and Administrative expenses to determine operating segment income before income taxes.
(2)
All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment.

 

Other segment expenses for each of the three years in the period ended December 31, 2025 include the following:

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Total Consolidated

 

Depreciation & Amortization

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

$

210.1

 

 

$

25.8

 

 

$

11.5

 

 

$

247.4

 

2024

 

 

199.8

 

 

 

29.1

 

 

 

10.2

 

 

 

239.1

 

2023

 

 

183.9

 

 

 

27.7

 

 

 

13.6

 

 

 

225.2

 

 

Other than the differences noted in the footnote above, the accounting policies followed by each of the segments, including intersegment transactions, are substantially consistent with the accounting policies described in Note 1.

Product line revenues from external customers for each of the three years ended December 31, 2025, 2024 and 2023 were as follows:

 

 

 

2025

 

 

2024

 

 

2023

 

Household Products

 

$

2,556.9

 

 

$

2,584.3

 

 

$

2,484.1

 

Personal Care Products

 

 

2,217.9

 

 

 

2,148.0

 

 

 

2,087.1

 

Total Consumer Domestic

 

 

4,774.8

 

 

 

4,732.3

 

 

 

4,571.2

 

Total Consumer International

 

 

1,129.4

 

 

 

1,071.5

 

 

 

975.7

 

Total SPD

 

 

299.0

 

 

 

303.3

 

 

 

321.0

 

Total Consolidated Net Sales

 

$

6,203.2

 

 

$

6,107.1

 

 

$

5,867.9

 

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products, hair care products and gummy dietary supplements.

Geographic Information

Approximately 82%, 82% and 83% of the net sales reported in the accompanying consolidated financial statements in 2025, 2024 and 2023, respectively, were to customers in the U.S. Approximately 96%, 96% and 96% of long-lived assets were located in the U.S. at December 31, 2025, 2024 and 2023, respectively. Other than the U.S., no one country accounts for more than 5% of consolidated net sales and 5% of total assets.

Customers

A group of four customers accounted for approximately 44%, 43% and 44% of consolidated net sales in 2025, 2024, and 2023, respectively, of which a single customer (Walmart Inc. and its affiliates) accounted for approximately 23%, 23% and 23% in 2025, 2024 and 2023, respectively.
v3.25.4
SCHEDULE II-Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II-Valuation and Qualifying Accounts

SCHEDULE II - Valuation and Qualifying Accounts

For each of the three years in the period ended December 31, 2025

(Dollars in millions)

 

 

 

 

 

 

 

 

Additions

 

 

Deductions

 

 

 

 

 

 

 

 

 

 

Beginning

 

 

Charged to

 

 

 

 

 

Amounts

 

 

 

 

 

Foreign

 

 

Ending

 

 

 

 

Balance

 

 

Expenses

 

 

Acquired

 

 

Written Off

 

 

Divested

 

 

Exchange

 

 

Balance

 

Allowance for Doubtful Accounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

 

$

5.1

 

 

$

0.6

 

 

$

0.0

 

 

$

(2.1

)

 

$

0.0

 

 

$

0.1

 

 

$

3.7

 

 

2024

 

 

 

7.3

 

 

 

0.1

 

 

 

0.0

 

 

 

(2.2

)

 

 

0.0

 

 

 

(0.1

)

 

 

5.1

 

 

2023

 

 

 

3.5

 

 

 

4.0

 

 

 

0.0

 

 

 

(0.2

)

 

 

0.0

 

 

 

0.0

 

 

 

7.3

 

Allowance for Cash Discounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

 

$

9.2

 

 

$

124.6

 

 

$

0.0

 

 

$

(125.4

)

 

$

0.0

 

 

$

0.1

 

 

$

8.5

 

 

2024

 

 

 

8.9

 

 

 

120.1

 

 

 

0.0

 

 

 

(119.7

)

 

 

0.0

 

 

 

(0.1

)

 

 

9.2

 

 

2023

 

 

 

6.6

 

 

 

115.1

 

 

 

0.0

 

 

 

(112.7

)

 

 

0.0

 

 

 

(0.1

)

 

 

8.9

 

Sales Returns and Allowances

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

 

$

25.9

 

 

$

111.8

 

 

$

0.0

 

 

$

(111.0

)

 

$

0.0

 

 

$

0.1

 

 

$

26.8

 

 

2024

 

 

 

35.0

 

 

 

107.4

 

 

 

0.0

 

 

 

(116.4

)

 

 

0.0

 

 

 

(0.1

)

 

 

25.9

 

 

2023

 

 

 

34.8

 

 

 

128.9

 

 

 

0.0

 

 

 

(128.7

)

 

 

0.0

 

 

 

0.0

 

 

 

35.0

 

Inventory Reserves

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

 

$

45.2

 

 

$

24.0

 

 

$

0.0

 

 

$

(30.7

)

 

$

(6.0

)

 

$

1.0

 

 

$

33.5

 

 

2024

 

 

 

52.5

 

 

 

26.1

 

 

 

0.0

 

 

 

(32.6

)

 

 

0.0

 

 

 

(0.8

)

 

 

45.2

 

 

2023

 

 

 

46.0

 

 

 

40.5

 

 

 

0.0

 

 

 

(34.5

)

 

 

0.0

 

 

 

0.5

 

 

 

52.5

 
v3.25.4
Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the U.S. (“US GAAP”) and include the accounts of the Company and its majority‑owned subsidiaries. Material subsequent events are evaluated and disclosed through the report issuance date. For equity investments in which the Company does not control or have the ability to exert significant influence over the investee, which generally is when the Company has less than a 20% ownership interest, the investments are accounted for under the cost method. In circumstances where the Company has greater than a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee, the investment is accounted for under the equity method. As a result, the Company accounts for its 50% interest in its Armand Products Company (“Armand”) joint venture and its 50% interest in The ArmaKleen Company (“ArmaKleen”) joint venture under the equity method. The Company's 50% interest in ArmaKleen was sold to our joint venture partner in October of 2024. Armand and ArmaKleen are specialty chemical businesses. The Company’s equity in earnings of Armand and ArmaKleen are not reflected in a reportable segment.

Use Of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Management makes estimates regarding inventory valuation, promotional and sales returns reserves, the carrying amount of goodwill and other intangible assets, the realization of deferred tax assets, tax reserves, business acquisition liabilities, liabilities related to other postretirement benefit obligations and other matters that affect the reported amounts and other disclosures in the financial statements. These estimates are based on judgment and available information. Actual results could differ materially from those estimates, and it is possible that changes in such estimates could occur in the near term.

Revenue Recognition

Revenue Recognition

Revenue is recognized when control of a promised good is transferred to a customer in an amount that reflects the consideration that the Company expects to be entitled to in exchange for that good. This usually occurs when finished goods are delivered to the Company’s customers or when finished goods are picked up by a customer or a customer’s carrier.

a.
Nature of Goods and Services

The Company primarily ships finished goods to its customers and operates in three segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”). The segments are based on differences in the nature of products and management organizational structures. The Consumer Domestic and Consumer International segments market a variety of personal care, household and over-the-counter products, including but not limited to baking soda, cat litter, laundry detergent, condoms, stain removers, hair removal, gummy dietary supplements, dry shampoo, oral care, cold remedy, acne treatment, and water flossers. The SPD segment focuses on sales to businesses and participates in three product areas: Animal Nutrition, Specialty Chemicals and Commercial & Professional. The Company’s products are distinct and separately identifiable on customer contracts or invoices, with each product sale representing a separate performance obligation.

The Company sells consumer products under a variety of brands through a broad distribution platform that includes supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar, pet and other specialty stores and websites and other e-commerce channels, all of which sell its products to consumers. The Company sells its specialty products to industrial customers, livestock producers and through distributors.

Refer to Note 18 for disaggregated revenue information with respect to each of the Company’s segments.

 

 

b.
When Performance Obligations are Satisfied

For performance obligations related to the shipping and invoicing of products, control transfers at the point in time upon which finished goods are delivered to the Company’s customers or when finished goods are picked up by a customer or a customer’s carrier. Once a product has been delivered or picked up by the customer, the customer is able to direct the use of, and obtain substantially all of the remaining benefits from, the asset. The Company considers control to have transferred upon delivery or customer receipt because the Company has an enforceable right to payment at that time, the customer has legal title to the asset, the Company has transferred physical possession of the asset, and the customer has significant risk and rewards of ownership of the asset.

c.
Variable Consideration

The Company conducts extensive promotional activities, primarily through the use of off-list discounts, slotting, coupons, cooperative advertising, periodic price reduction arrangements, and end-aisle and other in-store displays. The costs of such activities are netted against sales and are recorded when the related sale takes place. The reserves for sales returns and consumer and trade promotion liabilities are established based on the Company’s best estimate of the amounts necessary to settle future and existing obligations for products sold as of the balance sheet date. The Company uses historical trend experience and coupon redemption inputs in arriving at coupon reserve requirements, and uses forecasted appropriations, customer and sales organization inputs, and historical trend analysis in determining the reserves for other promotional activities and sales returns.

d.
Practical Expedients

The Company expenses incremental direct costs of obtaining a contract (broker commissions) when the related sale takes place. These costs are recorded in SG&A expenses in the accompanying consolidated statements of income.

The Company accounts for shipping and handling costs as fulfillment activities which are therefore recognized upon shipment of the goods.

The Company has applied the portfolio approach to all open contracts as they have similar characteristics and can reasonably expect that the effects on the financial statements of applying this guidance to the portfolio of contracts would not differ materially from applying this guidance to the individual contracts within the portfolio.

The Company excludes from its revenue any amounts collected from customers for sales (and similar) taxes.
Sales of Accounts Receivable

Sales of Accounts Receivable

The Company entered into a factoring agreement with a financial institution to sell certain customer receivables at discounted rates in 2015. Transactions under this agreement are accounted for as sales of accounts receivable and are removed from the Consolidated Balance Sheet at the time of the sales transaction. The level of customers associated with the Company’s factoring program and the sales performance by those customers has driven the amount factored each year. The total amount factored in each year was $100.5, $105.9, and $144.2 during the years ended December 31, 2025, 2024 and 2023, respectively.
Cost of Sales

Cost of Sales, Marketing and Selling, General and Administrative Expenses

Cost of sales include costs related to the manufacture and distribution of the Company’s products, including raw material, inbound freight, import duties and tariffs, direct labor (including employee compensation benefits) and indirect plant costs such as plant supervision, receiving, inspection, maintenance labor and materials, depreciation, taxes and insurance, purchasing, production planning, operations management, logistics, freight to customers, warehousing costs, internal transfer freight costs and plant impairment charges.
Marketing

Marketing expenses include costs for advertising (excluding the costs of cooperative advertising programs, which are reflected in net sales), costs for coupon insertion (mainly the cost of printing and distribution), consumer promotion costs (such as on-shelf advertisements and floor ads), public relations, package design expense and market research costs.
Selling, General and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses include, among others, costs related to functions such as sales, corporate management, research and development, marketing administration, information technology, finance and legal. Such costs include salary compensation related costs (such as benefits, incentive compensation and profit sharing), stock-based award costs, depreciation, travel and entertainment related expenses, professional and other consulting fees and amortization of intangible assets.
Foreign Currency Translation

Foreign Currency Translation

Unrealized gains and losses related to currency translation are recorded in Accumulated Other Comprehensive Income (Loss). Gains and losses on foreign currency transactions are recorded in the Consolidated Statements of Income.
Cash Equivalents

Cash Equivalents

Cash equivalents consist of highly liquid short-term investments and term bank deposits, which mature within three months of their original maturity date.
Inventories

Inventories

Inventories are valued at the lower of cost or market (net realizable value, which reflects any costs to sell or dispose). The Company identifies any slow moving, obsolete or excess inventory to determine whether an adjustment is required to establish a new carrying value. The determination of whether inventory items are slow moving, obsolete or in excess of needs requires estimates and assumptions about the future demand for the Company’s products, technological changes, and new product introductions. Estimates as to the future demand used in the valuation of inventory involve judgments regarding the ongoing success of the Company’s products. The Company evaluates its inventory levels and expected usage on a periodic basis and records adjustments as required. Adjustments to reflect inventory at net realizable value were $33.5 at December 31, 2025, and $45.2 at December 31, 2024.
Property, Plant and Equipment

Property, Plant and Equipment

Property, Plant and Equipment (“PP&E”) are stated at cost. Depreciation is recorded using the straight-line method over the estimated useful lives of the respective assets. Estimated useful lives for building and improvements, machinery and equipment, and office equipment range from 9-40, 3-20 and 3-10 years, respectively. Routine repairs and maintenance are expensed when incurred. Leasehold improvements are depreciated over a period no longer than the respective lease term, except where a lease renewal has been determined to be reasonably assured and failure to renew the lease results in a significant penalty to the Company.

PP&E is reviewed annually and whenever events or changes in circumstances indicate that possible impairment exists. The Company’s impairment review is based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of Company assets and liabilities. The analysis requires management judgment with respect to changes in technology, the continued success of product lines, and future volume, revenue and expense growth rates. The Company conducts annual reviews to identify idle and underutilized equipment, and reviews business plans for possible impairment. An indication of impairment occurs when the carrying value of the asset exceeds the future undiscounted cash flows. When an impairment is indicated, the estimated future cash flows are then discounted to determine the estimated fair value of the asset and an impairment charge is recorded for the difference between the carrying value and the net present value of estimated future cash flows.
Software

Software

The Company capitalizes certain costs of developing computer software. Amortization is recorded using the straight‑line method over the estimated useful life of the software, which is estimated to be no longer than 10 years.
Fair Value of Financial Instruments

Fair Value of Financial Instruments

Certain financial instruments are required to be recorded at fair value. The estimated fair values of such financial instruments (including investment securities and other derivatives) have been determined using market information and generally accepted valuation methodologies. Changes in assumptions or estimation methods could affect the fair value estimates. Other financial instruments, including cash equivalents and short-term debt, are recorded at cost, which approximates fair value. Additional information regarding the Company’s risk management activities, including derivative instruments and hedging activities, is separately disclosed. See Notes 2 and 3.
Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets

The Company has intangible assets of substantial value on its consolidated balance sheet. Intangible assets are generally related to intangible assets with a useful life, indefinite-lived trade names and goodwill. The Company determines whether an intangible asset (other than goodwill) has a useful life based on multiple factors, including how long the Company intends to generate cash flows from the asset.

Carrying values of goodwill and indefinite-lived trade names are reviewed periodically for possible impairment. The Company’s impairment analysis is based on a discounted cash flow approach that requires significant judgment with respect to unit volume, revenue and expense growth rates, and the selection of an appropriate discount rate and royalty rate. Management uses estimates based on expected trends in making these assumptions. With respect to goodwill, impairment occurs when the carrying value of the reporting unit exceeds the discounted present value of cash flows for that reporting unit. For trade names and other intangible assets, an impairment charge is recorded

for the difference between the carrying value and the net present value of estimated future cash flows, which represents the estimated fair value of the asset. Judgment is required in assessing whether assets may have become impaired between annual valuations. Indicators such as unexpected adverse economic factors, unanticipated technological change, distribution losses, or competitive activities and acts by governments and courts may indicate that an asset has become impaired. Intangible assets with finite lives are amortized over their estimated useful lives, which range from 3-20 years, using the straight-line method, and reviewed for impairment when changes in market circumstances occur.

Research and Development

Research and Development

The Company incurred research and development expenses in the amount of $145.6, $139.7 and $122.4 in 2025, 2024 and 2023, respectively. These expenses are included in SG&A expenses and are expensed as incurred.
Earnings Per Share ("EPS")

Earnings Per Share (“EPS”)

Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted-average number of shares outstanding during the reported period. Diluted EPS includes dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options. The following table sets forth a reconciliation of the weighted-average number of shares of Common Stock outstanding to the weighted-average number of shares outstanding on a diluted basis:

 

2025

 

 

2024

 

 

2023

 

Weighted average common shares outstanding - basic

 

242.7

 

 

 

244.4

 

 

 

244.9

 

Dilutive effect of stock options

 

1.6

 

 

 

2.5

 

 

 

2.7

 

Weighted average common shares outstanding - diluted

 

244.3

 

 

 

246.9

 

 

 

247.6

 

Antidilutive stock options outstanding

 

2.1

 

 

 

1.1

 

 

 

2.6

 
Employee and Director Stock Option Based Compensation

Employee and Director Stock Based Compensation

The fair value of stock-based compensation is determined at the grant date and the related expense is generally recognized over the required employee service period in which the share-based compensation vests. For employees and Directors that meet retirement eligibility requirements, the expense related to stock-based compensation is recognized on the date of grant as there is no service period required to vest in the awards. The following table presents the pre-tax expense associated with the fair value of stock awards included in SG&A expenses and in cost of sales:

 

 

For the Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Cost of sales

$

2.8

 

 

$

3.9

 

 

$

3.4

 

Selling, general and administrative expenses

 

54.2

 

 

 

56.2

 

 

 

61.5

 

Total

$

57.0

 

 

$

60.1

 

 

$

64.9

 
Income Taxes

Income and Other Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized to reflect the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the differences are expected to be recovered or settled. Management provides a valuation allowance against deferred tax assets for amounts which are not considered “more likely than not” to be realized. The Company records liabilities for potential assessments in various tax jurisdictions in accordance with GAAP. The liabilities relate to tax return positions that, although supportable by the Company, may be challenged by the tax authorities and do not meet the minimum recognition threshold required under applicable accounting guidance for the related tax benefit to be recognized in the income statement. The Company adjusts this liability as a result of changes in tax legislation, interpretations of laws by courts, rulings by tax authorities, changes in estimates and the expiration of the statute of limitations. Many of the judgments involved in adjusting the liability involve assumptions and estimates that are highly uncertain and subject to change. In this regard, settlement of any issue with, or an adverse determination in litigation against, a taxing authority could require the use of cash and result in an increase in the Company’s annual effective tax rate. Conversely, favorable resolution of an issue with a taxing authority would be recognized as a reduction to the Company’s annual effective tax rate.

The Company elected to record the payment of excise tax associated with Treasury Stock purchases in the financing section of the cash flow in accordance with ASC 230.
Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The standard was effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company has adopted the standard retrospectively to all prior periods in the financial statements, which resulted in additional disclosures. Refer to Note 18 for additional information.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosure which includes amendments that further expand income tax disclosures, by requiring the disaggregation of information in the rate reconciliation table, and income taxes paid by jurisdiction. The amendments are effective for fiscal years beginning after December 15, 2024. The Company has elected to adopt ASU 2023-09 prospectively beginning in fiscal year 2025. As a result, the rate reconciliation disclosure for fiscal years 2023 and 2024 will remain unchanged, and the expanded disaggregation requirements are reflected in these financial statements. Refer to footnote 12.

Recent Accounting Pronouncements Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). The ASU requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including purchases of inventory, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. ASU 2024-03, as clarified by ASU 2025-01 is effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with prospective or retrospective application permitted. The Company is currently evaluating the impact of adoption on the Company’s related disclosures.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
v3.25.4
Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Reconciliation Of Weighted Average Number Of Common Shares Outstanding The following table sets forth a reconciliation of the weighted-average number of shares of Common Stock outstanding to the weighted-average number of shares outstanding on a diluted basis:

 

2025

 

 

2024

 

 

2023

 

Weighted average common shares outstanding - basic

 

242.7

 

 

 

244.4

 

 

 

244.9

 

Dilutive effect of stock options

 

1.6

 

 

 

2.5

 

 

 

2.7

 

Weighted average common shares outstanding - diluted

 

244.3

 

 

 

246.9

 

 

 

247.6

 

Antidilutive stock options outstanding

 

2.1

 

 

 

1.1

 

 

 

2.6

 
Summary of Pre-Tax Expense Associated with Fair value of Unvested Stock Options and Restricted Stock Awards The following table presents the pre-tax expense associated with the fair value of stock awards included in SG&A expenses and in cost of sales:

 

 

For the Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Cost of sales

$

2.8

 

 

$

3.9

 

 

$

3.4

 

Selling, general and administrative expenses

 

54.2

 

 

 

56.2

 

 

 

61.5

 

Total

$

57.0

 

 

$

60.1

 

 

$

64.9

 
v3.25.4
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Carrying Amounts and Estimated Fair Values of Other Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at December 31, 2025 and 2024:

 

 

 

December 31, 2025

 

 

December 31, 2024

 

 

Input

 

Carrying

 

 

Fair

 

 

Carrying

 

 

Fair

 

 

Level

 

Amount

 

 

Value

 

 

Amount

 

 

Value

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

Level 1

 

$

217.5

 

 

$

217.5

 

 

$

793.3

 

 

$

793.3

 

Financial Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

3.15% Senior notes due August 1, 2027

Level 2

 

 

424.9

 

 

 

420.1

 

 

 

424.9

 

 

 

411.1

 

2.3% Senior notes due December 15, 2031

Level 2

 

 

399.5

 

 

 

355.4

 

 

 

399.4

 

 

 

338.9

 

5.6% Senior notes due November 15, 2032

Level 2

 

 

499.3

 

 

 

532.3

 

 

 

499.2

 

 

 

515.3

 

3.95% Senior notes due August 1, 2047

Level 2

 

 

397.9

 

 

 

318.4

 

 

 

397.8

 

 

 

307.7

 

5.0% Senior notes due June 15, 2052

Level 2

 

 

499.9

 

 

 

457.3

 

 

 

499.9

 

 

 

451.9

 
v3.25.4
Derivative Instruments and Risk Management (Tables)
 12 Months Ended
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amounts

The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table:

 

 

 

Notional

 

Notional

 

 

 

Amount

 

Amount

 

 

 

December 31, 2025

 

December 31, 2024

 

Derivatives designated as hedging instruments

 

 

 

 

 

Foreign exchange contracts

 

$

438.2

 

$

317.0

 

Diesel fuel contracts

 

4.5 gallons

 

0.8 gallons

 

Commodities contracts

 

43.6 pounds

 

0.0 pounds

 

Net Investment Hedge

 

$

25.0

 

$

0.0

 

Derivatives not designated as hedging instruments

 

 

 

 

 

Foreign exchange contracts

 

$

2.4

 

$

0.0

 

Equity derivatives

 

$

12.0

 

$

24.6

 
T
v3.25.4
Inventories (Tables)
 12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
Components of Inventories

Inventories consist of the following:

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Raw materials and supplies

$

143.7

 

 

$

140.4

 

Work in process

 

35.0

 

 

 

45.4

 

Finished goods

 

356.1

 

 

 

427.5

 

Total

$

534.8

 

 

$

613.3

 
v3.25.4
Property, Plant and Equipment, Net ("PP&E") (Tables)
 12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Components of Property, Plant and Equipment

PP&E consists of the following:

 

December 31,

 

 

December 31,

 

 

2025(1)

 

 

2024

 

Land

$

16.0

 

 

$

29.2

 

Buildings and improvements

 

367.5

 

 

 

348.2

 

Machinery and equipment

 

911.1

 

 

 

1,000.4

 

Software

 

138.9

 

 

 

129.6

 

Office equipment and other assets

 

131.6

 

 

 

129.3

 

Construction in progress

 

131.9

 

 

 

215.1

 

Gross PP&E

 

1,697.0

 

 

 

1,851.8

 

Less accumulated depreciation

 

874.2

 

 

 

920.1

 

Net PP&E

$

822.8

 

 

$

931.7

 

 

(1)In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.

 

For the Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

Depreciation expense on PP&E

$

89.7

 

 

$

83.2

 

 

$

72.8

 
v3.25.4
Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2025
Summary of Assets Acquired and Liabilities Assumed

The preliminary fair values of the net assets at acquisition are set forth as follows:

 

Accounts receivable

$

9.3

 

Inventory

 

25.8

 

Other current assets

 

1.3

 

Property, plant and equipment

 

5.5

 

Other long-term assets

 

2.1

 

Trade name

 

730.0

 

Customer relationship intangible asset

 

32.8

 

Goodwill

 

206.5

 

Accounts payable, accrued expenses and other liabilities

 

(23.3

)

Business acquisition liabilities - short-term

 

(140.0

)

Deferred income taxes

 

(183.8

)

Deferred and other long-term liabilities

 

(10.2

)

Cash purchase price (net of cash acquired)

$

656.0

 
Fair Values of Assets Acquired

The fair values of the net assets at acquisition are set forth as follows:

 

Accounts receivable

$

3.5

 

Inventory

 

11.3

 

Other current assets

 

1.5

 

Other long-term assets

 

5.8

 

Customer relationship intangible asset

 

8.4

 

Goodwill

 

2.8

 

Accounts payable, accrued expenses and other liabilities

 

(6.9

)

Long-term debt

 

(4.4

)

Deferred income taxes

 

(2.1

)

Cash purchase price (net of cash acquired)

$

19.9

 
v3.25.4
Goodwill and Other Intangibles, Net (Tables)
 12 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Indefinite Lived Intangible Assets

The following table presents the carrying value of indefinite-lived intangible assets:

 

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Gross Carrying Value Trade Names

$

1,680.7

 

 

$

1,960.7

 

VMS impairment

0.0

 

 

$

(281.3

)

Spinbrush impairment

 

(7.9

)

 

 

0.0

 

Net Carrying Value Trade Names

$

1,672.8

 

 

$

1,679.4

 
Intangible and Fixed Asset Impairment Charges

A summary of the VMS intangible and fixed asset impairment charges are as follows:

 

December 31,

 

 

2024

 

Trade Name

$

281.3

 

Customer Relationship Intangible Asset

 

15.8

 

PP&E

 

60.0

 

Total VMS impairment charges

$

357.1

 
Amortizable Intangible Assets

The following table provides information related to the carrying value of amortizable intangible assets:

 

December 31, 2025

 

 

 

 

December 31, 2024

 

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

Impairment

 

 

 

 

 

Period

 

Carrying

 

 

Accumulated

 

 

Impairment

 

 

 

 

 

Amount

 

 

Amortization

 

 

Charges(2)

 

 

Net

 

 

(Years)

 

Amount

 

 

Amortization

 

 

Charges(1)

 

 

Net

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade names

$

2,113.4

 

 

$

(562.1

)

 

$

(11.6

)

 

$

1,539.7

 

 

3-20

 

$

1,383.4

 

 

$

(479.6

)

 

$

0.0

 

 

$

903.8

 

Customer Relationships

 

598.5

 

 

 

(365.2

)

 

 

(0.7

)

 

 

232.6

 

 

15-20

 

 

644.9

 

 

 

(402.1

)

 

 

(15.8

)

 

 

227.0

 

Patents/Formulas

 

205.6

 

 

 

(139.2

)

 

 

0.0

 

 

 

66.4

 

 

4-20

 

 

205.5

 

 

 

(127.2

)

 

0.0

 

 

 

78.3

 

Total

$

2,917.5

 

 

$

(1,066.5

)

 

$

(12.3

)

 

$

1,838.7

 

 

 

 

$

2,233.8

 

 

$

(1,008.9

)

 

$

(15.8

)

 

$

1,209.1

 

 

(1) The $15.8 impairment charge relates to the VMS customer relationship intangible asset, which had a gross value of $79.2 and accumulated amortization of $63.4 prior to full impairment (as discussed above).

(2) The $12.3 impairment charge relates to the Flawless trade name and Spinbrush customer relationship intangible asset, which had a gross value of $76.2 and accumulated amortization of $63.9 prior to full impairment. The impairments were a result of the Company's decision to exit these businesses (as discussed above).

Carrying Amount of Goodwill

The changes in the carrying amount of goodwill for the years ended December 31, 2025 and 2024 are as follows:

 

Consumer

 

 

Consumer

 

 

Specialty

 

 

 

 

 

Domestic

 

 

International

 

 

Products

 

 

Total

 

Balance at December 31, 2023

$

2,061.1

 

 

$

234.4

 

 

$

136.0

 

 

$

2,431.5

 

Graphico acquired goodwill

 

0.0

 

 

 

2.8

 

 

 

0.0

 

 

 

2.8

 

Passport divestiture

 

0.0

 

 

 

0.0

 

 

 

(1.1

)

 

 

(1.1

)

Balance at December 31, 2024

$

2,061.1

 

 

$

237.2

 

 

$

134.9

 

 

$

2,433.2

 

Touchland acquired goodwill

 

206.5

 

 

 

0.0

 

 

 

0.0

 

 

 

206.5

 

VMS divestiture (as discussed above)

 

(12.6

)

 

 

0.0

 

 

 

0.0

 

 

 

(12.6

)

Other

 

0.4

 

 

 

0.0

 

 

 

0.0

 

 

 

0.4

 

Balance at December 31, 2025

$

2,255.4

 

 

$

237.2

 

 

$

134.9

 

 

$

2,627.5

 

 
v3.25.4
Leases (Tables)
 12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Summary of Lease Information

A summary of the Company’s lease information is as follows:

 

 

December 31,

 

 

December 31,

 

 

Classification

2025

 

 

2024

 

Assets

 

 

 

 

 

 

Right of use assets

Other Assets

$

166.0

 

 

$

182.3

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Current lease liabilities

Accrued Expenses and Other Liabilities

$

23.9

 

 

$

32.4

 

Long-term lease liabilities

Deferred and Other Long-term Liabilities

 

153.0

 

 

 

168.5

 

Total lease liabilities

 

$

176.9

 

 

$

200.9

 

 

 

 

 

 

 

 

Other information

 

 

 

 

 

 

Weighted-average remaining lease term (years)

 

 

7.4

 

 

 

7.4

 

Weighted-average discount rate

 

 

5.2

%

 

 

4.6

%

 

 

 

Twelve Months

 

 

 

Twelve Months

 

 

Twelve Months

 

 

 

 

Ended

 

 

 

Ended

 

 

Ended

 

 

 

 

December 31, 2025

 

 

 

December 31, 2024

 

 

December 31, 2023

 

 

Statement of Income

 

 

 

 

 

 

 

 

 

 

 

Lease cost(1)

 

$

42.2

 

 

 

$

40.2

 

 

$

31.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve Months

 

 

 

Twelve Months

 

 

 

 

 

 

 

Ended

 

 

 

Ended

 

 

 

 

 

 

 

December 31, 2025

 

 

 

December 31, 2024

 

 

 

 

 

Other information

 

 

 

 

 

 

 

 

 

 

 

Leased assets obtained in exchange for new lease liabilities(2)

 

$

15.4

 

 

 

$

28.0

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

$

42.5

 

 

 

$

35.3

 

 

 

 

 
(1)
Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The noncash component of lease expense for the twelve months ended December 31, 2025, 2024 and 2023 was $32.7, $30.9 and $24.3, respectively, is included in the amortization caption in the consolidated statement of cash flows.
(2)
Leased assets obtained in exchange for new lease liabilities in 2025 consisted of $48.6 of real estate lease additions and $3.7 of equipment lease additions, net of modifications, offset by $36.9 in lease terminations resulting from the sale of the VMS business. The additions include an increase to the Company's right of use asset and corresponding lease liabilities of $31.7 for an agreement between the Company and a third-party warehouse provider for new warehouse space in December 2025. In April 2025, the Company extended the lease term at one of its leased warehouse facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $11.0 recorded in the second quarter of 2025. Leased assets obtained in exchange for new lease liabilities in 2024 consisted of $16.8 of real estate lease additions and $11.2 of equipment lease additions, net of modifications. These additions included expanded space at one of the Company's leased manufacturing
facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $15.4 recorded in the first quarter of 2024.
Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements

The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows:

 

 

 

Operating

 

 

 

Leases

 

2026

 

$

32.4

 

2027

 

 

30.7

 

2028

 

 

26.6

 

2029

 

 

26.0

 

2030

 

 

25.9

 

2031 and thereafter

 

 

73.6

 

Total future minimum lease commitments

 

 

215.2

 

Less: Imputed interest

 

 

(38.3

)

Present value of lease liabilities

 

$

176.9

 
v3.25.4
Accounts Payable, Accrued and Other Liabilities (Tables)
 12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Expenses

Accounts payable, accrued expenses and other liabilities consist of the following:

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Accounts payable

$

732.4

 

 

$

705.1

 

Accrued marketing and promotion costs

 

221.4

 

 

 

259.6

 

Accrued wages and related benefit costs

 

145.7

 

 

 

151.4

 

Other accrued current liabilities

 

394.8

 

 

 

194.5

 

Total

$

1,494.3

 

 

$

1,310.6

 

 
v3.25.4
Long-Term Debt (Tables)
 12 Months Ended
Dec. 31, 2025
Debt Disclosure [Abstract]  
Components of Short-Term Borrowings and Long-Term Debt

Long-term debt consists of the following:

 

December 31,

 

 

December 31,

 

 

2025

 

 

2024

 

Long-term debt

 

 

 

 

 

3.15% Senior notes due August 1, 2027

$

425.0

 

 

$

425.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

2.3% Senior notes due December 15, 2031

 

400.0

 

 

 

400.0

 

Less: Discount

 

(0.5

)

 

 

(0.6

)

5.6% Senior notes due November 15, 2032

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.7

)

 

 

(0.8

)

3.95% Senior notes due August 1, 2047

 

400.0

 

 

 

400.0

 

Less: Discount

 

(2.1

)

 

 

(2.2

)

5.0% Senior notes due June 15, 2052

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

Debt issuance costs, net

 

(16.4

)

 

 

(16.6

)

Total long-term debt

$

2,205.1

 

 

$

2,204.6

 
v3.25.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Components of Income Before Taxes

The components of income before taxes are as follows:

 

 

2025

 

 

2024

 

 

2023

 

Domestic

 

$

876.6

 

 

$

666.5

 

 

$

872.4

 

Foreign

 

 

80.3

 

 

 

89.8

 

 

 

95.0

 

Total

 

$

956.9

 

 

$

756.3

 

 

$

967.4

 
Schedule of U.S. Federal, State and Foreign Income Taxes

The following table summarizes the provision for U.S. federal, state and foreign income taxes:

 

 

2025

 

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

 

 

 

U.S. federal

 

$

129.5

 

 

$

180.9

 

 

$

159.1

 

State

 

 

31.7

 

 

 

45.2

 

 

 

40.9

 

Foreign

 

 

22.9

 

 

 

26.9

 

 

 

25.6

 

 

 

 

184.1

 

 

 

253.0

 

 

 

225.6

 

Deferred:

 

 

 

 

 

 

 

 

 

U.S. federal

 

 

44.3

 

 

 

(64.5

)

 

 

(11.3

)

State

 

 

(9.7

)

 

 

(15.7

)

 

 

(2.8

)

Foreign

 

 

1.4

 

 

 

(1.8

)

 

 

0.3

 

 

 

 

36.0

 

 

 

(82.0

)

 

 

(13.8

)

Total provision

 

$

220.1

 

 

$

171.0

 

 

$

211.8

 

 
Components of Deferred Tax Assets and Liabilities

Deferred tax assets (liabilities) consist of the following at December 31, 2025 and 2024:

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Accounts receivable

 

$

7.2

 

 

$

7.4

 

Deferred compensation

 

 

55.8

 

 

 

51.7

 

Pension, postretirement, and postemployment benefits

 

 

4.8

 

 

 

2.9

 

Inventory reserve

 

 

7.7

 

 

 

8.6

 

Sec 174 R&D capitalization

 

 

13.4

 

 

 

59.4

 

ASC 842 lease liabilities

 

 

32.9

 

 

0.0

 

Tax credit carryforwards/other tax attributes

 

 

9.1

 

 

 

5.1

 

International operating loss carryforwards

 

 

8.9

 

 

 

8.4

 

Other

 

 

18.1

 

 

 

8.8

 

Total gross deferred tax assets

 

 

157.9

 

 

 

152.3

 

Valuation allowances

 

 

(17.1

)

 

 

(14.3

)

Total deferred tax assets

 

 

140.8

 

 

 

138.0

 

Deferred tax liabilities:

 

 

 

 

 

 

Goodwill

 

 

(311.0

)

 

 

(298.7

)

Trade names and other intangibles

 

 

(579.2

)

 

 

(415.0

)

Property, plant, and equipment

 

 

(96.2

)

 

 

(85.2

)

ASC 842 Right of Use assets

 

 

(30.4

)

 

0.0

 

Interest rate swaps

 

 

(3.2

)

 

 

(3.7

)

Total deferred tax liabilities

 

 

(1,020.0

)

 

 

(802.6

)

Net deferred tax liability

 

$

(879.2

)

 

$

(664.6

)

Long term net deferred tax asset

 

 

7.7

 

 

 

4.6

 

Long term net deferred tax liability

 

 

(886.9

)

 

 

(669.2

)

Net deferred tax liability

 

$

(879.2

)

 

$

(664.6

)

Effective Tax Rate Reconciliation

The difference between tax expense and the tax that would result from the application of the federal statutory rate is as follows:

 

 

2025

 

 

Amount

 

Percent

 

Federal

$

119.0

 

 

63.2

%

State

 

40.6

 

 

21.6

%

Foreign

 

28.5

 

 

15.2

%

Total Income Tax Paid

$

188.1

 

 

100.0

%

 

 

2025

 

 

Amount

 

Percent

 

U.S. Federal Statutory Tax Rate

$

200.9

 

 

21.0

%

State and Local Income Taxes, Net of Federal Income Tax Effect (a)

 

17.4

 

 

1.8

 

Foreign Tax Effects

 

8.2

 

 

0.9

 

Effect of Cross-Border Tax Laws

 

(3.1

)

 

-0.3

 

Tax Credits

 

(6.2

)

 

-0.6

 

Changes in Valuation Allowances

 

3.2

 

 

0.3

 

Nontaxable or Nondeductible Items

 

5.2

 

 

0.5

 

Changes in Unrecognized Tax Benefits

 

1.0

 

 

0.1

 

Other Adjustments

 

(6.5

)

 

-0.7

 

     ASC 842 Right of Use Assets

 

26.5

 

 

2.8

 

     ASC 842 Lease Liabilities

 

(28.6

)

 

-3.0

 

     Other

 

(4.4

)

 

-0.5

 

Effective Tax Rate

$

220.1

 

 

23.0

%

 

(a) State taxes in Florida, Illinois, New Jersey, New York, and Texas made up of the majority (greater than 50%) of the tax effect in this category.

 

 

 

 

2024

 

 

2023

 

Statutory rate

 

 

 

21

%

 

 

21

%

Tax that would result from use of the federal statutory rate

 

 

$

158.8

 

 

$

203.1

 

State and local income tax, net of federal effect

 

 

 

23.3

 

 

 

30.1

 

Varying tax rates of foreign affiliates

 

 

 

6.9

 

 

 

6.8

 

Valuation Allowances

 

 

 

2.1

 

 

0.0

 

Stock Options Exercised

 

 

 

(23.0

)

 

 

(21.8

)

Reserve for Uncertain Tax Position

 

 

 

0.3

 

 

 

(0.3

)

Other

 

 

 

2.6

 

 

 

(6.1

)

Recorded tax expense

 

 

$

171.0

 

 

$

211.8

 

Effective tax rate

 

 

 

22.6

%

 

 

21.9

%
Reconciliation of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

2025

 

 

2024

 

 

2023

 

Unrecognized tax benefits at January 1

 

$

5.4

 

 

$

5.1

 

 

$

5.8

 

Gross increases - tax positions in current period

 

 

6.1

 

 

 

0.9

 

 

0.0

 

Lapse of statute of limitations

 

 

(0.7

)

 

 

(0.6

)

 

 

(0.7

)

Unrecognized tax benefits at December 31

 

$

10.8

 

 

$

5.4

 

 

$

5.1

 
v3.25.4
Stock Based Compensation Plans and Other Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Option Activity

Stock option transactions for the year ended December 31, 2025 were as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

Options

 

 

Price

 

 

Term

 

 

Value

 

Outstanding as of December 31, 2024

 

8.4

 

 

$

77.10

 

 

 

 

 

 

 

Granted

 

1.1

 

 

 

110.19

 

 

 

 

 

 

 

Exercised

 

(0.5

)

 

 

58.25

 

 

 

 

 

 

 

Cancelled

 

(0.2

)

 

 

91.53

 

 

 

 

 

 

 

Outstanding as of December 31, 2025

 

8.8

 

 

$

81.83

 

 

 

5.6

 

 

$

63.9

 

Exercisable as of December 31, 2025

 

5.9

 

 

$

73.65

 

 

 

4.4

 

 

$

63.2

 
Summary of Information Relating to Options Outstanding and Exercisable

The following table summarizes information relating to options outstanding and exercisable as of December 31, 2025:

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

Weighted

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

Outstanding

 

 

Average

 

 

Average

 

 

Exercisable

 

 

Average

 

Range of

 

as of

 

 

Remaining

 

 

Exercise

 

 

as of

 

 

Exercise

 

Exercise Prices

 

12/31/2025

 

 

Contractual Life

 

 

Price

 

 

12/31/2025

 

 

Price

 

$40.01 - $50.00

 

 

0.2

 

 

 

0.7

 

 

$

48.94

 

 

 

0.2

 

 

$

48.94

 

$50.01 - $60.00

 

 

1.1

 

 

 

2.2

 

 

$

51.25

 

 

 

1.1

 

 

$

51.25

 

$60.01 - $70.00

 

 

0.0

 

 

 

0.0

 

 

$

0.0

 

 

 

0.0

 

 

$

0.0

 

$70.01 - $80.00

 

 

2.1

 

 

 

4.0

 

 

$

75.34

 

 

 

2.1

 

 

$

75.34

 

$80.01 - $90.00

 

 

3.3

 

 

 

6.3

 

 

$

84.30

 

 

 

2.4

 

 

$

84.73

 

$90.01 - $100.00

 

 

0.2

 

 

 

8.1

 

 

$

94.11

 

 

 

0.1

 

 

$

92.53

 

$100.01 - $110.00

 

 

1.0

 

 

 

8.2

 

 

$

100.76

 

 

 

0.0

 

 

$

0.0

 

$110.01 - $120.00

 

 

0.9

 

 

 

9.2

 

 

$

112.06

 

 

 

0.0

 

 

$

0.0

 

 

 

 

8.8

 

 

 

5.6

 

 

$

81.83

 

 

 

5.9

 

 

$

73.65

 
Information Regarding Intrinsic Value of Stock Options Exercised and Stock Compensation Expense Related to Stock Option Awards

The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards:

 

2025

 

 

2024

 

 

2023

 

Intrinsic Value of Stock Options Exercised

$

23.0

 

 

$

134.0

 

 

$

125.5

 

Stock Compensation Expense Related to Stock Option Awards

$

26.9

 

 

$

28.7

 

 

$

26.3

 

Issued Stock Options

 

1.1

 

 

 

1.1

 

 

 

1.0

 

Weighted Average Fair Value of Stock Options issued (per share)

$

32.86

 

 

$

29.90

 

 

$

24.06

 

Fair Value of Stock Options Issued

$

34.9

 

 

$

31.5

 

 

$

24.9

 
Assumptions Used in Valuation of Issued Stock Options

The following table provides a summary of the assumptions used in the valuation of issued stock options:

 

2025

 

 

2024

 

 

2023

 

Risk-free interest rate

 

4.2

%

 

 

4.2

%

 

 

4.0

%

Expected life in years

 

7.0

 

 

 

7.2

 

 

 

7.3

 

Expected volatility

 

22.6

%

 

 

22.3

%

 

 

22.4

%

Dividend yield

 

1.1

%

 

 

1.1

%

 

 

1.3

%
v3.25.4
Accumulated Other Comprehensive Income (Loss) (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Components of Changes in Accumulated Other Comprehensive Income (Loss)

The components of changes in accumulated other comprehensive income (“AOCI”) are as follows:

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

Foreign

 

 

Defined

 

 

 

 

 

Other

 

 

Currency

 

 

Benefit

 

 

Derivative

 

 

Comprehensive

 

 

Adjustments

 

 

Plans

 

 

Agreements

 

 

Income (Loss)

 

Balance December 31, 2022

$

(46.4

)

 

$

1.7

 

 

$

15.4

 

 

$

(29.3

)

Other comprehensive income (loss) before reclassifications

 

8.6

 

 

 

3.9

 

 

 

(4.9

)

 

 

7.6

 

Amounts reclassified to consolidated statement of
   income(a)

 

0.0

 

 

 

0.0

 

 

 

(7.3

)

 

 

(7.3

)

Tax benefit (expense)

 

0.0

 

 

 

(1.0

)

 

 

2.8

 

 

 

1.8

 

Other comprehensive income (loss)

 

8.6

 

 

 

2.9

 

 

 

(9.4

)

 

 

2.1

 

Balance December 31, 2023

$

(37.8

)

 

$

4.6

 

 

$

6.0

 

 

$

(27.2

)

Other comprehensive income (loss) before reclassifications

 

(15.4

)

 

 

(0.2

)

 

 

20.8

 

 

 

5.2

 

Amounts reclassified to consolidated statement of
   income(a)

 

0.0

 

 

 

0.0

 

 

 

(4.0

)

 

 

(4.0

)

Tax benefit (expense)

 

0.0

 

 

 

0.0

 

 

 

(4.9

)

 

 

(4.9

)

Other comprehensive income (loss)

 

(15.4

)

 

 

(0.2

)

 

 

11.9

 

 

 

(3.7

)

Balance December 31, 2024

$

(53.2

)

 

$

4.4

 

 

$

17.9

 

 

$

(30.9

)

Other comprehensive income (loss) before reclassifications

 

21.9

 

 

 

0.6

 

 

 

(10.1

)

 

 

12.4

 

Amounts reclassified to consolidated statement of
   income(a)

 

0.0

 

 

 

0.0

 

 

 

(5.1

)

 

 

(5.1

)

Tax benefit (expense)

 

0.0

 

 

 

(0.2

)

 

 

3.9

 

 

 

3.7

 

Other comprehensive income (loss)

 

21.9

 

 

 

0.4

 

 

 

(11.3

)

 

 

11.0

 

Balance December 31, 2025

$

(31.3

)

 

$

4.8

 

 

$

6.6

 

 

$

(19.9

)
Amounts reclassified to cost of sales, selling, general and administrative expenses, or interest expense.
v3.25.4
Related Party Transactions (Tables)
 12 Months Ended
Dec. 31, 2025
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions

The following summarizes the balances and transactions between the Company and each of Armand and ArmaKleen, in which the Company held a 50% ownership interest.

 

Armand

 

 

ArmaKleen(2)

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

2025

 

 

2024

 

 

2023

 

 

2025

 

 

2024

 

 

2023

 

Purchases by Company

$

13.0

 

 

$

13.7

 

 

$

14.9

 

 

$

0.0

 

 

$

0.0

 

 

$

0.0

 

Sales by Company

$

0.0

 

 

$

0.0

 

 

$

0.0

 

 

$

0.0

 

 

$

0.9

 

 

$

1.4

 

Outstanding Accounts Receivable

$

1.1

 

 

$

0.9

 

 

$

1.6

 

 

$

0.0

 

 

$

0.0

 

 

$

1.4

 

Outstanding Accounts Payable

$

1.2

 

 

$

1.0

 

 

$

0.8

 

 

$

0.0

 

 

$

0.0

 

 

$

0.0

 

Administration & Management Oversight Services(1)

$

2.6

 

 

$

2.3

 

 

$

2.3

 

 

$

0.0

 

 

$

1.6

 

 

$

2.1

 
(1)
Billed by Company and recorded as a reduction of SG&A expenses.
(2)
In October 2024, the Company sold its 50% interest in ArmaKleen to our joint venture partner.
v3.25.4
Segments (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Selected Financial Information Relating To Company's Segments

The following tables present financial information relating to the Company’s segments for each of the three years in the period ended December 31, 2025:

 

 

Year Ended December 31, 2025

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

4,774.8

 

 

$

1,129.4

 

 

$

299.0

 

 

 

-

 

 

$

6,203.2

 

Cost of sales

 

 

2,544.0

 

 

 

625.5

 

 

 

190.4

 

 

 

68.5

 

 

 

3,428.4

 

Gross Profit

 

 

2,230.8

 

 

 

503.9

 

 

 

108.6

 

 

 

(68.5

)

 

 

2,774.8

 

Marketing expenses

 

 

532.7

 

 

 

172.7

 

 

 

3.5

 

 

 

-

 

 

 

708.9

 

Research and Development(2)

 

 

129.1

 

 

 

13.5

 

 

 

3.0

 

 

 

-

 

 

 

145.6

 

Selling, general and administrative expenses

 

 

648.2

 

 

 

201.5

 

 

 

61.5

 

 

 

(68.5

)

 

 

842.7

 

Income from Operations

 

 

920.8

 

 

 

116.2

 

 

 

40.6

 

 

 

-

 

 

 

1,077.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2024

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

4,732.3

 

 

$

1,071.5

 

 

$

303.3

 

 

$

-

 

 

$

6,107.1

 

Cost of sales

 

 

2,450.1

 

 

 

605.5

 

 

 

193.5

 

 

 

67.9

 

 

 

3,317.0

 

Gross Profit

 

 

2,282.2

 

 

 

466.0

 

 

 

109.8

 

 

 

(67.9

)

 

 

2,790.1

 

Marketing expenses

 

 

538.5

 

 

 

156.9

 

 

 

2.7

 

 

 

-

 

 

 

698.1

 

Research and Development(2)

 

 

123.7

 

 

 

12.7

 

 

 

3.3

 

 

 

-

 

 

 

139.7

 

Selling, general and administrative expenses

 

 

607.7

 

 

 

183.6

 

 

 

64.7

 

 

 

(67.9

)

 

 

788.1

 

VMS Trade name and other asset impairments

 

 

327.4

 

 

 

29.7

 

 

 

-

 

 

 

-

 

 

 

357.1

 

Income from Operations

 

 

684.9

 

 

 

83.1

 

 

 

39.1

 

 

 

-

 

 

 

807.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2023

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

4,571.2

 

 

$

975.7

 

 

$

321.0

 

 

 

-

 

 

$

5,867.9

 

Cost of sales

 

 

2,434.0

 

 

 

568.7

 

 

 

216.3

 

 

 

60.4

 

 

 

3,279.4

 

Gross Profit

 

 

2,137.2

 

 

 

407.0

 

 

 

104.7

 

 

 

(60.4

)

 

 

2,588.5

 

Marketing expenses

 

 

509.5

 

 

 

127.7

 

 

 

4.1

 

 

 

-

 

 

 

641.3

 

Research and Development(2)

 

 

107.1

 

 

 

11.1

 

 

 

4.2

 

 

 

-

 

 

 

122.4

 

Selling, general and administrative expenses

 

 

590.9

 

 

 

164.0

 

 

 

72.9

 

 

 

(60.4

)

 

 

767.4

 

Income from Operations

 

 

929.7

 

 

 

104.2

 

 

 

23.5

 

 

 

-

 

 

 

1,057.4

 

 

 

(1)
Reflects the administrative costs of the production planning and logistics functions which are elements of Cost of Sales in the Company’s Consolidated Statements of Income but are allocated to the operating segments in Selling, General and Administrative expenses to determine operating segment income before income taxes.
(2)
All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment.
Schedule of Other Segment Expenses

Other segment expenses for each of the three years in the period ended December 31, 2025 include the following:

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Total Consolidated

 

Depreciation & Amortization

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

$

210.1

 

 

$

25.8

 

 

$

11.5

 

 

$

247.4

 

2024

 

 

199.8

 

 

 

29.1

 

 

 

10.2

 

 

 

239.1

 

2023

 

 

183.9

 

 

 

27.7

 

 

 

13.6

 

 

 

225.2

 

 
Product Line Revenues From External Customers

Product line revenues from external customers for each of the three years ended December 31, 2025, 2024 and 2023 were as follows:

 

 

 

2025

 

 

2024

 

 

2023

 

Household Products

 

$

2,556.9

 

 

$

2,584.3

 

 

$

2,484.1

 

Personal Care Products

 

 

2,217.9

 

 

 

2,148.0

 

 

 

2,087.1

 

Total Consumer Domestic

 

 

4,774.8

 

 

 

4,732.3

 

 

 

4,571.2

 

Total Consumer International

 

 

1,129.4

 

 

 

1,071.5

 

 

 

975.7

 

Total SPD

 

 

299.0

 

 

 

303.3

 

 

 

321.0

 

Total Consolidated Net Sales

 

$

6,203.2

 

 

$

6,107.1

 

 

$

5,867.9

 
v3.25.4
Significant Accounting Policies - Additional Information (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
Segment
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Oct. 31, 2024
Significant Accounting Policies [Line Items]        
Number of reportable segments | Segment 3      
Number of product 3      
Proceed from sale of accounts receivable $ 100.5 $ 105.9 $ 144.2  
Adjustments to reflect inventory at net realizable value 33.5 45.2    
Sec 174 R&D Capitalization 145.6 139.7 $ 122.4  
Operating lease, right of use assets 166.0 182.3    
Operating lease, liability 176.9 200.9    
Property, Plant and Equipment, Net 822.8 [1] 931.7    
Deferred Income Taxes 886.9 669.2    
Retained earnings $ 6,768.2 $ 6,319.7    
Minimum        
Significant Accounting Policies [Line Items]        
Intangible assets, estimated useful life (years) 3 years      
Minimum | Building and Building Improvements        
Significant Accounting Policies [Line Items]        
Property, plant and equipment, useful life 9 years      
Minimum | Machinery and Equipment        
Significant Accounting Policies [Line Items]        
Property, plant and equipment, useful life 3 years      
Minimum | Office Equipment        
Significant Accounting Policies [Line Items]        
Property, plant and equipment, useful life 3 years      
Maximum        
Significant Accounting Policies [Line Items]        
Intangible assets, estimated useful life (years) 20 years      
Maximum | Software        
Significant Accounting Policies [Line Items]        
Intangible assets, estimated useful life (years) 10 years      
Maximum | Building and Building Improvements        
Significant Accounting Policies [Line Items]        
Property, plant and equipment, useful life 40 years      
Maximum | Machinery and Equipment        
Significant Accounting Policies [Line Items]        
Property, plant and equipment, useful life 20 years      
Maximum | Office Equipment        
Significant Accounting Policies [Line Items]        
Property, plant and equipment, useful life 10 years      
Armand Products Company        
Significant Accounting Policies [Line Items]        
Percentage of ownership interest 50.00% 50.00% 50.00%  
ArmaKleen Company        
Significant Accounting Policies [Line Items]        
Percentage of ownership interest 50.00% 50.00% 50.00% 50.00%
[1] In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.
v3.25.4
Significant Accounting Policies - Reconciliation of Weighted Average Number of Shares of Common Stock Outstanding (Details) - shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]      
Weighted average shares outstanding - Basic 242,700,000 244,400,000 244,900,000
Dilutive effect of stock options 1,600,000 2,500,000 2,700,000
Weighted average common shares outstanding - diluted 244,300,000 246,900,000 247,600,000
Antidilutive stock options outstanding 2,100,000 1,100,000 2,600,000
v3.25.4
Significant Accounting Policies - Summary of Pre-Tax Expense Associated with Fair value of Unvested Stock Options and Restricted Stock Awards (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock compensation expense $ 26.9 $ 28.7 $ 26.3
Cost of Sales      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock compensation expense 2.8 3.9 3.4
Selling, General and Administrative Expenses      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock compensation expense 54.2 56.2 61.5
Unvested Stock Options Fair Value      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock compensation expense $ 57.0 $ 60.1 $ 64.9
v3.25.4
Significant Accounting Policies - Summary of Adjustments to Balance Sheet due to Adoption of Guidance (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]    
Property, Plant and Equipment, Net $ 822.8 [1] $ 931.7
Other Assets 343.3 378.0
Accounts payable and accrued expenses 1,494.3 1,310.6
Deferred and Other Long-term Liabilities 320.5 332.6
Deferred Income Taxes 886.9 669.2
Retained earnings $ 6,768.2 $ 6,319.7
[1] In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.
v3.25.4
Fair Value Measurements - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Jul. 25, 2017
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior Notes $ 2,205.1 $ 2,204.6  
Carrying Amount      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Cash equivalents 217.5 793.3  
Fair Value | Fair Value, Inputs, Level 1      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Cash equivalents 217.5 793.3  
3.15% Senior notes due August 1, 2027      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Term loan     $ 425.0
3.15% Senior notes due August 1, 2027 | Carrying Amount      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior Notes 424.9 424.9  
3.15% Senior notes due August 1, 2027 | Fair Value | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior notes 420.1 411.1  
2.3% Senior notes due December 15, 2031 | Carrying Amount      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior Notes 399.5 399.4  
2.3% Senior notes due December 15, 2031 | Fair Value | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior notes 355.4 338.9  
5.6% Senior notes due November 15, 2032 | Carrying Amount      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior Notes 499.3 499.2  
5.6% Senior notes due November 15, 2032 | Fair Value | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior notes 532.3 515.3  
3.95% Senior notes due August 1, 2047      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Term loan     $ 400.0
3.95% Senior notes due August 1, 2047 | Carrying Amount      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior Notes 397.9 397.8  
3.95% Senior notes due August 1, 2047 | Fair Value | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior notes 318.4 307.7  
5.0% Senior notes due June 15, 2052 | Carrying Amount      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior Notes 499.9 499.9  
5.0% Senior notes due June 15, 2052 | Fair Value | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Senior notes $ 457.3 $ 451.9  
v3.25.4
Fair Value Measurements - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Parenthetical) (Details)
Dec. 31, 2025
Dec. 31, 2024
Jul. 25, 2017
3.15% Senior notes due August 1, 2027      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 3.15% 3.15% 3.15%
3.15% Senior notes due August 1, 2027 | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 3.15% 3.15%  
2.3% Senior notes due December 15, 2031      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 2.30% 2.30%  
2.3% Senior notes due December 15, 2031 | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 2.30% 2.30%  
5.6% Senior notes due November 15, 2032      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 5.60% 5.60%  
5.6% Senior notes due November 15, 2032 | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 5.60% 5.60%  
3.95% Senior notes due August 1, 2047      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 3.95% 3.95% 3.95%
3.95% Senior notes due August 1, 2047 | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 3.95% 3.95%  
5.0% Senior notes due June 15, 2052 | Fair Value, Inputs, Level 2      
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]      
Interest rate of debt 5.00% 5.00%  
v3.25.4
Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Notional amount $ 25.0    
Increase (decrease) in estimate of contingent consideration liability $ 19.0 $ 0.0 $ 0.0
v3.25.4
Derivative Instruments and Risk Management - Additional Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Face value of unexpired foreign currency contracts $ 440.6  
Notional amount $ 25.0  
Foreign Exchange Contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Face value of unexpired foreign currency contracts   $ 438.2
Designated as Hedging Instrument    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivative hedging agreements covering diesel fuel requirements 83.00%  
Designated as Hedging Instrument | Foreign Exchange Contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Notional amount $ 438.2 $ 317.0
v3.25.4
Derivative Instruments and Risk Management - Schedule of Notional Amounts (Details)
lb in Millions, gal in Millions, $ in Millions
Dec. 31, 2025
USD ($)
gal
lb
Dec. 31, 2024
USD ($)
lb
gal
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount $ 25.0  
Designated as Hedging Instrument | Foreign Exchange Contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount 438.2 $ 317.0
Designated as Hedging Instrument | Net Investment Hedge    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount $ 25.0 $ 0.0
Designated as Hedging Instrument | Diesel Fuel Contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount, Volume | gal 4.5 0.8
Designated as Hedging Instrument | Commodities Contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount, Volume | lb 43.6 0.0
Not Designated as Hedging Instrument | Foreign Exchange Contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount $ 2.4 $ 0.0
Not Designated as Hedging Instrument | Equity Derivatives    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount $ 12.0 $ 24.6
v3.25.4
Components of Inventories (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Inventory, Finished Goods and Work in Process, Net of Reserves [Abstract]    
Raw materials and supplies $ 143.7 $ 140.4
Work in process 35.0 45.4
Finished goods 356.1 427.5
Total $ 534.8 $ 613.3
v3.25.4
Property, Plant and Equipment, Net ("PP&E") - Components of Property, Plant and Equipment (Details) - USD ($)
$ in Millions
Dec. 31, 2025
 [1]
Dec. 31, 2024
Property, Plant and Equipment [Line Items]    
Gross PP&E $ 1,697.0 $ 1,851.8
Less accumulated depreciation and amortization 874.2 920.1
Net PP&E 822.8 931.7
Land    
Property, Plant and Equipment [Line Items]    
Gross PP&E 16.0 29.2
Building and Building Improvements    
Property, Plant and Equipment [Line Items]    
Gross PP&E 367.5 348.2
Machinery and Equipment    
Property, Plant and Equipment [Line Items]    
Gross PP&E 911.1 1,000.4
Software    
Property, Plant and Equipment [Line Items]    
Gross PP&E 138.9 129.6
Office equipment and other assets    
Property, Plant and Equipment [Line Items]    
Gross PP&E 131.6 129.3
Construction in progress    
Property, Plant and Equipment [Line Items]    
Gross PP&E $ 131.9 $ 215.1
[1] In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.
v3.25.4
Property, Plant and Equipment, Net ("PP&E") - Components of Property, Plant and Equipment (Parenthetical) (Details) - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross $ 1,697,000,000 [1] $ 1,851,800,000
Property, Plant and Equipment, Net 822,800,000 [1] $ 931,700,000
Property, Plant and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 223.1  
Property, Plant and Equipment, Net $ 142.9  
[1] In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.
v3.25.4
Property, Plant and Equipment, Net ("PP&E") - Depreciation and Interest Charges on Property, Plant and Equipment (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Abstract]      
Depreciation expense $ 89.7 $ 83.2 $ 72.8
v3.25.4
Acquisitions - Additional Information (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 16, 2025
Jun. 03, 2024
Dec. 24, 2021
May 01, 2019
Dec. 31, 2020
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Jun. 30, 2024
Business Acquisition [Line Items]                    
Net Sales           $ 6,203,200,000 $ 6,107,100,000 $ 5,867,900,000    
Minimum                    
Business Acquisition [Line Items]                    
Business acquisition, period     2 years           2 years  
Average life of the other intangible assets, years     10 years 15 years 10 years          
Graphico Acquisition [Member]                    
Business Acquisition [Line Items]                    
Closing payment of net of cash acquired   $ 19,900,000       19,900,000        
Acquisitions minority shares                   $ 2,000,000
Net Sales               $ 38,000,000    
Average life of the other intangible assets, years   15 years                
Touchland Acquisition [Member]                    
Business Acquisition [Line Items]                    
Closing payment of net of cash acquired $ 656,000,000         656,000,000        
Payment to be made if certain operating performance is achieved           10,200,000        
Additional cash payment 159,000,000         $ 5,000,000        
Net Sales             $ 115,000,000      
Common Stock valued $ 50                  
Percentage of Vesting Shares Acquired 50.00%                  
net cash payment $ 5,000,000                  
v3.25.4
Acquisitions - Summary of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Jul. 16, 2025
Dec. 31, 2024
Dec. 31, 2023
Business Combination [Line Items]        
Goodwill $ 2,627.5   $ 2,433.2 $ 2,431.5
Touchland Acquisition [Member]        
Business Combination [Line Items]        
Accounts receivable 9.3      
Inventory 25.8      
Other current assets 1.3      
Property, plant and equipment 5.5      
Other long-term assets 2.1      
Trade name 730.0      
Customer relationship intangible asset 32.8      
Goodwill 206.5      
Accounts payable, accrued and other liabilities (23.3)      
Business acquisition liabilities - short-term (140.0)      
Deferred income taxes (183.8)      
Deferred and other long-term liabilities (10.2)      
Cash purchase price (net of cash acquired) $ 656.0 $ 656.0    
v3.25.4
Acquisitions - Fair Values of Net Assets Acquired (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Jun. 03, 2024
Dec. 31, 2023
Business Acquisition [Line Items]        
Goodwill $ 2,627.5 $ 2,433.2   $ 2,431.5
Graphico Acquisition [Member]        
Business Acquisition [Line Items]        
Accounts receivable 3.5      
Inventory 11.3      
Other current assets 1.5      
Other long-term assets 5.8      
Customer relationship intangible asset 8.4      
Goodwill 2.8      
Accounts payable, accrued expenses and other liabilities (6.9)      
Long-term debt (4.4)      
Deferred income taxes (2.1)      
Cash purchase price (net of cash acquired) $ 19.9   $ 19.9  
v3.25.4
Divestitures and Business Exits (Additional Information) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 09, 2025
May 01, 2025
Dec. 31, 2025
Dec. 31, 2025
VMS Divestiture [Member]        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Disposal of Property, Plant and Equipment $ 142.9      
Disposal of Inventory 54.0      
Disposal of Goodwill 12.6      
Disposal of other net assets 9.3      
Net cash proceeds $ 160.3      
Percentage of Consolidated Net Sales from Divested Vitamin Business 5.00%      
Pre-tax charge on Divestiture     $ 58.5  
Post-tax charge of Divestiture     $ 45.6  
Spinbrush Divestiture        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Pre-tax loss on Divestiture   $ 21.2    
Disposal Group Including Discontinued Operation Costs Of Goods Sold   12.6    
Disposal Group, Including Discontinued Operation General and Administrative Expense   8.6    
Disposal Group Including Discontinued Operation Revenue       $ 53.6
Flawless Business Exit        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Pre-tax loss on Divestiture   17.6    
Disposal Group Including Discontinued Operation Costs Of Goods Sold   6.0    
Disposal Group, Including Discontinued Operation General and Administrative Expense   11.6    
Disposal Group Including Discontinued Operation Revenue       29.3
Waterpik Showerheads Business Exit        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Pre-tax loss on Divestiture   $ 6.5    
Disposal Group Including Discontinued Operation Revenue       $ 35.5
v3.25.4
Goodwill and Other Intangibles, Net - Summary of Indefinite Lived Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Indefinite-lived Intangible Assets [Line Items]    
Net Carrying Value Trade Names $ 3,511.5 $ 2,888.5
Trade Names    
Indefinite-lived Intangible Assets [Line Items]    
Gross Carrying Value, Trade names 1,680.7 1,960.7
Net Carrying Value Trade Names 1,672.8 1,679.4
VMS Impairment    
Indefinite-lived Intangible Assets [Line Items]    
Impairment 0.0 (281.3)
Spinbrush impairment    
Indefinite-lived Intangible Assets [Line Items]    
Impairment $ (7.9) $ 0.0
v3.25.4
Goodwill and Other Intangibles, Net - Intangible and Fixed Asset Impairment Charges (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2024
USD ($)
Indefinite-Lived Intangible Assets [Line Items]  
Total VMS impairment charges $ 357.1
Trade Names  
Indefinite-Lived Intangible Assets [Line Items]  
Total VMS impairment charges 281.3
Customer Relationship Intangible Asset [Member]  
Indefinite-Lived Intangible Assets [Line Items]  
Total VMS impairment charges 15.8
Property Plant and Equipment [Member]  
Indefinite-Lived Intangible Assets [Line Items]  
Total VMS impairment charges $ 60.0
v3.25.4
Goodwill and Other Intangibles, Net - Additional Information (Details) - USD ($)
 12 Months Ended
Oct. 01, 2025
Oct. 01, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Amortization expense of intangible assets     $ 121,100,000 $ 121,500,000 $ 124,300,000
Estimated amortization expense, 2026     135,000,000    
Impairment charges on assets     10,100,000 12,100,000 8,900,000
Property, Plant and Equipment, Net     $ 822,800,000 [1] 931,700,000  
Impairment, Intangible Asset, Statement of Income or Comprehensive Income [Extensible Enumeration]     Selling, General and Administrative Expense    
Fair value exceeded carrying value 117.00% 135.00%      
Asset impairment charge and other asset write-offs     $ 10,100,000 12,100,000 8,900,000
Net of sales     6,203,200,000 6,107,100,000 $ 5,867,900,000
Flawless spinbrush          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Carrying value of assets     7,900,000    
Net of sales     53,600,000    
Cost of sales     12,600,000    
Selling, general and administrative expenses     8,600,000    
Property Plant and Equipment [Member]          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Property, Plant and Equipment, Net     142.9    
Trade Names          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Impairment charges on assets     $ 281,300,000    
Carrying value of assets $ 644,700,000     $ 0  
Discount on estimated future cashflow     8.25%    
Asset impairment charge and other asset write-offs     $ 281,300,000    
WATERPIK          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Discount on estimated future cashflow 8.00%        
EBITA margins 25.00%        
Maximum          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Estimated amortization expense, 2030     $ 134,000,000    
Amortization period (Years)     20 years    
Sales growth rates     15.20%    
Maximum | Trade Names          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Amortization period (Years)     20 years    
Minimum          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Estimated amortization expense, 2030     $ 120,000,000    
Amortization period (Years)     3 years    
Sales growth rates     2.10%    
Minimum | Trade Names          
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]          
Amortization period (Years)     3 years    
[1] In connection with the VMS divestiture as described in Note 7, the Company divested PP&E with a gross value of $223.1 and a net book value of $142.9 in December of 2025.
v3.25.4
Goodwill and Other Intangibles, Net - Summary of Amortizable Intangible Assets (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 2,917.5 $ 2,233.8
Accumulated Amortization (1,066.5) (1,008.9)
Impairment Charges (12.3) [1] (15.8) [2]
Net $ 1,838.7 1,209.1
Minimum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 3 years  
Maximum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 20 years  
Trade Names    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 2,113.4 1,383.4
Accumulated Amortization (562.1) (479.6)
Impairment Charges (11.6) [1] 0 [2]
Net $ 1,539.7 903.8
Trade Names | Minimum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 3 years  
Trade Names | Maximum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 20 years  
Customer Relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 598.5 644.9
Accumulated Amortization (365.2) (402.1)
Impairment Charges (0.7) [1] (15.8) [2]
Net $ 232.6 227
Customer Relationships | Minimum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 15 years  
Customer Relationships | Maximum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 20 years  
Patents    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 205.6 205.5
Accumulated Amortization (139.2) (127.2)
Impairment Charges 0 [1] 0 [2]
Net $ 66.4 $ 78.3
Patents | Minimum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 4 years  
Patents | Maximum    
Finite-Lived Intangible Assets [Line Items]    
Amortization period (Years) 20 years  
[1] The $12.3 impairment charge relates to the Flawless trade name and Spinbrush customer relationship intangible asset, which had a gross value of $76.2 and accumulated amortization of $63.9 prior to full impairment. The impairments were a result of the Company's decision to exit these businesses (as discussed above).
[2] The $15.8 impairment charge relates to the VMS customer relationship intangible asset, which had a gross value of $79.2 and accumulated amortization of $63.4 prior to full impairment (as discussed above).
v3.25.4
Goodwill and Other Intangibles, Net - Amortizable Intangible Assets (Parenthetical) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]      
Impairment charges on assets $ 10,100,000 $ 12,100,000 $ 8,900,000
Accumulated Amortization 1,066.5 $ 1,008.9  
Flawless trade name and Spinbrush customer relationship [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment charges on assets 12,300,000    
Accumulated Amortization 63,900,000    
Customer relationship intangible asset 76,200,000    
Indefinite-Lived Intangible Assets [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment charges on assets 15,800,000    
Accumulated Amortization 63,400,000    
Customer relationship intangible asset $ 79,200,000    
v3.25.4
Goodwill and Other Intangibles, Net - Summary of Carrying Amount of Goodwill (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Goodwill [Line Items]    
Beginning balance $ 2,433.2 $ 2,431.5
Goodwill acquired during the period 206.5  
Tax related and other 0.4  
Ending balance 2,627.5 2,433.2
Graphico Acquisition [Member]    
Goodwill [Line Items]    
Goodwill acquired during the period   2.8
Ending balance 2.8  
Passport Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale   (1.1)
VMS Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale (12.6)  
Consumer Domestic    
Goodwill [Line Items]    
Beginning balance 2,061.1 2,061.1
Goodwill acquired during the period 206.5  
Tax related and other 0.4  
Ending balance 2,255.4 2,061.1
Consumer Domestic | Graphico Acquisition [Member]    
Goodwill [Line Items]    
Goodwill acquired during the period   0.0
Consumer Domestic | Passport Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale   0.0
Consumer Domestic | VMS Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale (12.6)  
Consumer International    
Goodwill [Line Items]    
Beginning balance 237.2 234.4
Goodwill acquired during the period 0.0  
Tax related and other 0.0  
Ending balance 237.2 237.2
Consumer International | Graphico Acquisition [Member]    
Goodwill [Line Items]    
Goodwill acquired during the period   2.8
Consumer International | Passport Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale   0.0
Consumer International | VMS Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale 0.0  
Specialty Products    
Goodwill [Line Items]    
Beginning balance 134.9 136.0
Goodwill acquired during the period 0.0  
Tax related and other 0.0  
Ending balance 134.9 134.9
Specialty Products | Graphico Acquisition [Member]    
Goodwill [Line Items]    
Goodwill acquired during the period   0.0
Specialty Products | Passport Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale   $ (1.1)
Specialty Products | VMS Divestiture [Member]    
Goodwill [Line Items]    
Written off related to sale $ 0.0  
v3.25.4
Summary of Lease information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]      
Right of use assets $ 166.0 $ 182.3  
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets  
Current lease liabilities $ 23.9 $ 32.4  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued expenses and other liabilities Accrued expenses and other liabilities  
Long-term lease liabilities $ 153.0 $ 168.5  
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Deferred and Other Long-term Liabilities Deferred and Other Long-term Liabilities  
Total lease liabilities $ 176.9 $ 200.9  
Weighted-average remaining lease term (years) 7 years 4 months 24 days 7 years 4 months 24 days  
Weighted-average discount rate 5.20% 4.60%  
Lease cost [1] $ 42.2 $ 40.2 $ 31.7
Leased assets obtained in exchange for new lease liabilities net of modifications [2] 15.4 28.0  
Cash paid for amounts included in the measurement of lease liabilities $ 42.5 $ 35.3  
[1] Lease expense is included in cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The noncash component of lease expense for the twelve months ended December 31, 2025, 2024 and 2023 was $32.7, $30.9 and $24.3, respectively, is included in the amortization caption in the consolidated statement of cash flows.
[2] Leased assets obtained in exchange for new lease liabilities in 2025 consisted of $48.6 of real estate lease additions and $3.7 of equipment lease additions, net of modifications, offset by $36.9 in lease terminations resulting from the sale of the VMS business. The additions include an increase to the Company's right of use asset and corresponding lease liabilities of $31.7 for an agreement between the Company and a third-party warehouse provider for new warehouse space in December 2025. In April 2025, the Company extended the lease term at one of its leased warehouse facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $11.0 recorded in the second quarter of 2025. Leased assets obtained in exchange for new lease liabilities in 2024 consisted of $16.8 of real estate lease additions and $11.2 of equipment lease additions, net of modifications. These additions included expanded space at one of the Company's leased manufacturing facilities. This resulted in an increase to the Company’s right of use assets and corresponding lease liabilities of approximately $15.4 recorded in the first quarter of 2024.
v3.25.4
Summary of Lease information (Parenthetical) (Details) - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]        
Noncash component of lease expense   $ 32.7 $ 30.9 $ 24.3
Real estate lease additions   48.6 16.8  
Equipment lease addition   3.7 11.2  
Increase Decrease In Right Of Use Asset $ 11.0 31.7 $ 15.4  
Lease terminations from the sales   $ 36.9    
v3.25.4
Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Operating Leases    
2026 $ 32.4  
2027 30.7  
2028 26.6  
2029 26.0  
2030 25.9  
2031 and thereafter 73.6  
Total future minimum lease commitments 215.2  
Less: Imputed Interest (38.3)  
Present value of lease liabilities $ 176.9 $ 200.9
v3.25.4
Accounts Payable, Accrued and Other Liabilities (Additional Information) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]      
Supply Chain Finance Program Outstanding Obligations $ 84.7 $ 98.5  
Supply Chain Financing payments included in operating activities within the Company's Consolidated Statements of Cash Flows $ 409.3 $ 388.7 $ 387.1
v3.25.4
Accounts Payable, Accrued and Other Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Accounts Payable and Accrued Liabilities, Current [Abstract]    
Accounts payable $ 732.4 $ 705.1
Accrued marketing and promotion costs 221.4 259.6
Accrued wages and related benefit costs 145.7 151.4
Other accrued current liabilities 394.8 194.5
Total $ 1,494.3 $ 1,310.6
v3.25.4
Summary of Long-Term Debt (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Jul. 25, 2017
Short-term borrowings        
Commercial paper issuances $ 0.0      
Long-term debt        
Debt issuance costs, net (16.4) $ (16.6)    
Total long-term debt 2,205.1 2,204.6    
Net long-term debt 2,205.1 2,204.6    
3.15% Senior notes due August 1, 2027        
Long-term debt        
Underwritten public offering senior notes 425.0 425.0    
Less: Discount (0.1) (0.1)    
Term loan       $ 425.0
2.3% Senior notes due December 15, 2031        
Long-term debt        
Underwritten public offering senior notes 400.0 400.0    
Less: Discount (0.5) (0.6)    
5.6% Senior notes due November 15, 2032        
Long-term debt        
Underwritten public offering senior notes 500.0 500.0    
Less: Discount (0.7) (0.8)    
3.95% Senior notes due August 1, 2047        
Long-term debt        
Underwritten public offering senior notes 400.0 400.0    
Less: Discount (2.1) (2.2)    
Term loan       $ 400.0
5.00% Senior notes due June 15, 2052        
Long-term debt        
Underwritten public offering senior notes 500.0 500.0    
Less: Discount $ (0.1) $ (0.1)    
Term loan     $ 500.0  
v3.25.4
Summary of Long-Term Debt (Parenthetical) (Details)
 12 Months Ended
Jul. 25, 2017
Dec. 31, 2025
Dec. 31, 2024
3.15% Senior notes due August 1, 2027      
Debt Instrument [Line Items]      
Interest rate of debt 3.15% 3.15% 3.15%
Maturity date of debt Aug. 01, 2027 Aug. 01, 2027 Aug. 01, 2027
2.3% Senior notes due December 15, 2031      
Debt Instrument [Line Items]      
Interest rate of debt   2.30% 2.30%
Maturity date of debt   Dec. 15, 2031 Dec. 15, 2031
5.6% Senior notes due November 15, 2032      
Debt Instrument [Line Items]      
Interest rate of debt   5.60% 5.60%
Maturity date of debt   Nov. 15, 2032 Nov. 15, 2032
3.95% Senior notes due August 1, 2047      
Debt Instrument [Line Items]      
Interest rate of debt 3.95% 3.95% 3.95%
Maturity date of debt Aug. 01, 2047 Aug. 01, 2047 Aug. 01, 2047
5.0% Senior notes due June 15, 2052      
Debt Instrument [Line Items]      
Interest rate of debt   5.00% 5.00%
Maturity date of debt   Jun. 15, 2052 Jun. 15, 2052
v3.25.4
Long-Term Debt - Additional Information (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Jul. 17, 2025
Oct. 01, 2022
Aug. 31, 2022
Jun. 02, 2022
Jul. 25, 2017
Jul. 25, 2017
Jul. 31, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 15, 2031
Oct. 31, 2022
Aug. 01, 2022
Debt Instrument [Line Items]                          
Repayments of long-term debt               $ 0.0 $ (204.6) $ (200.0)      
Commercial paper issuances               0.0          
Aggregate commitments               $ 361.4          
3.15% Senior notes due August 1, 2027                          
Debt Instrument [Line Items]                          
Maturity date of debt           Aug. 01, 2027   Aug. 01, 2027 Aug. 01, 2027        
Debt instrument, variable interest rate           3.15%              
Term loan         $ 425.0 $ 425.0              
Interest rate of debt         3.15% 3.15%   3.15% 3.15%        
3.95% Senior notes due August 1, 2047                          
Debt Instrument [Line Items]                          
Maturity date of debt           Aug. 01, 2047   Aug. 01, 2047 Aug. 01, 2047        
Term loan         $ 400.0 $ 400.0              
Interest rate of debt         3.95% 3.95%   3.95% 3.95%        
5.00% Senior notes due June 15, 2052                          
Debt Instrument [Line Items]                          
Maturity date of debt       Jun. 15, 2052                  
Term loan                   $ 500.0      
Interest rate of debt   2.875%               5.00%     2.45%
Repayments of long-term debt   $ (400.0)         $ (300.0)            
5.6% Senior Notes due November 15, 2032                          
Debt Instrument [Line Items]                          
Maturity date of debt     Nov. 15, 2032                    
Term loan                       $ 500.0  
Interest rate of debt                       5.60%  
2.3% Senior Notes                          
Debt Instrument [Line Items]                          
Maturity date of debt               Dec. 15, 2031          
2.3% Senior Notes | TheraBreath                          
Debt Instrument [Line Items]                          
Proceeds from long term borrowing         $ 400.0                
Interest rate of debt         2.30% 2.30%              
2.3% Senior Notes | Floating Rate Senior Notes due 2031 | TheraBreath                          
Debt Instrument [Line Items]                          
Interest rate of debt                     2.30%    
Commercial Paper                          
Debt Instrument [Line Items]                          
Maximum borrowing capacity               $ 0.0          
Amount borrowed under unsecured revolving credit facility               $ 1,993.0          
Notes maximum maturity days               397 days          
New Unsecured Revolving Credit Facility                          
Debt Instrument [Line Items]                          
Maximum borrowing capacity               $ 0.0          
Maturity date of debt Jul. 17, 2030                        
Other Commitment $ 2,750.0                        
Credit agreement (1,500.0)                        
Aggregate commitments $ 2,000.0                        
v3.25.4
Components of Income Before Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Domestic $ 876.6 $ 666.5 $ 872.4
Foreign 80.3 89.8 95.0
Income before Income Taxes $ 956.9 $ 756.3 $ 967.4
v3.25.4
Schedule of U.S. Federal, State and Foreign Income Taxes (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
U.S. federal $ 129.5 $ 180.9 $ 159.1
State, Current 31.7 45.2 40.9
Foreign, Current 22.9 26.9 25.6
Current income tax expense (benefit) 184.1 253.0 225.6
U.S. federal, Deferred 44.3 (64.5) (11.3)
State, Deferred (9.7) (15.7) (2.8)
Foreign, Deferred 1.4 (1.8) 0.3
Deferred income tax expense (benefit) 36.0 (82.0) (13.8)
Total provision $ 220.1 $ 171.0 $ 211.8
v3.25.4
Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Accounts receivable $ 7.2 $ 7.4
Deferred compensation 55.8 51.7
Pension, postretirement and postemployment benefits 4.8 2.9
Inventory reserve 7.7 8.6
Sec 174 R&D capitalization 13.4 59.4
ASC 842 lease liabilities 32.9 0.0
Tax credit carryforwards/other tax attributes 9.1 5.1
International operating loss carryforwards 8.9 8.4
Other 18.1 8.8
Total gross deferred tax assets 157.9 152.3
Valuation allowances (17.1) (14.3)
Total deferred tax assets 140.8 138.0
Deferred tax liabilities:    
Goodwill (311.0) (298.7)
Trade names and other intangibles (579.2) (415.0)
Property, plant and equipment (96.2) (85.2)
ASC 842 Right of Use assets (30.4) 0.0
Interest rate swaps (3.2) (3.7)
Total deferred tax liabilities (1,020.0) (802.6)
Net deferred tax liability (879.2) (664.6)
Long term net deferred tax asset 7.7 4.6
Long term net deferred tax liability $ (886.9) $ (669.2)
v3.25.4
Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Effective Income Tax Rate Reconciliation [Line Items]      
U.S. Federal Statutory Tax Rate 21.00% 21.00% 21.00%
State and Local Income Taxes, Net of Federal Income Tax effect [1] 1.80%    
Foreign Tax Effects 0.90%    
Effect of Cross-Border Tax Laws (0.30%)    
Tax Credits (0.60%)    
Changes in Valuation in Valuation Allowances 0.30%    
Nontaxable or Nondeductible Items 0.50%    
Changes in Unrecognized Tax Benefits 0.10%    
Other Adjustments (0.70%)    
Tax that would result from use of the federal statutory rate $ 200.9 $ 158.8 $ 203.1
State and local income tax, net of federal effect 17.4 [1] 23.3 30.1
Varying tax rates of foreign affiliates 8.2 6.9 6.8
Effect of Cross-Border Tax Laws (3.1)    
Tax Credits (6.2)    
Changes in Valuation in Valuation Allowances 3.2 2.1 0.0
Nontaxable or Nondeductible Items 5.2    
Changes in Unrecognized Tax Benefits 1.0    
Stock Options Exercised   (23.0) (21.8)
Reserve for Uncertain Tax Position   0.3 (0.3)
Other Adjustments (6.5) 2.6 (6.1)
Total provision 220.1 $ 171.0 $ 211.8
Effective Tax Rate, Amount $ 220.1    
Effective tax rate 23.00% 22.60% 21.90%
ASC 842 Right of Use Assets      
Effective Income Tax Rate Reconciliation [Line Items]      
Other Adjustments 2.80%    
Other Adjustments $ 26.5    
ASC 842 Lease Liabilities      
Effective Income Tax Rate Reconciliation [Line Items]      
Other Adjustments (3.00%)    
Other Adjustments $ (28.6)    
Other      
Effective Income Tax Rate Reconciliation [Line Items]      
Other Adjustments (0.50%)    
Other Adjustments $ (4.4)    
[1] State taxes in Florida, Illinois, New Jersey, New York, and Texas made up of the majority (greater than 50%) of the tax effect in this category.
v3.25.4
Income Taxes - Additional Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Aug. 16, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax [Line Items]        
Loss carryforward   $ 8.1 $ 8.3  
Valuation allowance   8.1 8.3  
Deferred tax assets, valuation allowances   17.1 14.3  
Decrease in unrecognized tax benefits is reasonably possible   0.5    
Uncertain tax positions that would affect the effective tax rate   9.1 4.5 $ 4.2
Uncertain tax positions that would result in adjustments to deferred taxes   1.7 0.9 0.9
Interest expense associated with uncertain tax positions   0.5 0.4 0.3
Unrecognized tax benefits, accrued interest expense   2.0 1.3 $ 0.9
Corporate Minimum Tax 15.00%      
Excise tax on stock buybacks 1.00%      
Quimica Geral Do Nordeste Sa        
Income Tax [Line Items]        
Deferred tax assets, valuation allowances   0.6 0.7  
Foreign Country Member | Unrealized Foreign Tax Credit Carryforwards        
Income Tax [Line Items]        
Deferred tax assets, valuation allowances   8.4 5.2  
Deferred Tax Assets, Tax Credit Carryforwards, Foreign   $ 9.3 $ 5.2  
v3.25.4
Income Taxes - Summary of Income Tax Paid (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
Effective Income Tax Rate Reconciliation [Line Items]  
Federal $ 119.0
State 40.6
Foreign 28.5
Total Income Tax Paid $ 188.1
Federal, Percent 63.20%
State, Percent 21.60%
Foreign, Percent 15.20%
Total Income Tax Paid, Percent 100.00%
v3.25.4
Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Unrecognized tax benefits at January 1 $ 5.4 $ 5.1 $ 5.8
Gross increases - tax positions in current period 6.1 0.9 0.0
Lapse of statute of limitations (0.7) (0.6) (0.7)
Unrecognized tax benefits at December 31 $ 10.8 $ 5.4 $ 5.1
v3.25.4
Stock Based Compensation Plans and Other Benefit Plans - Additional Information (Details) - USD ($)
 12 Months Ended
Jan. 01, 2024
Oct. 01, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Non-cash compensation expense     $ 58,000,000 $ 59,200,000 $ 63,600,000  
Common stock restricted shares     293,709,982 293,709,982    
Common Stock Value     $ 293,700,000 $ 293,700,000    
Percentage of incentive bonus contribution     85.00%      
Touchland Acquisition [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Restricted shares, stock compensation expense     $ 11,500,000      
Deferred Compensation Plans            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Stock compensation, liability     134,900,000 135,800,000    
Amounts charged to earnings     2,800,000 $ 2,000,000 3,700,000  
Shares held in rabbi trust       92,000    
Deferred Compensation Plans | Other Assets            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Funded balances     $ 120,900,000 $ 127,200,000    
Deferred Compensation Plans | Management            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Percentage of compensation contribution 70.00%   85.00%      
Deferred Compensation Plans | Director            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Percentage of compensation contribution       100.00%    
Exercise Options Granted Between Two Thousand Seven Through Two Thousand Seventeen Within Three Year From Date Of Termination            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Minimum required participant age and years of service           65 years
Common Stock | Touchland Acquisition [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Value of shares transferred in acquisition     $ 50,000,000      
Percenatge of shares required to reissued     50.00%      
Employee Stock Option            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Stock exercise period, years     10 years      
Vesting period     3 years      
Minimum service period, years     5 years      
Minimum required participant age with five years of service     55 years      
Compensation cost not yet recognized     $ 22,600,000      
Period of amortization expected to be recognized     3 years      
Non-cash compensation expense     $ 26,900,000 $ 28,700,000 26,300,000  
Restricted Stock Units (RSUs) [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Compensation cost not yet recognized     15,200,000 12,400,000    
Restricted shares, stock compensation expense       900,000 1,300,000  
Stock compensation, liability     $ 3,400,000 $ 4,400,000    
RSU awarded to employees     145,550 121,050    
Weighted average grant fair value     $ 104.72 $ 102.4    
Restricted Stock Units (RSUs) [Member] | Hero Aquisition [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Vesting period   3 years        
Restricted shares, stock compensation expense     $ 5,800,000 $ 20,300,000 $ 29,200,000  
RSU awarded to employees   854,882        
RSU awarded total fair value   $ 61,500,000        
Acquisition of vested shares     854,882      
Performance Stock Units (PSUs) [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock restricted shares     18,140 19,960 19,650  
Weighted average grant fair value     $ 136.76 $ 122.24 $ 110.95  
Performance Stock Units (PSUs) [Member] | Maximum [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Performance Stock Issued Range     200.00%      
Performance Stock Units (PSUs) [Member] | Minimum [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Performance Stock Issued Range     0.00%      
Employee Stock Purchase Plan [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Shares Reserved For ESPP     750,000      
Maximum Value Purchased Under ESPP     $ 25,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent     85.00%      
Employee Stock Purchase Plan [Member] | Minimum [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Shares Reserved For ESPP     660,582      
v3.25.4
Stock Based Compensation Plans and Other Benefit Plans - Summary of Option Activity (Details)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Beginning Balance, Options | shares 8.4
Granted, Options | shares 1.1
Exercised, Options | shares (0.5)
Cancelled, Options | shares (0.2)
Ending Balance, Options | shares 8.8
Exercisable as of December 31, 2025, Options | shares 5.9
Beginning Balance, Weighted-Average Exercise Price | $ / shares $ 77.1
Granted, Weighted-Average Exercise Price | $ / shares 110.19
Exercised, Weighted-Average Exercise Price | $ / shares 58.25
Cancelled, Weighted-Average Exercise Price | $ / shares 91.53
Ending Balance, Weighted-Average Exercise Price | $ / shares 81.83
Exercisable as of December 31, 2025, Weighted-Average Exercise Price | $ / shares $ 73.65
Outstanding as of December 31, 2025, Weighted-Average Remaining Contractual Term, years 5 years 7 months 6 days
Exercisable as of December 31, 2025, Weighted-Average Remaining Contractual Term, years 4 years 4 months 24 days
Outstanding as of December 31, 2025, Aggregate Intrinsic Value | $ $ 63.9
Exercisable as of December 31, 2025, Aggregate Intrinsic Value | $ $ 63.2
v3.25.4
Stock Based Compensation Plans and Other Benefit Plans - Summary of Information Relating to Options Outstanding and Exercisable (Details) - $ / shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Outstanding as of 12/31/2025 8,800,000  
Weighted Average Remaining Contractual Life 5 years 7 months 6 days  
Options Outstanding Weighted-Average Exercise Price $ 81.83 $ 77.1
Exercisable as of 12/31/2025 5,900,000  
Options Exercisable Weighted-Average Exercise Price $ 73.65  
$40.01 - $50.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 40.01  
Range of Exercise Prices, Upper Limit $ 50  
Outstanding as of 12/31/2025 200,000  
Weighted Average Remaining Contractual Life 8 months 12 days  
Options Outstanding Weighted-Average Exercise Price $ 48.94  
Exercisable as of 12/31/2025 200,000  
Options Exercisable Weighted-Average Exercise Price $ 48.94  
50.01 - $60.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 50.01  
Range of Exercise Prices, Upper Limit $ 60  
Outstanding as of 12/31/2025 1,100,000  
Weighted Average Remaining Contractual Life 2 years 2 months 12 days  
Options Outstanding Weighted-Average Exercise Price $ 51.25  
Exercisable as of 12/31/2025 1,100,000  
Options Exercisable Weighted-Average Exercise Price $ 51.25  
$60.01 - $70.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 60.01  
Range of Exercise Prices, Upper Limit $ 70  
Outstanding as of 12/31/2025 0  
Weighted Average Remaining Contractual Life 0 years  
Options Outstanding Weighted-Average Exercise Price $ 0  
Exercisable as of 12/31/2025 0  
Options Exercisable Weighted-Average Exercise Price $ 0  
$70.01 - $80.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 70.01  
Range of Exercise Prices, Upper Limit $ 80  
Outstanding as of 12/31/2025 2.1  
Weighted Average Remaining Contractual Life 4 years  
Options Outstanding Weighted-Average Exercise Price $ 75.34  
Exercisable as of 12/31/2025 2.1  
Options Exercisable Weighted-Average Exercise Price $ 75.34  
$80.01 - $90.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 80.01  
Range of Exercise Prices, Upper Limit $ 90  
Outstanding as of 12/31/2025 3.3  
Weighted Average Remaining Contractual Life 6 years 3 months 18 days  
Options Outstanding Weighted-Average Exercise Price $ 84.3  
Exercisable as of 12/31/2025 2.4  
Options Exercisable Weighted-Average Exercise Price $ 84.73  
$90.01 - $100.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 90.01  
Range of Exercise Prices, Upper Limit $ 100  
Outstanding as of 12/31/2025 0.2  
Weighted Average Remaining Contractual Life 8 years 1 month 6 days  
Options Outstanding Weighted-Average Exercise Price $ 94.11  
Exercisable as of 12/31/2025 0.1  
Options Exercisable Weighted-Average Exercise Price $ 92.53  
$100.01 - $110.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 100.01  
Range of Exercise Prices, Upper Limit $ 110  
Outstanding as of 12/31/2025 1  
Weighted Average Remaining Contractual Life 8 years 2 months 12 days  
Options Outstanding Weighted-Average Exercise Price $ 100.76  
Exercisable as of 12/31/2025 0  
Options Exercisable Weighted-Average Exercise Price $ 0  
$110.01 - $120.00    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Range of Exercise Prices, Lower Limit 110.01  
Range of Exercise Prices, Upper Limit $ 120  
Outstanding as of 12/31/2025 0.9  
Weighted Average Remaining Contractual Life 9 years 2 months 12 days  
Options Outstanding Weighted-Average Exercise Price $ 112.06  
Exercisable as of 12/31/2025 0  
Options Exercisable Weighted-Average Exercise Price $ 0  
v3.25.4
Stock Based Compensation Plans and Other Benefit Plans - Schedule of Share Based Compensation Stock Options (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]      
Intrinsic Value of Stock Options Exercised $ 23.0 $ 134.0 $ 125.5
Stock Compensation Expense Related to Stock Option Awards $ 26.9 $ 28.7 $ 26.3
Issued Stock Options 1.1 1.1 1.0
Weighted Average Fair Value of Stock Options issued (per share) $ 32.86 $ 29.9 $ 24.06
Fair Value of Stock Options Issued $ 34.9 $ 31.5 $ 24.9
v3.25.4
Stock Based Compensation Plans and Other Benefit Plans - Assumptions Used in Valuation of Issued Stock Options (Details)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]      
Risk-free interest rate 4.20% 4.20% 4.00%
Expected life in years 7 years 7 years 2 months 12 days 7 years 3 months 18 days
Expected volatility 22.60% 22.30% 22.40%
Dividend yield 1.10% 1.10% 1.30%
v3.25.4
Share Repurchases - Additional Information (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 1 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2025
May 31, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Oct. 28, 2021
Accelerated Share Repurchases [Line Items]              
Open market share repurchase     3.2 3.6      
Open market share repurchase amount     $ 300.0 $ 300.0      
Payment for share repurchase       $ 900.0 $ 0.0 $ 300.1  
Stock repurchase program remaining authorized repurchase amount             $ 1,000.0
Shares Issued Price Per Share     $ 92.81 $ 83.59      
Commercial Bank              
Accelerated Share Repurchases [Line Items]              
Stock repurchase program remaining authorized repurchase amount       $ 228.9      
Evergreen Program              
Accelerated Share Repurchases [Line Items]              
Stock repurchase program, authorized amount     $ 170.0        
Repurchase Program              
Accelerated Share Repurchases [Line Items]              
Stock repurchase program, authorized amount     $ 130.0 $ 3.6      
Payment for share repurchase   $ 300.0          
Stock repurchased during period, shares 0.3 2.8   3.1      
Shares Issued Price Per Share $ 95.71            
v3.25.4
Accumulated Other Comprehensive Income (Loss) - Components of Changes in Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income Loss [Line Items]      
Begining Balance $ (30.9) $ (27.2) $ (29.3)
Other comprehensive income (loss) before reclassifications 12.4 5.2 7.6
Amounts reclassified to consolidated statement of income [1] (5.1) (4.0) (7.3)
Tax benefit (expense) 3.7 (4.9) 1.8
Other comprehensive income (loss) 11.0 (3.7) 2.1
Ending Balance (19.9) (30.9) (27.2)
Foreign Currency Adjustments      
Accumulated Other Comprehensive Income Loss [Line Items]      
Begining Balance (53.2) (37.8) (46.4)
Other comprehensive income (loss) before reclassifications 21.9 (15.4) 8.6
Amounts reclassified to consolidated statement of income [1] 0.0 0.0 0.0
Tax benefit (expense) 0.0 0.0 0.0
Other comprehensive income (loss) 21.9 (15.4) 8.6
Ending Balance (31.3) (53.2) (37.8)
Defined Benefit Plans      
Accumulated Other Comprehensive Income Loss [Line Items]      
Begining Balance 4.4 4.6 1.7
Other comprehensive income (loss) before reclassifications 0.6 (0.2) 3.9
Amounts reclassified to consolidated statement of income [1] 0.0 0.0 0.0
Tax benefit (expense) (0.2) 0.0 (1.0)
Other comprehensive income (loss) 0.4 (0.2) 2.9
Ending Balance 4.8 4.4 4.6
Derivative Agreements      
Accumulated Other Comprehensive Income Loss [Line Items]      
Begining Balance 17.9 6.0 15.4
Other comprehensive income (loss) before reclassifications (10.1) 20.8 (4.9)
Amounts reclassified to consolidated statement of income [1] (5.1) (4.0) (7.3)
Tax benefit (expense) 3.9 (4.9) 2.8
Other comprehensive income (loss) (11.3) 11.9 (9.4)
Ending Balance $ 6.6 $ 17.9 $ 6.0
[1] Amounts reclassified to cost of sales, selling, general and administrative expenses, or interest expense.
v3.25.4
Commitments, Contingencies and Guarantees - Additional Information (Details)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 16, 2025
USD ($)
Oct. 13, 2022
USD ($)
Dec. 24, 2021
Dec. 24, 2021
USD ($)
Dec. 01, 2020
USD ($)
Jan. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Tons
Dec. 31, 2021
Jan. 31, 2024
USD ($)
Commitments And Contingencies Disclosure [Line Items]                    
Annual purchase commitment, in tons | Tons               240,000    
Commitments               $ 361.4    
Outstanding guarantees and letters of credit               9.1    
First installment payable                   $ 2.0
Business acquisition additional cash payable second installment             $ 5.9      
Business acquisition liability               159.0    
Zicam Acquisition                    
Commitments And Contingencies Disclosure [Line Items]                    
Additional cash payment   $ 8.0     $ 20.0          
TheraBreath Acquisition                    
Commitments And Contingencies Disclosure [Line Items]                    
Additional cash payment       $ 14.0            
TheraBreath Acquisition | Subsequent Event [Member]                    
Commitments And Contingencies Disclosure [Line Items]                    
Business acquisition remaining cash payable installment           $ 5.0        
Hero Aquisition [Member]                    
Commitments And Contingencies Disclosure [Line Items]                    
Business acquisition, period   5 years                
Touchland Acquisition [Member]                    
Commitments And Contingencies Disclosure [Line Items]                    
Additional cash payment $ 159.0             $ 5.0    
Business Acquisition Liabilities $ 140.0                  
Maximum | TheraBreath Acquisition                    
Commitments And Contingencies Disclosure [Line Items]                    
Business acquisition, period       4 years            
Minimum                    
Commitments And Contingencies Disclosure [Line Items]                    
Business acquisition, period     2 years           2 years  
Minimum | TheraBreath Acquisition                    
Commitments And Contingencies Disclosure [Line Items]                    
Business acquisition, period       2 years            
v3.25.4
Related Party Transactions - Additional Information (Details)
Dec. 31, 2025
Dec. 31, 2024
Oct. 31, 2024
Dec. 31, 2023
Armand Products Company        
Related Party Transaction [Line Items]        
Percentage of ownership interest 50.00% 50.00%   50.00%
ArmaKleen Company        
Related Party Transaction [Line Items]        
Percentage of ownership interest 50.00% 50.00% 50.00% 50.00%
v3.25.4
Related Party Transactions - Balance and Transactions Between Company and Related Party (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Armand Products Company      
Related Party Transaction [Line Items]      
Purchases by Company $ 13.0 $ 13.7 $ 14.9
Sales By Company 0.0 0.0 0.0
Outstanding Accounts Receivable 1.1 0.9 1.6
Outstanding Accounts Payable 1.2 1.0 0.8
Administration & Management Oversight Services [1] 2.6 2.3 2.3
ArmaKleen Company      
Related Party Transaction [Line Items]      
Purchases by Company [2] 0.0 0.0 0.0
Sales By Company [2] 0.0 0.9 1.4
Outstanding Accounts Receivable [2] 0.0 0.0 1.4
Outstanding Accounts Payable [2] 0.0 0.0 0.0
Administration & Management Oversight Services [1],[2] $ 0.0 $ 1.6 $ 2.1
[1] Billed by Company and recorded as a reduction of SG&A expenses.
[2] In October 2024, the Company sold its 50% interest in ArmaKleen to our joint venture partner.
v3.25.4
Segments - Additional Information (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2025
USD ($)
Segment
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Oct. 31, 2024
Segment Reporting Information [Line Items]        
Number of reportable segments | Segment 3      
Equity in earnings of affiliates $ 7.9 $ 9.1 $ 8.7  
Geographic Concentration Risk | Sales Revenue, Goods, Net | Major Customer        
Segment Reporting Information [Line Items]        
Concentration risk, percentage 5.00%      
Geographic Concentration Risk | Long Lived Assets | Major Customer        
Segment Reporting Information [Line Items]        
Concentration risk, percentage 5.00%      
Customer Concentration Risk | Sales Revenue, Goods, Net | Major Customer        
Segment Reporting Information [Line Items]        
Concentration risk, percentage 44.00% 43.00%    
Customer Concentration Risk | Sales Revenue, Goods, Net | Major Customers Group        
Segment Reporting Information [Line Items]        
Concentration risk, percentage     44.00%  
Customer Concentration Risk | Sales Revenue, Goods, Net | Wal-Mart Stores Inc And Affiliates        
Segment Reporting Information [Line Items]        
Concentration risk, percentage 23.00% 23.00% 23.00%  
Customer name Walmart Inc. and its affiliates      
UNITED STATES | Geographic Concentration Risk | Sales Revenue, Goods, Net        
Segment Reporting Information [Line Items]        
Concentration risk, percentage 82.00% 82.00% 83.00%  
UNITED STATES | Geographic Concentration Risk | Long Lived Assets        
Segment Reporting Information [Line Items]        
Concentration risk, percentage 96.00% 96.00% 96.00%  
Armand Products Company        
Segment Reporting Information [Line Items]        
Percentage of ownership interest 50.00% 50.00% 50.00%  
ArmaKleen Company        
Segment Reporting Information [Line Items]        
Percentage of ownership interest 50.00% 50.00% 50.00% 50.00%
Armand Products Company and ArmaKleen Company        
Segment Reporting Information [Line Items]        
Equity in earnings of affiliates $ 7.9 $ 9.1 $ 8.7  
v3.25.4
Segments - Selected Financial Information Relating To Company's Segments (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Net Sales $ 6,203.2 $ 6,107.1 $ 5,867.9
Cost of sales 3,428.4 3,317.0 3,279.4
Gross profit 2,774.8 2,790.1 2,588.5
Marketing Expenses 708.9 698.1 641.3
Research and Development 145.6 139.7 122.4
Selling, General and Administrative Expenses 988.3 927.8 889.8
Total VMS impairment charges   357.1  
Income from Operations 1,077.6 807.1 1,057.4
Depreciation & Amortization 247.4 239.1 225.2
VMS Trade Name [Member]      
Segment Reporting Information [Line Items]      
Total VMS impairment charges 0.0 357.1 0.0
Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 6,203.2 6,107.1 5,867.9
Cost of sales 3,428.4 3,317.0 3,279.4
Gross profit 2,774.8 2,790.1 2,588.5
Marketing Expenses 708.9 698.1 641.3
Research and Development [1] 145.6 139.7 122.4
Selling, General and Administrative Expenses 842.7 788.1 767.4
Income from Operations 1,077.6 807.1 1,057.4
Operating Segments | VMS Trade Name [Member]      
Segment Reporting Information [Line Items]      
Total VMS impairment charges   357.1  
Operating Segments | Consumer Domestic      
Segment Reporting Information [Line Items]      
Net Sales 4,774.8 4,732.3 4,571.2
Cost of sales 2,544.0 2,450.1 2,434.0
Gross profit 2,230.8 2,282.2 2,137.2
Marketing Expenses 532.7 538.5 509.5
Research and Development [1] 129.1 123.7 107.1
Selling, General and Administrative Expenses 648.2 607.7 590.9
Income from Operations 920.8 684.9 929.7
Depreciation & Amortization 210.1 199.8 183.9
Operating Segments | Consumer Domestic | VMS Trade Name [Member]      
Segment Reporting Information [Line Items]      
Total VMS impairment charges   327.4  
Operating Segments | Consumer International      
Segment Reporting Information [Line Items]      
Net Sales 1,129.4 1,071.5 975.7
Cost of sales 625.5 605.5 568.7
Gross profit 503.9 466.0 407.0
Marketing Expenses 172.7 156.9 127.7
Research and Development [1] 13.5 12.7 11.1
Selling, General and Administrative Expenses 201.5 183.6 164.0
Income from Operations 116.2 83.1 104.2
Depreciation & Amortization 25.8 29.1 27.7
Operating Segments | Consumer International | VMS Trade Name [Member]      
Segment Reporting Information [Line Items]      
Total VMS impairment charges   29.7  
Operating Segments | Specialty Products      
Segment Reporting Information [Line Items]      
Net Sales 299.0 303.3 321.0
Cost of sales 190.4 193.5 216.3
Gross profit 108.6 109.8 104.7
Marketing Expenses 3.5 2.7 4.1
Research and Development [1] 3.0 3.3 4.2
Selling, General and Administrative Expenses 61.5 64.7 72.9
Income from Operations 40.6 39.1 23.5
Depreciation & Amortization 11.5 10.2 13.6
Operating Segments | Specialty Products | VMS Trade Name [Member]      
Segment Reporting Information [Line Items]      
Total VMS impairment charges   0.0  
Operating Segments | Consolidating Reclassification      
Segment Reporting Information [Line Items]      
Net Sales [2] 0.0 0.0 0.0
Cost of sales [2] 68.5 67.9 60.4
Gross profit [2] (68.5) (67.9) (60.4)
Marketing Expenses [2] 0.0 0.0 0.0
Research and Development [1],[2] 0.0 0.0 0.0
Selling, General and Administrative Expenses [2] (68.5) (67.9) (60.4)
Income from Operations [2] $ 0.0 0.0 $ 0.0
Operating Segments | Consolidating Reclassification | VMS Trade Name [Member]      
Segment Reporting Information [Line Items]      
Total VMS impairment charges [2]   $ 0.0  
[1] All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment.
[2] Reflects the administrative costs of the production planning and logistics functions which are elements of Cost of Sales in the Company’s Consolidated Statements of Income but are allocated to the operating segments in Selling, General and Administrative expenses to determine operating segment income before income taxes
v3.25.4
Segments - Product Line Revenues from External Customers (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Net Sales $ 6,203.2 $ 6,107.1 $ 5,867.9
Operating Segments      
Segment Reporting Information [Line Items]      
Net Sales 6,203.2 6,107.1 5,867.9
Operating Segments | Consumer Domestic      
Segment Reporting Information [Line Items]      
Net Sales 4,774.8 4,732.3 4,571.2
Operating Segments | Consumer Domestic | Household Products      
Segment Reporting Information [Line Items]      
Net Sales 2,556.9 2,584.3 2,484.1
Operating Segments | Consumer Domestic | Personal Care Products      
Segment Reporting Information [Line Items]      
Net Sales 2,217.9 2,148.0 2,087.1
Operating Segments | Consumer International      
Segment Reporting Information [Line Items]      
Net Sales 1,129.4 1,071.5 975.7
Operating Segments | Specialty Products      
Segment Reporting Information [Line Items]      
Net Sales $ 299.0 $ 303.3 $ 321.0
v3.25.4
SCHEDULE II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Allowance for Doubtful Accounts      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Beginning Balance $ 5.1 $ 7.3 $ 3.5
Additions, Charged to Expenses 0.6 0.1 4.0
Additions, Acquired 0.0 0.0 0.0
Deductions, Amounts Written Off (2.1) (2.2) (0.2)
Divested 0.0 0.0 0.0
Foreign Exchange 0.1 (0.1) 0.0
Ending Balance 3.7 5.1 7.3
Allowance for Cash Discounts      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Beginning Balance 9.2 8.9 6.6
Additions, Charged to Expenses 124.6 120.1 115.1
Additions, Acquired 0.0 0.0 0.0
Deductions, Amounts Written Off (125.4) (119.7) (112.7)
Divested 0.0 0.0 0.0
Foreign Exchange 0.1 (0.1) (0.1)
Ending Balance 8.5 9.2 8.9
Sales Returns and Allowances      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Beginning Balance 25.9 35.0 34.8
Additions, Charged to Expenses 111.8 107.4 128.9
Additions, Acquired 0.0 0.0 0.0
Deductions, Amounts Written Off (111.0) (116.4) (128.7)
Divested 0.0 0.0 0.0
Foreign Exchange 0.1 (0.1) 0.0
Ending Balance 26.8 25.9 35.0
Inventory Reserves      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Beginning Balance 45.2 52.5 46.0
Additions, Charged to Expenses 24.0 26.1 40.5
Additions, Acquired 0.0 0.0 0.0
Deductions, Amounts Written Off (30.7) (32.6) (34.5)
Divested (6.0) 0.0 0.0
Foreign Exchange 1.0 (0.8) 0.5
Ending Balance $ 33.5 $ 45.2 $ 52.5